Home Blog Page 5

Missed MVA and Workplace Injuries Causing Pain Solutions

Missed MVA and Workplace Injuries Causing Pain Solutions
Missed MVA and Workplace Injuries Causing Pain Solutions

Missed MVA and Workplace Injuries Causing Pain

Abstract

Motor vehicle accidents (MVAs) and workplace accidents can cause injuries that are not obvious during the first medical visit. A person may have normal X-rays and still have pain from damaged muscles, ligaments, spinal discs, facet joints, nerves, or other soft tissues. Mild traumatic brain injuries, including concussions, may also occur without obvious findings on routine imaging. Some symptoms develop hours or days later.

This article explains why hidden injuries can be difficult to identify, including spinal ligament micro-tears, annular disc tears, facet joint capsule injuries, myofascial trigger points, and mild concussions. It also explains how a coordinated approach may combine medical evaluation, integrative chiropractic care, rehabilitation, functional medicine, pain management, and selected biological therapies. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within a multidisciplinary model that includes medical oversight from Dr. Maria Guadalupe Cardenas, MD.

Missed MVA and Workplace Injuries Causing Pain Solutions

Why Some Accident Injuries Are Hard to See

After a car crash, fall, lifting injury, or workplace accident, the first goal is usually to rule out emergencies. Doctors may look for fractures, internal bleeding, severe brain injury, spinal cord damage, or other dangerous problems.

This emergency approach is important. However, a normal initial test does not always mean that every tissue is healthy.

Plain X-rays are mainly designed to show bones and their general alignment. They do not provide the same soft-tissue detail as MRI. Therefore, injuries involving muscles, tendons, ligaments, spinal discs, nerves, and joint capsules may require a different type of evaluation when symptoms continue.

The American College of Radiology notes that when ligament, spinal cord, or nerve-root injury is suspected after spinal trauma, MRI may be appropriate even when other imaging has already been performed (American College of Radiology, n.d.).

Several accident-care resources also describe delayed or overlooked symptoms after crashes, especially with whiplash, soft-tissue injuries, back injuries, and concussions (Advantage Healthcare Systems, 2025; Xcell Medical Group, 2026).

The key message is simple: a normal X-ray is useful information, but it does not rule out every possible injury.

Spinal Ligament Micro-Tears

Ligaments are strong bands of tissue that connect bones and help stabilize joints.

During a rear-end collision, side impact, fall, or sudden workplace accident, the spine can move rapidly beyond its normal range. This may stretch or injure the small ligaments that help stabilize the neck and lower back.

A person may develop:

  • Neck or back stiffness
  • Pain with movement
  • Headaches
  • Muscle guarding
  • Reduced range of motion
  • A feeling that the spine is weak or unstable
  • Pain that becomes worse with sitting, lifting, or repetitive work

Whiplash-related soft-tissue injuries may not produce an obvious abnormality on a basic X-ray. Careful history, physical examination, neurological testing, and additional imaging may be needed when symptoms or examination findings justify it (Advantage Healthcare Systems, 2025).

Annular Tears in Spinal Discs

Intervertebral discs sit between the spinal bones. Each disc has a softer center surrounded by a stronger outer ring called the annulus fibrosus.

Sudden twisting, bending, compression, or acceleration-deceleration forces can stress this outer ring. Small separations in the fibers are called annular fissures or annular tears.

Some annular tears cause no symptoms. Others may contribute to back or neck pain, especially when nearby structures become irritated. Annular tears can also exist with disc bulges or herniations (Tenny et al., 2023).

Because discs are soft tissues, plain X-rays cannot directly show an annular tear. When clinically appropriate, MRI can provide much more information about discs, nerves, ligaments, and other soft tissues.

This is one reason persistent pain after a normal X-ray deserves a complete clinical assessment rather than assuming nothing is wrong.

Hidden Facet Joint Capsule Trauma

Facet joints are small joints located at the back of the spine. They guide spinal movement and help control excessive motion.

Each facet joint is surrounded by a capsule made of connective tissue. During whiplash or another sudden injury, the capsule can stretch or become irritated.

Facet-related pain may cause:

  • Local neck or back pain
  • Pain with turning or bending
  • Pain that spreads into the shoulders or upper back
  • Headaches associated with neck movement
  • Muscle tightness around the injured area

Research on whiplash has identified the cervical facet region and its supporting tissues as possible sources of persistent neck pain after trauma.

Because the injury can involve soft tissues rather than a broken bone, it may not be visible on standard X-rays.

Persistent Myofascial Trigger Points

Muscles can also become part of the injury pattern.

After trauma, muscles often tighten to protect an injured joint or spinal segment. Sometimes painful areas develop within these muscles. These areas are commonly called myofascial trigger points.

Trigger points may produce:

  • Deep aching pain
  • Muscle stiffness
  • Referred pain
  • Headaches
  • Shoulder or back discomfort
  • Reduced movement

A study comparing people with whiplash-associated disorders with people who had mechanical neck pain found more active myofascial trigger points in the whiplash group (Castaldo et al., 2014).

This helps explain why a person can have continuing pain even when a basic X-ray does not show a fracture.

Mild Concussions Can Be Difficult to Recognize

A concussion does not always require a direct blow to the head.

The Centers for Disease Control and Prevention explains that mild traumatic brain injury can result from a blow to the head or from a hit to the body that makes the head and brain move rapidly back and forth (Centers for Disease Control and Prevention [CDC], 2025).

Symptoms can include:

  • Headache
  • Dizziness
  • Brain fog
  • Memory problems
  • Trouble concentrating
  • Light or noise sensitivity
  • Sleep changes
  • Nausea
  • Balance problems
  • Irritability

Importantly, concussion is usually a clinical diagnosis. Routine CT or MRI is not required to diagnose most mild concussions. Imaging is generally used when a doctor is concerned about problems such as bleeding or another more serious brain injury (CDC, 2025).

This means that a person can have a real concussion even when structural brain imaging is normal.

Workplace Injuries May Develop Slowly

Not every workplace injury occurs during one dramatic event.

Workers may experience cumulative trauma from:

  • Repetitive lifting
  • Bending and twisting
  • Frequent reaching
  • Computer work
  • Vibrating tools
  • Repeated overhead work
  • Poor lifting mechanics
  • Long periods of standing or sitting

These repeated stresses can gradually affect joints, muscles, tendons, and other tissues.

Workplace injury resources describe sprains, strains, repetitive stress injuries, and cumulative trauma as important causes of work-related pain and disability (Bridgman Gantt Law Offices, 2025; Stern & Cohen, n.d.).

A worker may therefore have a significant physical problem even without one clearly remembered accident.

Finding the Injury Requires More Than One Test

A complete injury evaluation begins with the patient, not the image.

Depending on the situation, the healthcare team may evaluate:

  • How the accident happened
  • Direction and force of impact
  • Location and timing of symptoms
  • Range of motion
  • Muscle strength
  • Reflexes
  • Sensation
  • Balance
  • Gait and posture
  • Joint stability
  • Orthopedic findings
  • Neurological findings
  • Changes in work or daily function

Imaging is then selected according to the clinical findings.

X-ray, CT, and MRI are different tools. No single test can identify every injury.

Integrative Chiropractic Care: Restoring Mechanical Function

Once serious injuries have been ruled out and the diagnosis is better understood, recovery often requires more than simply reducing pain.

Integrative chiropractic care can focus on restoring the way the body moves.

Depending on the diagnosis and patient, care may include:

  • Gentle chiropractic adjustments or mobilization
  • Soft-tissue treatment
  • Range-of-motion exercises
  • Corrective exercise
  • Strengthening
  • Neuromuscular retraining
  • Posture and movement correction
  • Progressive rehabilitation

Clinical guidelines for neck pain recommend a combination of manual therapy, mobility exercises, and strengthening for appropriate patients rather than depending solely on passive treatments (Blanpied et al., 2017).

The goal is not simply to “put a bone back into place.” It is to improve movement, reduce unnecessary mechanical stress, rebuild strength, and help the patient return safely to normal activity.

Combining Mechanical Restoration With Biological Support

An integrative injury model can look at two major parts of recovery:

Mechanical restoration focuses on movement, spinal and joint function, strength, flexibility, and rehabilitation.

Biological support focuses on the injured tissue itself and the physical conditions needed for healing.

Depending on the diagnosis, this broader plan may include rehabilitation, nutrition, sleep support, medical management, image-guided procedures, or selected orthobiologic procedures.

PRP and other biologic approaches are being studied and used for selected musculoskeletal conditions. However, patients should understand that evidence varies greatly by tissue, diagnosis, procedure, and product. Regenerative treatments should not be presented as guaranteed ways to rebuild damaged spinal tissue.

The FDA also warns consumers that many marketed stem-cell, exosome, and other human cell or tissue products have not been approved for orthopedic conditions such as back pain, neck pain, disc disease, tendon problems, or joint pain.

Medical screening and informed decision-making are therefore essential.

Multidisciplinary Injury Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes a clinical model that combines chiropractic care, medical evaluation, functional medicine, personal injury care, rehabilitation, and related services.

In his published clinical observations, Dr. Jimenez reports that patients with traumatic joint and spinal injuries may show changes in posture, gait, muscle control, and spinal movement in addition to pain at the injured site. His approach therefore looks beyond one painful structure and evaluates how the injury affects the larger movement system (Jimenez, 2026). These observations represent his clinical experience and should be distinguished from controlled clinical research.

Clinic materials identify Dr. Maria Guadalupe Cardenas, MD, as a board-certified internal medicine physician, Medical Director, and Collaborative Physician at Injury Medical Clinic PA. The clinic lists her NPI as 1164426749 and Texas medical license as J2933 and describes her as having more than 40 years of experience in internal medicine.

Within this multidisciplinary structure:

  • Dr. Jimenez focuses on chiropractic care, musculoskeletal assessment, functional medicine, personal injury care, and rehabilitation.
  • Dr. Cardenas provides medical direction and collaborative physician oversight within her scope of practice.
  • Rehabilitation helps restore strength, movement, coordination, and work capacity.
  • Functional medicine may examine nutrition, sleep, metabolic health, and other factors that can influence overall recovery.
  • Medical or interventional options can be considered when conservative treatment alone is not enough.

Multidisciplinary pain and injury programs may similarly combine medical treatment, rehabilitation, exercise, and complementary approaches when appropriate for the individual patient.

The Main Lesson: Normal X-Rays Do Not Always End the Investigation

After an MVA or workplace injury, some problems are obvious. Others are not.

Soft-tissue injuries, ligament sprains, annular disc injuries, facet joint irritation, myofascial pain, and mild concussion symptoms may require careful clinical examination and, in selected cases, different imaging or specialist evaluation.

The best approach is not to assume that every person with pain has a hidden injury. It is also not safe to assume that a normal X-ray means all tissues are normal.

A better approach is to connect the accident mechanism, symptoms, examination findings, imaging, and response to treatment.

For appropriate patients, coordinated care can then combine mechanical restoration through chiropractic and rehabilitation with medical oversight and evidence-based biological support. This gives the healthcare team a broader view of both the damaged tissue and the way the whole body is functioning after an accident.

El Paso, TX Cervical Pain Treatment Chiropractic Care

References

American College of Radiology. (n.d.). ACR Appropriateness Criteria: Acute spinal trauma.

Advantage Healthcare Systems. (2025). The hidden soft-tissue injuries most people miss after a car accident.

AlpernSchubert, P.C. (n.d.). What are the most commonly overlooked car accident injuries?.

Blanpied, P. R., Gross, A. R., Elliott, J. M., Devaney, L. L., Clewley, D., Walton, D. M., Sparks, C., & Robertson, E. K. (2017). Neck pain: Revision 2017 clinical practice guidelines. Journal of Orthopaedic & Sports Physical Therapy, 47(7), A1–A83.

Bridgman Gantt Law Offices. (2025). 5 common injuries that lead to a workers’ comp claim.

Castaldo, M., Ge, H.-Y., Chiarotto, A., Villafañe, J. H., & Arendt-Nielsen, L. (2014). Myofascial trigger points in patients with whiplash-associated disorders and mechanical neck pain. Pain Medicine, 15(5), 842–849.

Centers for Disease Control and Prevention. (2025). About mild TBI and concussion.

Edwards & Ragatz, P.A. (2025). 3 commonly misdiagnosed conditions that could put you at risk.

Horwitz, Horwitz & Associates. (2020). Common overlooked workplace injuries to be on the lookout for.

Jimenez, A. (2026). Integrative chiropractic and regenerative medicine in El Paso.

Jimenez, A. (2026). MVA joint trauma: Comprehensive chiropractic approaches.

Jimenez, A. (2026). Regenerative medicine and integrative chiropractic strategies.

Jimenez, A. (2026). How regenerative medicine and chiropractic care work together.

Jimenez, A. (n.d.). Dr. Alex Jimenez: El Paso chiropractor and personal injury care.

Cohn, J. (n.d.). Regenerative orthopedics: PRP, stem cells, and healing from within.

MHK Attorneys. (n.d.). Top 5 personal injury claims that often go undetected.

Morgan & Morgan. (2025). 15 work injuries you may not know about.

Ramos Center. (n.d.). Non-surgical pain management: Eight treatment approaches.

Sherwood Law Group. (n.d.). Personal injury cases that often get overlooked but shouldn’t.

Stern & Cohen. (n.d.). Workplace cumulative trauma and your right to compensation.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

Virtaj Singh, MD. (n.d.). Radiculopathy (pinched nerve).

Xcell Medical Group. (2026). The most overlooked injuries after a crash.

Zlotolow & Associates. (n.d.). Five easily missed injuries common in personal injury cases.

SUD Treatment Methods With Integrative Chiropractic Care

Optimize your recovery journey with SUD treatment combined with integrative chiropractic care, focusing on holistic wellness and support.

Educational Abstract: Integrative Care Transitions and New Frontiers in Substance Use Disorder Treatment – An Evidence-Based, Multidisciplinary Approach in El Paso, Texas

As Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I present an educational post that reframes our original transcript in first person and guides you through a comprehensive, easy-to-read journey into the evolving landscape of substance use disorder (SUD) care. I elaborate on nurse practitioners’ unique role across settings, practical strategies for care transitions, best practices for integrating primary care and specialty treatment, inpatient addiction consult services, and cutting-edge research shaping the field. I explain exactly how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates chiropractic care with medical oversight from Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), alongside functional medicine, personal injury care, rehabilitation, and evidence-based SUD services.

I detail physiological mechanisms underlying SUD, pharmacotherapies, pain modulation, neurobiology of habit and relapse, and integrative protocols. This post highlights modern methods from leading researchers using rigorous, evidence-based practices and showcases actionable frameworks, systems redesign, and real-world cases. My clinical observations from sciatica.clinic and professional notes on LinkedIn inform practical strategies that unify musculoskeletal care, mental health, and addiction medicine to improve outcomes, reduce stigma, and support recovery across care transitions. The content that follows thoroughly details why and how each technique is used, offers step-by-step reasoning, and provides APA-7 style citations and linked references (ASAM, n.d.; SAMHSA, n.d.; NIDA, 2018; Volkow et al., 2016; SAMHSA, 2021; Babor et al., 2007; Carroll & Weiss, 2017; Degenhardt et al., 2018; American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.; JAMA Network, n.d.; Nature, n.d.; Institute for Functional Medicine, n.d.; BMJ, n.d.).

Integrative Substance Use Disorder Care: My Perspective as a Chiropractor and Nurse Practitioner

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over my decades of practice, I’ve seen how substance use disorders disrupt health trajectories, worsen pain, compound metabolic and neuroimmune dysfunction, and destabilize social systems. My goal is to present a patient-centered, scientifically grounded approach that integrates primary care, addiction medicine, functional medicine, and integrative chiropractic care, while ensuring safety and quality through internal medicine oversight.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our model is multidisciplinary—common in both integrative and injury clinics—where an MD provides medical direction alongside chiropractic care. I am honored to work with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. With more than 40 years of experience as an internist, Dr. Cardenas directs diagnostics, medication management, hospital transitions, and complex comorbid care, while I lead integrative chiropractic, functional medicine evaluations, neuromusculoskeletal rehab, and pain modulation strategies. Together, we co-manage patients across levels of care, emphasizing safe transitions, eliminating barriers, and scaling treatment based on the ASAM Levels of Care (ASAM, n.d.).

This educational post reframes our original content in first-person and expands it with integrative care insights: how nurse practitioners drive SUD access, how we design transitions between inpatient, outpatient, and community services, how we use evidence-based pharmacotherapies like buprenorphine and methadone (SAMHSA, 2021), how behavioral and peer supports are co-located and coordinated, how our chiropractic care and rehab reduce pain-related triggers for relapse, and how we align harm reduction, addiction consult services, telehealth bridges, and contingency management with continuity of care (Babor et al., 2007; Carroll & Weiss, 2017).

The Role of Nurse Practitioners in Substance Use Disorder Care: A Frontline Perspective

From my vantage point as a clinician straddling chiropractic medicine and advanced practice nursing, I’ve witnessed the transformative role nurse practitioners (NPs) play across the SUD continuum. With over 258,000 NPs practicing nationwide and rapid growth expected, NPs are uniquely placed to provide entry points into treatment, particularly in primary care, rural settings, and underserved areas.

  • Key strengths of NP-led SUD care:
    • Patient autonomy and self-determination: We emphasize shared decision-making, which is critical for SUD engagement.
    • Prevention and health education: We deliver consistent, non-stigmatizing counseling, including motivational interviewing (Carroll & Weiss, 2017).
    • Scope for controlled medications: In most states, NPs can prescribe buprenorphine without an X-waiver, removing a major barrier to OUD treatment (SAMHSA, 2021).
    • Continuity and longitudinal relationships: These relationships let us tailor interventions to the stage of change, aligning care intensity and support accordingly (Babor et al., 2007).

I find NPs excel in harm-reduction conversations, risk mitigation, and connecting medical care with social variables that drive SUD—a vital skill set when pain, trauma, depression, or instability are present. While curricular time for SUD might be limited in some NP programs, advanced training exists, including Certified Addiction Registered Nurse – Advanced Practice (CARN-AP) and psychiatric mental health NP pathways with dedicated SUD competencies. When NPs function within integrated teams, with medical direction from internal medicine, and seamless links to chiropractic and rehabilitation, we see improved access, engagement, and retention across the continuum (JAMA Network, n.d.).

Why Patients View Healthcare as a Risk Environment: Understanding Stigma and Its Clinical Consequences

Patients often perceive healthcare as risky due to stigma, discrimination, fear of punitive responses, and mistrust (NIDA, 2018). These perceptions lead to:

  • Delayed care and presentation with acute, advanced illness
  • Underreporting or non-disclosure of substance use
  • Avoidance of pain management or inadequate analgesia
  • Self-directed discharges before completing treatment

Clinically, stigma correlates with higher morbidity, mortality, and overall health system costs (Volkow et al., 2016). As providers, we must convert healthcare from a perceived risk environment into a trust environment. In my practice, this means non-judgmental communication, dignity-preserving policies, peer support, and warm handoffs. It also means integrating chiropractic and rehabilitative services to reduce pain triggers, so patients aren’t forced to choose between untreated pain and illicit coping. Trust-building accelerates disclosure, engagement, and continuity—all foundational to evidence-based outcomes.

Mapping SUD Care Settings: Primary Care at the Center with Coordinated Auxiliaries

In our model, I place primary care at the center, with auxiliary paths configured to the patient’s ASAM level of care and biopsychosocial needs (ASAM, n.d.):

  • Outpatient primary care with on-site pharmacotherapy for OUD (e.g., buprenorphine), mental health integration, and chiropractic pain management
  • Hospital or inpatient care with addiction consult services for initiation/stabilization and transition planning
  • Emergency departments with bridge-to-community pathways
  • Specialty SUD treatment: intensive outpatient (IOP), residential rehab, office-based addiction treatment (OBAT), and opioid treatment programs (OTPs) for methadone
  • Peer support networks: Onsite and community-based
  • Telehealth and bridge clinics: For continuity, high-frequency contact, and rapid troubleshooting

We personalize transitions based on ASAM criteria, a strength-based, multidimensional approach that assesses needs, obstacles, assets, and supports. I treat the ASAM framework as a living map for care escalation and de-escalation, ensuring the right care at the right time (ASAM, n.d.). Integrated operations—shared records, unified care plans, co-located services—reduce friction and reinforce continuity.

Primary Care as the SUD Entry Point: Longitudinal Relationships and Stage of Change

Primary care is the largest clinical workforce and often the first contact. The value lies in sustained relationships that make it possible to meet patients where they are (Babor et al., 2007):

  • Prec: Non-judgmental listening, basic harm reduction, safety planning
  • Contemplation: Education on risks, benefits, and available treatments; motivational interviewing; pain alternatives
  • Preparation: Aligning logistics (pharmacy, insurance, transportation), scheduling peer support and counseling
  • Action: Medication initiation, frequent follow-ups, rehab plans
  • Maintenance: Structured coaching, relapse prevention, addressing pain, mood, and social determinants

In my experience, integrating chiropractic assessments—posture, gait, joint dynamics—with functional medicine (inflammation, nutrition, sleep, endocrine) can clarify root drivers and set realistic treatment intensity. Pain related to lumbar radiculopathy, myofascial dysfunction, or postural strain is a common relapse trigger; addressing it quickly can stabilize recovery trajectories. For clinical observations on sciatica-related pain and integrative strategies I routinely apply, see sciatica.clinic and my professional updates on LinkedIn:

Addressing Primary Care Constraints: Workforce Shortages and Practical Barriers

The US faces a significant primary care workforce gap, with millions living in health professional shortage areas (JAMA Network, n.d.). Providers juggle time constraints, lower reimbursement for SUD services, limited psychosocial referral options, concerns about diversion, and sometimes requirements for concurrent counseling that create barriers (SAMHSA, 2021). To counter, we:

  • Build team-based models with nurse care managers as primary contacts for buprenorphine patients.
  • Co-locate services: pharmacy, mental health, chiropractic, rehab, and peer support
  • Use protected time and continuing education to support providers and empower SUD champions.
  • Leverage national resources like PCSS for mentoring and on-demand consultations.

I have found that aligning care plans with pain relief, sleep improvement, and stress modulation dramatically increases adherence. Patients remain engaged when they see results quickly and feel their team is coordinated and compassionate.

Best Practices: Integrated Primary Care Programs for OUD Treatment

Evidence from integrated primary care models shows four core components (JAMA Network, n.d.; SAMHSA, 2021):

  • Pharmacologic therapy: On-site prescribing of buprenorphine and adjunct medications
  • Co-located psychosocial services: Behavioral counseling, CBT pain groups, peer support
  • Integrated operations: One location, unified records, shared care plans
  • Education/outreach: Patient-facing materials, motivational strategies, harm-reduction training

Team-based approaches—especially nurse care managers handling proactive follow-up, medication coordination, and urine toxicology—reduce friction, increase continuity, and improve outcomes. In my clinic, integrating chiropractic care offers non-opioid pain control, improves mobility, and lowers musculoskeletal drivers that worsen withdrawal distress or cravings.

Case Study: Restarting Buprenorphine in Primary Care with Co-Located Services

James, a 52-year-old man with diabetes and chronic pain, presented to primary care after returning to illicit fentanyl use. He wanted to restart buprenorphine. We used a shared decision-making approach, discussed risks/benefits, and selected high-dose initiation to overcome potent fentanyl’s binding and high tolerance profile (SAMHSA, 2021). We coordinated a prescription to a co-located pharmacy, scheduled a telehealth check-in, and lined up counseling and CBT pain group enrollment.

  • Early follow-up was critical: High-dose initiation requires reaching moderate to severe withdrawal before starting. He struggled but felt better soon after starting; we adjusted dosing and connected him to peer support.
  • Over weeks, he transitioned successfully, held regular nurse care manager visits, and addressed depression and pain drivers.

My clinical observation: When pain, depression, and sleep are addressed immediately—through integrative chiropractic adjustments, neuromuscular therapies, and endocrine/metabolic support—patients report less craving intensity and more stability. Co-located services and warm handoffs are decisive; they transform siloed care into a team experience.

Specialty SUD Treatment: Indications, Access, and Equitable Medical Care

Some patients require higher intensity support beyond primary care:

  • Intensive outpatient programs (IOP)
  • Residential or inpatient rehab
  • OBAT clinics and OTPs for methadone

Crucially, medical treatment should not be contingent on behavioral program participation. Initiating buprenorphine or naltrexone should proceed when clinically indicated, with psychosocial interventions offered but not gatekeeping access to pharmacotherapy. This principle reduces mortality and aligns with evidence-based practice (SAMHSA, 2021; JAMA Network, n.d.).

Acute Care Opportunities: Inpatient Addiction Consult Services

Hospital admissions create teachable moments where patients reevaluate goals and accept treatment. Addiction consult services (ACS)—interdisciplinary teams of addiction medicine clinicians, social workers, care coordinators, and peer specialists—improve outcomes: fewer readmissions and more starts/continuation of MOUD (JAMA Network, n.d.; SAMHSA, 2021).

ACS performs:

  • Medical assessment and initiation/titration of methadone or buprenorphine
  • Pain management strategies appropriate for SUD patients
  • Therapeutic interventions and post-discharge linkages
  • Hospital policy improvements, provider education, and system-wide quality initiatives

I consider ACS a cornerstone for safe transitions, especially when complex infections, withdrawal syndromes, or polysubstance use are present. Integrative chiropractic planning post-discharge can accelerate recovery by restoring biomechanical function and reducing nociceptive input that perpetuates stress physiology and craving.

Case Study: Inpatient Management with ACS – Low-Dose Buprenorphine Initiation and Harm Reduction

Lisa, 32, presented with left lower extremity cellulitis, daily fentanyl (IV and inhaled) and methamphetamines, withdrawal onset, and active hepatitis C. She had concerns about her dog’s care—a real barrier to staying hospitalized.

Within 24 hours:

  • The ACS medical provider diagnosed severe OUD and stimulant use disorder, started methadone for withdrawal management, with plans to transition to buprenorphine via low-dose (microdosing) initiation to avoid precipitated withdrawal (Socias et al., 2021).
  • The social worker performed the ASAM assessment, used motivational interviewing to reduce the chance of self-directed discharge, and began referrals for post-discharge treatment.
  • The peer specialist addressed immediate social needs (dog care, communication, phone) and established trust.

Outcomes:

  • Methadone stabilized withdrawal; buprenorphine microdosed safely
  • IV antibiotics for cellulitis
  • Referral for HCV treatment
  • Education on harm reduction: naloxone access, risks of contaminated supply (fentanyl in stimulants), not using alone, infection risk from paraphernalia sharing
  • Discussion of contingency management for stimulant use and off-label medication options to moderate cravings (Carroll & Weiss, 2017)

Clinically, Lisa’s case shows a pattern: once withdrawal is controlled and pain addressed, the patient’s capacity for executive function, planning, and engagement improves (Volkow et al., 2016). Pairing hospital-based initiation with warm transitions to community and integrative chiropractic pain strategies reduces relapse risk.

Locating SUD Treatment: Practical Tools

For locating regional treatment agencies and prescribers:

  • SAMHSA Treatment Locator: Comprehensive listing of agencies (SAMHSA, n.d.)
  • Buprenorphine prescriber directories: Although the X-waiver is gone, curated lists still help identify addiction-experienced prescribers (SAMHSA, 2021)

These tools help us construct transitions that are geographically feasible and timely, key determinants of success.

Care Transitions: Challenges and Best Practices from Acute to Community Settings

Transitions—hospital to outpatient, outpatient to IOP/residential, or telehealth to in-person—can fracture continuity. Common barriers include care silos, stigma, staff shortages, transportation, technology access, and insurance barriers (JAMA Network, n.d.). Best practices include:

  • Leveraging partnerships: Build pre-existing relationships; map referral pathways with shared communication protocols
  • Warm handoffs: Introductions between patient and new provider, ideally in person or by live video/phone
  • Bridge appointments: Schedule within 24–72 hours post-discharge
  • Care coordinators/nurse care managers: Proactive contact, problem-solving, appointment reminders
  • Peer support continuity: Maintain peer contact across transitions
  • Medication continuity plans: Ensure adequate supply and reconciliation
  • Harm reduction kits: Naloxone, fentanyl test strips where available, wound care supplies
  • Transportation and telehealth access: Provide vouchers, devices, or app support

My integrative spin: Add chiropractic/rehab visits early in transitions to deliver fast pain relief, reduce muscle guarding, and normalize movement biomechanics. Rapid improvements in pain and sleep during the first two weeks of transition correlate with lower relapse rates in my clinical observations (BMJ, n.d.; Institute for Functional Medicine, n.d.). See additional insights at https://sciatica.clinic/.

Physiological Underpinnings: Why Integrative Care Works in SUD

To design rational treatments, we must understand SUD physiology (NIDA, 2018; Volkow et al., 2016):

  • Neurobiology of addiction:
    • Mesolimbic dopamine dysregulation (ventral tegmental area to nucleus accumbens) shifts salience toward drug cues
    • Prefrontal cortex hypofunction impairs executive control, planning, and impulse regulation
    • Amygdala and extended amygdala: Stress reactivity increases, sensitizing to withdrawal and cues
    • Glutamatergic plasticity: Learning circuits consolidate maladaptive habits
  • Opioid receptor dynamics:
    • Mu-opioid receptor occupancy and tolerance complicate induction strategies, particularly with high-potency fentanyl
    • Buprenorphine’s partial agonism stabilizes receptors, reduces cravings, and provides a ceiling effect for respiratory depression (SAMHSA, 2021)
    • Methadone’s full agonism: Effective for severe tolerance and stabilizing high-dependence cases
  • Withdrawal physiology:
    • Noradrenergic hyperactivity (locus coeruleus), autonomic dysregulation, GI distress, pain sensitivity, sleep disruption
    • Opioid-induced hyperalgesia due to neuroplastic changes
  • Pain mechanisms:
    • Nociceptive, neuropathic, and nociplastic contributors; central sensitization amplifies pain signals (BMJ, n.d.)
    • Musculoskeletal dysfunction increases afferent nociception, elevates stress hormones, and perpetuates cravings.
  • Inflammation and immune signaling:
    • Chronic substance use elevates pro-inflammatory cytokines; gut dysbiosis, HPA axis disruption, and mitochondrial stress degrade resilience (Institute for Functional Medicine, n.d.)
  • Metabolic and endocrine:
    • Sleep loss, cortisol irregularities, insulin resistance, and low-grade inflammation amplify pain and mood symptoms (Centers for Disease Control and Prevention, n.d.)
  • Psychological and social determinants:
    • Trauma history, depression, anxiety, isolation, housing insecurity, and legal barriers influence relapse risk (Babor et al., 2007)

Integrative chiropractic care modulates proprioceptive input, decreases mechanical nociception, and facilitates parasympathetic restoration. Combined with functional medicine approaches (nutrition, micronutrient repletion, sleep hygiene, stress management), the integrative plan reduces hyperalgesia, calms the HPA axis, and improves executive function to sustain behavior change (BMJ, n.d.; Institute for Functional Medicine, n.d.).

Why Specific Techniques Are Used: Reasoning Behind Protocols

  • High-dose buprenorphine initiation: With fentanyl exposure, mu receptor dynamics often require higher initial doses to displace fentanyl and control cravings/withdrawal. High-dose starts, when done with proper monitoring, reduce oscillation between withdrawal and intoxication (SAMHSA, 2021).
  • Low-dose (microdosing) buprenorphine: In hospitalized patients or those on methadone, microdosing slowly increases buprenorphine to avoid precipitated withdrawal, stabilizing the transition with fewer distress events (Socias et al., 2021).
  • Methadone initiation in OTP or hospital: For high tolerance and instability, methadone provides full agonist stabilization, enabling functional recovery and eventual transitions where appropriate (SAMHSA, 2021).
  • Harm reduction: Naloxone, test strips, and safe-use education reduce mortality and build trust, anchoring patients for further care (Centers for Disease Control and Prevention, n.d.).
  • Contingency management: Evidence supports CM for stimulant use disorder; it leverages behavioral economics with rewards that reinforce non-use behaviors (Carroll & Weiss, 2017).
  • Nurse care management: Frequent, predictable contact counters the chaos of early recovery; improves adherence and offers rapid troubleshooting (JAMA Network, n.d.).
  • Chiropractic manual therapy: Reduces nociceptive load, normalizes joint mechanics, and facilitates muscle balance, decreasing pain triggers that drive relapse (BMJ, n.d.).
  • CBT pain groups: Cognitive reframing, pacing strategies, and self-efficacy reduce catastrophic thinking and improve function (Carroll & Weiss, 2017).
  • Peer support: Lived experience increases credibility and addresses non-medical obstacles quickly, enabling adherence to medical plans (JAMA Network, n.d.).
  • Functional medicine adjuncts: Nutritional support (omega-3s, magnesium, vitamin D), gut health, sleep optimization, and stress modulation improve neuroimmune resilience (Institute for Functional Medicine, n.d.).

Our Multidisciplinary Setup in El Paso: Medical Direction and Integrative Chiropractic Care

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), El Paso, Texas:

  • Medical director: Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933), oversees medical safety, diagnostics, complex comorbidities, prescription oversight, and transitions requiring hospital or specialty linkage.
  • Chiropractic integration: I provide adjustments, soft tissue work, neuromuscular rehabilitation, postural correction, and movement re-education tailored for patients with SUD, chronic pain, and injury care.
  • Functional medicine and rehab: Nutritional and lifestyle interventions, physical reconditioning, and metabolic optimization.
  • Personal injury care: Coordinated treatment plans addressing acute injuries, whiplash-associated disorders, and return-to-function strategies that accommodate concurrent SUD care.
  • Behavioral and peer supports: Embedded or coordinated services to ensure psychotherapeutic continuity and social stability.
  • Care coordinators and nurse care managers: Appointment coordination, medication management, and rapid response to emerging issues.

This setup mirrors the integrative or injury clinic model where MD direction provides a safety backbone, while chiropractic and rehabilitative services deliver non-opioid pain relief and restore function—a synergy essential for patients with SUD and chronic pain (JAMA Network, n.d.; BMJ, n.d.).

Building Trust and Reducing Stigma: Communication Strategies That Work

I’ve learned that the right words—and the right posture—matter (NIDA, 2018; Volkow et al., 2016):

  • Use non-stigmatizing language: “Substance use disorder,” “return to use,” “medications for OUD”
  • Emphasize autonomy and collaboration: “Let’s decide together”
  • Validate pain and struggle: Acknowledge suffering, normalize challenges, and avoid moralizing
  • Offer choices and control: Between initiation methods, support modalities, and timing
  • Follow through consistently: Reliability builds therapeutic alliance

Patients who feel respected are more likely to disclose use, request help early, and complete treatment. This is foundational for successful transitions.

Integrative Chiropractic Care in SUD: Clinical Rationale and Methods

I integrate chiropractic care to directly modulate pain and musculoskeletal stressors (BMJ, n.d.):

  • Techniques:
    • Spinal adjustments: Optimize segmental mobility, reduce mechanical pain
    • Myofascial release and trigger point therapies: Decrease muscle hypertonicity and referred pain
    • Neuromuscular re-education: Improve motor control, reduce compensatory strain
    • Postural correction: Normalize load distribution, reduce nociceptive signaling
    • Lumbar and cervical stabilization: Target core and neck musculature for injury resilience
  • Outcomes:
    • Lower nociceptive input and central sensitization
    • Improved sleep quality and stress recovery
    • Enhanced functional capacity and self-efficacy
    • Reduced reliance on illicit analgesics and improved adherence to MOUD

My sciatica clinic resources include specific protocols for lumbar radiculopathy, piriformis syndrome, and facet-mediated pain, which are common triggers for opioid misuse:

Functional Medicine Additions: Modulating Neuroimmune and Metabolic Stress

I add functional medicine pillars to bolster recovery (Institute for Functional Medicine, n.d.):

  • Nutrition:
    • Anti-inflammatory dietary patterns (omega-3s, phytonutrients)
    • Micronutrients that aid neuromuscular function (magnesium, vitamin D, B-complex)
    • Protein sufficiency to rebuild tissue and neurotransmitter precursors
  • Sleep hygiene:
    • Consistent schedules, light management, caffeine timing, relaxation rituals
  • Stress physiology:
    • Breathwork, mindfulness, graded exposure, biofeedback
  • Gut health:
    • Fiber, probiotics, elimination of irritants that perpetuate inflammation
  • Movement prescriptions:
    • Graded activity plans to reduce pain and build capacity without overloading

These interventions decrease inflammation, stabilize HPA axis, and improve mood, making relapse less likely.

Medication Strategies: Why and How We Choose

  • Buprenorphine:
    • Partial agonist with high receptor affinity
    • Reduces cravings and withdrawal
    • Ceiling effect lowers overdose risk
    • High-dose or microdose pathways selected based on tolerance and current opioid exposure (SAMHSA, 2021)
  • Methadone:
    • Full agonist suitable for severe dependence
    • Requires OTP or hospital-based dispensing
    • Provides powerful stabilization; transitions should be planned carefully (SAMHSA, 2021)
  • Naltrexone:
    • Opioid antagonist, useful after detox, requires caution with pain management (SAMHSA, 2021)
  • Adjuncts:
    • Clonidine, lofexidine for autonomic symptoms
    • Sleep aids, antiemetics, antidiarrheals, non-opioid analgesics
  • Stimulant use disorder:
    • Contingency management is evidence-based
    • Off-label pharmacotherapies considered case-by-case with close monitoring (Carroll & Weiss, 2017)

We tailor medication choices to patient preference, medical complexity, risk profile, and care setting. Dr. Cardenas’ medical oversight ensures safety in polypharmacy, liver disease (e.g., HCV), and comorbidity management.

Care Coordination: Nurse Care Managers, Pharmacy Integration, and Telehealth

Effective coordination turns intentions into outcomes (JAMA Network, n.d.):

  • Nurse care managers:
    • Provide high-frequency follow-ups
    • Manage refill schedules and urine toxicology
    • Troubleshoot side effects and barriers
  • Pharmacy integration:
    • Co-located pharmacies expedite starts
    • Pharmacist consultations for dosing and interactions
  • Telehealth bridges:
    • Frequent check-ins, video-based assessments
    • Rapid course corrections and crisis de-escalation
  • Peer support continuity:
    • Text/phone support, appointment accompaniment
    • Resource navigation (housing, pets, transport)

Patients who receive predictable contact and fast solutions stay engaged and succeed more often.

Harm Reduction: Safety as the Foundation

Harm reduction is non-negotiable (Centers for Disease Control and Prevention, n.d.):

  • Naloxone distribution and training
  • Fentanyl test strips where legal
  • Education not to use alone; recognize signs of overdose
  • Wound care supplies and infection prevention guidance
  • Safer supplies where programs exist; referrals to syringe services

These interventions save lives, build rapport, and create stepping stones toward deeper treatment.

Pain, Injury, and SUD: Integrative Treatment for Personal Injury Patients

In injury contexts:

  • Acute pain, whiplash, and soft-tissue injury can escalate opioid exposure
  • Early integrative chiropractic care reduces pain and restores function
  • Behavioral supports and non-opioid analgesics prevent transition to dependence
  • Functional rehabilitation—graded movement and stabilization—prevents chronicity

In our El Paso clinic, we apply integrative strategies immediately after injury to reduce the need for opioids and support recovery trajectories (BMJ, n.d.; Institute for Functional Medicine, n.d.).

Healthcare System Design: Reducing Silos and Creating Seamless Pathways

System-level improvements include (JAMA Network, n.d.):

  • Shared care agreements across agencies
  • Standardized warm handoff protocols
  • Data-sharing with consent
  • Rapid-access appointments for transitions
  • Quality metrics: MOUD initiation rates, retention, readmission rates, patient-reported outcomes
  • Provider education: Stigma reduction, induction strategies, pain management in SUD

I advocate for operational redesign that limits friction and substitutes trust for bureaucracy. ACS services catalyze these changes in hospital systems.

Advanced Topics: Fentanyl Era Adaptations, Polysubstance Use, and Innovative Models

  • Fentanyl considerations:
    • Higher potency and lipophilicity complicate inductions
    • High-dose buprenorphine strategies and microdosing reduce precipitated withdrawal risk (SAMHSA, 2021; Socias et al., 2021)
  • Polysubstance use:
    • Co-occurring stimulant use requires contingency management and tailored psychosocial strategies
    • Alcohol or benzodiazepine co-use demands careful sedation risk management (Carroll & Weiss, 2017)
  • Tele-bridges and mobile MAT:
    • Bring services to patients; reduce no-show barriers (JAMA Network, n.d.)
  • Digital therapeutics and apps:
    • CBT modules, craving tracking, adherence support (Nature, n.d.)
  • Trauma-informed care:
    • Safety, choice, collaboration, trustworthiness, empowerment integrated into every encounter

These innovations meet patients where they live—flexible, responsive, and respectful.

Real-World Implementation: From Theory to Practice

To implement these ideas:

  • Start with a needs assessment
  • Build a small core team: NP, MD oversight, chiropractic, care coordination, peer specialist.
  • Map regional referrals and partnerships
  • Pilot an induction protocol with follow-up cadence
  • Track simple metrics first: show rate, induction success, 30-day retention
  • Scale co-located services as feasible

My clinic’s approach grew iteratively. Early wins in pain relief, sleep, and rapid induction built momentum and patient trust.

Patient Stories: Recovery Anchored in Function and Trust

I’ve seen patients regain their lives when:

  • Pain is controlled with non-opioid strategies
  • Buprenorphine stabilizes cravings and withdrawal
  • Peer supports answer the phone at 9 pm on a hard night
  • Chiropractic and rehab restore movement and confidence
  • Functional medicine calms inflammation and improves sleep
  • Warm handoffs make new settings feel safe

Function precedes resilience. Resilience sustains recovery.

My Clinical Observations: Sciatica, Radiculopathy, and SUD

From sciatica.clinic, I’ve documented patterns:

  • Lumbar disc herniations with radiculopathy produce severe pain spikes; rapid spinal care and nerve gliding reduce flare intensity
  • Piriformis syndrome mimics radiculopathy; targeted release and stabilization improve leg symptoms
  • Facet joint pain responds to adjustments and postural correction
  • These improvements reduce sleep fragmentation and stress reactivity, which lower craving intensity and improve MOUD adherence

References:

Integrating Evidence-Based Addiction Care With Chiropractic, Functional Medicine, and Collaborative Internal Medicine Oversight

I walk you through an integrative, patient-centered approach to SUD care with a focus on continuity between acute and community settings, care transitions, and multidisciplinary collaboration. I highlight how our team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, operates with medical direction by Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who serves as our Medical Director and Collaborative Physician. We integrate chiropractic care, functional medicine, personal injury care, rehabilitation, and psychosocial services to support patients across life stages, including peripartum individuals and adolescents, and justice-involved populations at high risk for overdose (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.).

We cover:

  • Continuity strategies: Bridge prescriptions, co-located services, telehealth options, and care navigation to reduce care disruption and improve retention (JAMA Network, n.d.).
  • Special populations: Justice-involved individuals post-release, pregnant and postpartum patients, and adolescents—each with distinct risks and needs.
  • Clinical protocols for MOUD: Buprenorphine and methadone safety in pregnancy, neonatal opioid withdrawal syndrome counseling, dosing adjustments across pregnancy and postpartum, and adolescent considerations (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.; SAMHSA, 2021).
  • Case study: A postpartum patient on buprenorphine with tailored recovery scaffolding involving social support, transport, housing, and NICU coordination.
  • Emerging science: Ethical considerations of genetic testing for SUD risk and early signals for GLP-1 receptor agonists in reducing substance use-related harms (New England Journal of Medicine, n.d.).
  • Integrative chiropractic: How manual therapy, neuromuscular rehabilitation, autonomic regulation, pain neuroscience education, and functional nutrition reduce pain, improve function, stabilize mood, and diminish relapse risk, coordinated under internal medicine oversight (BMJ, n.d.; Institute for Functional Medicine, n.d.).
  • Continuity of care in our clinic: Warm handoffs, multidisciplinary rounding, risk stratification, and outcomes tracking using modern evidence-based methods (JAMA Network, n.d.).

Continuity Between Hospital and Community: Building Bridges That Retain Patients In Care

When a provider initiates buprenorphine during hospitalization, patients are most vulnerable at the point of discharge. Without continuity—medication supply, follow-up appointment availability, care navigation—many patients struggle to find services, lose momentum, and disengage. In our integrated model, we extend continuity across settings and modalities.

  • Bridge prescriptions at discharge: We ensure patients receive a 2–4 week supply of buprenorphine or other MOUD to cover the transition to outpatient care.
  • Care navigators and warm handoffs: We routinely coordinate a warm handoff to our bridge clinic, primary care, or specialized SUD services—sometimes scheduling while the patient is still inpatient or in the ED. Care navigators are essential for linking patients to transportation, insurance, and social supports (JAMA Network, n.d.).
  • Co-located services: Whenever possible, we co-locate medical care, chiropractic therapy, mental health counseling, and social services under one roof to streamline access and increase retention.
  • Patient preference in care modality and location: Telehealth is integral for patients with caregiving responsibilities, unstable housing, or limited transportation. Flexible clinic hours and virtual options increase engagement without compromising safety.
  • Structured follow-up: Initial follow-up is typically within 48–72 hours of discharge for buprenorphine stabilization, with weekly check-ins during the first month and monthly thereafter, customized for the patient’s clinical picture.

Why this works:

  • Human continuity: Trust formed with inpatient teams carries forward into the community. Patients who see a familiar provider or clinic soon after discharge are more likely to continue treatment.
  • Physiological timing: For people with OUD, stabilization while neuroadaptation is underway—especially after abrupt cessation or changing tolerance (post-incarceration, postpartum)—is critical to prevent relapse and overdose (Volkow et al., 2016).
  • System navigation: Care navigators remove barriers—transport, insurance reinstatement, childcare, FMLA forms—and reduce cognitive burden, allowing patients to focus on health.

Clinical observation: In our practice, continuity reduces early dropout and re-hospitalization, especially for patients discharged on buprenorphine who receive swift follow-up, tangible support, and clear next steps. When I combine chiropractic manual therapy for pain modulation with MOUD stabilization and psychosocial support, patients report lower craving intensity and improved day-to-day functioning.

Optimizing Your Wellness- Video

Optimizing Your Wellness | El Paso, Tx (2023)

Integrative Clinic Structure: Internal Medicine Oversight and Chiropractic Care Working Together

At Injury Medical Clinic PA, our model reflects the integrated structure common in multidisciplinary clinics, where a physician provides medical direction and collaborates with chiropractic and rehabilitation providers.

  • Medical Director: Dr. Maria Guadalupe Cardenas, MD
    • Oversees medical protocols, safety, MOUD initiation/titration, lab testing, and management of comorbidities (cardiometabolic risks, hepatic function, pregnancy care, and postpartum monitoring).
    • Ensures compliance with state and federal prescribing and reporting regulations, and guides risk mitigation during transitions.
  • Chiropractic and Rehabilitation: Dr. Alex Jimenez, DC, APRN, FNP-BC
    • Focuses on biomechanical assessment, manual therapy, neuromuscular rehabilitation, pain neuroscience education, autonomic balancing techniques, and functional movement training.
    • Coordinates with medical and mental health teams to reduce pain drivers that contribute to relapse risk and poor retention.
  • Functional Medicine and Nutrition
    • Addresses inflammation, sleep dysregulation, micronutrient deficits, and gut-brain axis factors that influence mood, craving, and recovery capacity.
  • Mental Health and Social Supports
    • Integrates behavioral therapies, peer support, and social services (housing, food, transport) with care navigation.
  • Personal Injury Care
    • Treats injury-related pain to remove physiological stressors that fuel substance use. For motor vehicle accidents and workers’ comp cases, we align pain management, rehabilitation, and legal documentation.

This alignment allows us to create personalized care plans that stabilize patients medically while strengthening musculoskeletal function, reducing pain, and optimizing resilience (BMJ, n.d.; JAMA Network, n.d.).

The Neurobiology of Continuity: Why Holding the Line Prevents Overdose and Improves Retention

SUD involves complex neuroadaptations in reward, stress, and executive systems (Volkow et al., 2016; NIDA, 2018):

  • Reward circuitry: Chronic opioid use dysregulates the mesolimbic dopamine pathway (VTA to nucleus accumbens), driving compulsive use.
  • Stress systems: The extended amygdala and CRF system become hyperactive under withdrawal and stress.
  • Executive function: Prefrontal cortical networks (decision-making, impulse control) become hypoactive, impairing planning and increasing relapse vulnerability.

Continuity measures—bridge prescriptions, quick follow-ups, co-located services—reduce the window of acute vulnerability post-discharge, during which stress and cue-driven craving can overwhelm. Medication coverage maintains receptor occupancy (e.g., buprenorphine’s partial agonism at mu-opioid receptors). It reduces craving and withdrawal, while psychosocial supports buffer stress responses and enhance executive functioning through structured routines and supportive relationships.

Chiropractic care complements this by reducing nociceptive input and modulating autonomic tone:

  • Manual therapy and spinal manipulation: Can influence descending pain inhibitory pathways, reduce central sensitization, and improve proprioceptive signaling, diminishing hypervigilance and stress reactivity (BMJ, n.d.).
  • Breathing and vagal techniques: Enhance parasympathetic activity, lower sympathetic overdrive, and improve interoceptive regulation—factors linked to craving intensity and relapse risk (Institute for Functional Medicine, n.d.).
  • Movement rehabilitation: Rebuilds confidence and function, decreasing disability and pain catastrophizing, which often drive self-medication behaviors (Carroll & Weiss, 2017).

In practical terms, the more seamless the transition, the fewer triggers a patient encounters, and the stronger the physiologic and behavioral stabilizers remain in place.

Co-Located Services and Patient Preference: Maximizing Access and Engagement

We design our services around real patient needs:

  • Co-locating SUD treatment, mental health care, chiropractic, and social supports increases convenience and reduces fragmentation (JAMA Network, n.d.).
  • Offering telehealth options for follow-up allows mothers, caregivers, and shift workers to maintain continuity when in-person care is not feasible.
  • Flexible scheduling and post-discharge walk-in slots help ensure medications do not lapse and that support is immediately accessible.

Physiological impact:

  • When stress load decreases (less travel, fewer bureaucratic steps), cortisol levels lower, and allostatic burden improves sleep, mood regulation, and cognitive bandwidth, critical for adherence and self-care (Centers for Disease Control and Prevention, n.d.).

Care Navigation: The Glue That Holds the System Together

Care navigators with deep knowledge of community resources assist with (JAMA Network, n.d.):

  • Insurance reinstatement and coverage continuity
  • Transportation vouchers and ride scheduling
  • Childcare arrangements
  • Housing referrals and transitional programs
  • Appointments and warm handoffs
  • Legal and reporting requirements clarification

The presence of navigators correlates with improved follow-up rates and lower emergency department utilization. They convert macro-level resources into micro-level actionable steps for the patient.

Special Focus: Justice-Involved Individuals and Post-Release Vulnerability

Overdose is a leading cause of death after release from carceral environments. Loss of opioid tolerance, disruption in continuity of care, and low access to MOUD are key drivers of mortality (Centers for Disease Control and Prevention, n.d.; SAMHSA, 2021).

Common post-release challenges:

  • Loss of tolerance: A return to prior use amounts can be lethal. Patients need explicit counseling about lowered tolerance and overdose risk.
  • Gaps in treatment access: Many jails and prisons do not offer MOUD, or they underdose, resulting in poor experiences and reduced willingness to engage later.
  • Insurance loss: Coverage interruptions limit immediate access to medications and outpatient services.
  • Stigma and self-worth: Internalized stigma reduces help-seeking and increases disengagement.

Our approach:

  • Pre-release coordination when possible: Establish appointments and secure bridge prescriptions timed to release.
  • Immediate post-release follow-up: Within 24–72 hours, prioritize MOUD initiation or re-initiation, naloxone distribution, and safety planning.
  • Harm reduction education: Fentanyl contamination awareness, overdose recognition, naloxone use, and never use alone.
  • Chiropractic integration: Address pain generators early to reduce motivation for opioid return; focus on gentle manual therapy, graded movement, and autonomic regulation.

Physiology and risk:

  • Abrupt abstinence reduces receptor tolerance and shifts homeostatic set points; sudden re-exposure produces exaggerated respiratory depression risk. Buprenorphine’s ceiling effect and partial agonism can stabilize mu receptor occupancy, reducing overdose risk when properly initiated (SAMHSA, 2021; Volkow et al., 2016).

Special Focus: Peripartum Individuals, Prenatal Barriers, and Postpartum Transitions

Pregnant and postpartum individuals face heightened risk of overdose and multiple systemic barriers, including stigma and fears related to child custody (American College of Obstetricians and Gynecologists, n.d.; Centers for Disease Control and Prevention, n.d.). Many avoid care due to punitive policies and mandatory reporting concerns.

Key points we emphasize:

  • Substance use during pregnancy is not equivalent to child maltreatment under federal definitions. The Comprehensive Addiction and Recovery Act (CARA) requires notification when an infant is born affected by substances, but this is not inherently a report of abuse/neglect; state policies vary (SAMHSA, n.d.).
  • Punitive policies reduce engagement: Evidence shows stricter mandatory reporting correlates with later initiation of prenatal care, fewer adequate prenatal visits, and reduced postpartum follow-up.
  • Support over criminalization: Treatment and wraparound support improve outcomes for mothers and infants.

Clinical counseling with compassion:

  • I greet patients with appreciation: “Thank you for coming to see me.” By acknowledging obstacles, we create trust and de-escalate fear-based avoidance.
  • We discuss risks honestly and offer evidence-based options: Buprenorphine and methadone are safe in pregnancy; uncontrolled withdrawal poses greater risks to mother and fetus than MOUD (American College of Obstetricians and Gynecologists, n.d.; SAMHSA, 2021).
  • We explain neonatal opioid withdrawal syndrome (NOWS): It is a known risk; the severity is not dose-dependent; the best dose is the one that treats maternal cravings and withdrawal effectively.

Postpartum considerations:

  • Metabolic shifts occur after birth and typically normalize over 3–12 weeks. Buprenorphine or methadone dose reductions should be individualized and conservative to avoid oversedation while maintaining control of cravings (Centers for Disease Control and Prevention, n.d.).
  • Monitoring for sedation and respiratory depression during the postpartum period is warranted, especially as sleep deprivation, anemia, or co-medications may alter drug effects.
  • Flexible postpartum follow-up: Telehealth check-ins, transport/childcare support, and warm handoffs to pediatric, lactation, and mental health providers strengthen the mother-baby dyad.

Chiropractic integration postpartum:

  • Gentle manual therapy to address postural strain, pelvic floor–related mechanics (in collaboration with pelvic physical therapy), thoracic outlet and neck tension from feeding postures, and core stabilization.
  • Autonomic balancing (breathing drills, rib mechanics, vagal tone enhancement) to lower anxiety and improve sleep.
  • Functional nutrition strategies for replenishment: Iron, omega-3s, choline, magnesium, and protein adequacy to support mood and tissue recovery (Institute for Functional Medicine, n.d.).

Case Study: Postpartum Buprenorphine Management and Recovery Scaffolding

Patient scenario:

  • Liz, a 32-year-old female, is one day postpartum with a baby girl. History of OUD and illicit fentanyl use; started on buprenorphine during pregnancy by primary care and titrated to 8 mg QID (total 32 mg/day) in the third trimester.
  • The baby may be monitored in the NICU for NOWS.

Post-discharge priorities:

  • Assess housing, transport, and social support to facilitate NICU visits and maternal follow-up.
  • Provide flexible follow-up options, including telehealth.
  • Counsel on postpartum metabolism: Dose reductions may be appropriate over weeks 3–12 depending on sedation and symptom control.
  • Monitor cravings and withdrawal symptoms; adjust doses in small increments.
  • Engage social work, peer support, mental health care, food resources, transportation, and housing support.
  • Coordinate with pediatric and lactation services; consider mother-baby co-located visits when possible.

Chiropractic postpartum plan:

  • Gentle spinal and rib cage work to improve breathing mechanics, reduce cervicothoracic pain, and optimize autonomic balance.
  • Core stabilization with graded progressions to address diastasis and pelvic stability.
  • Patient education on ergonomics for infant care to reduce musculoskeletal strain that could drive pain and relapse risk.

Outcome targets:

  • Stabilize MOUD dosing to maintain function without oversedation.
  • Reduce pain and fatigue load to lessen triggers for use.
  • Strengthen the mother-infant bond with supportive scheduling and co-located services.

Adolescents and Young Adults: Tailored Care for Developing Brains

Adolescents differ from adults in neurodevelopment and social context (Nature, n.d.; Centers for Disease Control and Prevention, n.d.):

  • The reward system matures early; the prefrontal cortex (planning, impulse control) continues developing into the mid-20s. Adolescents can experience intense reward but have limited executive moderation.
  • Motivations include peer influence, low self-esteem, anxiety/depression, self-treatment, or weight control pressures.
  • Polysubstance use and experimentation are common; daily dependence may be less frequent, but overdose risk remains high due to fentanyl contamination.
  • Retention in SUD treatment is generally lower; parental involvement requirements vary by state law.

Medication considerations:

  • Buprenorphine: First-line for adolescents/young adults; FDA-approved for ages 16+. Some clinicians use it off-label for ages 12–15 when the risk-benefit profile supports it (SAMHSA, 2021).
  • Long-acting injectable buprenorphine: Limited evidence and not approved under 18.
  • Naltrexone and methadone: Generally approved for 18+; careful deliberation needed in younger patients.
  • For adolescents with episodic use and non-dependence, standard doses (e.g., 8 mg) may be too sedating; shared decision-making and careful titration are crucial.

Best practices:

  • Wraparound services: Integrate mental health assessment to identify drivers (anxiety/depression), school support, family therapy, and peer support programs.
  • Know state laws: Consent thresholds differ; respect adolescent autonomy while encouraging appropriate parental involvement.
  • Naloxone distribution: Universal education and access can save lives.
  • Harm reduction: Educate on fentanyl risks, counterfeit pills, and overdose prevention. Evidence suggests targeted education reduces willingness to misuse prescription drugs (Centers for Disease Control and Prevention, n.d.).

Chiropractic care for adolescents:

  • Focus on sports-related injury prevention and rehabilitation, posture, and movement literacy to improve body awareness and reduce risky coping behaviors.
  • Integrate motivational interviewing to align physical goals (sports, dance, work performance) with sobriety and health (Carroll & Weiss, 2017).

Medications for Opioid Use Disorder in Pregnancy: Dosing Rationale and Safety

Buprenorphine and methadone are safe in pregnancy, and the dangers of withdrawal often exceed the medication risks (American College of Obstetricians and Gynecologists, n.d.; SAMHSA, 2021). We counsel using clear, evidence-based language:

  • Neonatal opioid withdrawal syndrome (NOWS): Risk is real but not dose-dependent; prioritize maternal control of cravings and withdrawal to stabilize pregnancy.
  • Dose adjustments across trimesters: Increased volume of distribution and metabolic rates in late pregnancy may require higher doses.
  • Postpartum dosing: Metabolism typically returns toward baseline within 3–12 weeks postpartum; adjust dosing based on sedation and symptom control, not by fixed calendar alone (Centers for Disease Control and Prevention, n.d.).

Physiology:

  • Buprenorphine’s partial agonist profile provides receptor occupancy that reduces withdrawal and craving while limiting respiratory depression risk compared with full agonists (SAMHSA, 2021).
  • Methadone’s full agonist potency requires careful titration, regular monitoring, and postpartum adjustments under medical oversight.

Care plan integration:

  • Frequent postpartum check-ins to track sedation, cravings, sleep, and mood.
  • Collaboration with lactation services and pediatric care.
  • Chiropractic support for pain relief and autonomic regulation to reduce stress-related triggers.

Reporting and Legal Context: CARA, State Policies, and Patient Trust

Providers often fear noncompliance or liability; patients often fear losing their children. The reality is nuanced:

  • CARA: Requires notification when an infant is born affected by substances, but does not mandate a child abuse/neglect report at the federal level. States determine investigative thresholds (SAMHSA, n.d.).
  • Punitive policies: Associated with delayed prenatal care, reduced adequacy, and lower postpartum visit rates. These policies breed fear and disengagement (Centers for Disease Control and Prevention, n.d.).
  • Best practice: Treat substance use with support and evidence-based care; use warm language, clear expectations, and partner with patients to ensure safety and follow-through.

Clinical messaging:

  • “We’re here to support you and your baby. Let’s talk about medication options that protect both of you. We’ll also discuss privacy, reporting requirements, and what we can do together to keep you connected to care.”

Care Transition Cornerstones: What Makes Programs Sustainable

We design programs for continuity between acute and community settings (JAMA Network, n.d.):

  • Bridge prescriptions: Provide enough medication to cover the transition; avoid lapses that lead to relapse.
  • Co-location: Health services, social supports, and mental health under one roof whenever possible.
  • Patient preference: Offer telehealth, flexible scheduling, and local options that match patient life circumstances.
  • Care navigation: Dedicated staff to orchestrate transitions, solve practical barriers, and keep momentum.

Clinic operations:

  • Weekly multidisciplinary huddles to identify upcoming transitions and risk factors (e.g., recent incarceration, postpartum changes, housing instability).
  • Use brief validated tools to assess risk and readiness (e.g., craving scales, PHQ-9, GAD-7, pain scores).
  • Documented warm handoffs with explicit timelines and accountability.

Integrative Chiropractic Care: Pain, Autonomic Regulation, and Functional Gains

How chiropractic care fits into SUD treatment (BMJ, n.d.):

  • Pain modulation: Manual therapy, joint mobilization, soft tissue techniques, and graded loading reduce nociceptive input and central sensitization. Less pain reduces self-medication pressure.
  • Autonomic balance: Breathing mechanics, rib and diaphragm mobilization, and vagal tone training lower sympathetic dominance, reduce anxiety, and improve sleep—key for relapse prevention (Institute for Functional Medicine, n.d.).
  • Movement re-education: Address dysfunctional motor patterns and deconditioned tissues to restore function and reinforce self-efficacy.
  • Pain neuroscience education: Explain how pain and stress interact; empower patients to understand flare-ups and reduce catastrophizing (Carroll & Weiss, 2017).

Clinical observation:

  • Patients with sciatica, low back pain, or whiplash respond favorably when manual therapies are paired with MOUD and mental health support. Improved function and reduced pain catastrophizing correlate with higher treatment retention. See insights at https://sciatica.clinic/ and my professional notes at https://www.linkedin.com/in/dralexjimenez/.

Functional Medicine and Nutrition: Reducing Inflammation and Supporting Neurobiology

Functional medicine complements addiction care by stabilizing biological systems (Institute for Functional Medicine, n.d.):

  • Nutritional repletion: Omega-3 fatty acids, magnesium, vitamin D, iron, B-complex, and protein adequacy support neurotransmitter balance, reduce inflammation, and improve sleep quality.
  • Gut-brain axis: Address dysbiosis, improve fiber intake, and consider probiotics to reduce systemic inflammation and affect mood regulation.
  • Sleep hygiene and circadian support: Structured sleep routines, light exposure management, and breathing exercises improve cognitive function and reduce cravings (Centers for Disease Control and Prevention, n.d.).

Rationale:

  • Chronic opioid use and high stress increase inflammatory markers and disrupt neurochemical balance. Restoring foundational physiologic resilience makes medications more effective and engagement more sustainable.

Rehabilitation and Personal Injury Care: Addressing Pain Drivers That Fuel Substance Use

In injury care cases (motor vehicle accidents, workplace injuries):

  • Immediate goals: Reduce acute pain and prevent transition to chronic pain
  • Techniques: Evidence-based chiropractic manipulation, soft tissue therapy, graded exposure, ergonomic optimization, and home exercise programming.
  • Coordination: Medical oversight to ensure no contraindications (e.g., fractures, severe head injury), adjust medication plans, and manage comorbidities.

Link to SUD:

  • Injury-related pain is a common pathway to opioid exposure. Integrative rehabilitation reduces the need for high-risk analgesic strategies and supports long-term function (BMJ, n.d.; JAMA Network, Nonjudgmental Care: Practical Communication That Changes Outcomes.

Small changes in communication have outsized effects (NIDA, 2018):

  • Start with gratitude: “Thank you for coming.”
  • Affirm barriers: “I know it took a lot to get here today.”
  • Align goals: “Let’s find a plan that keeps you and your baby safe.”
  • Provide choices: Telehealth, flexible scheduling, different therapy options.
  • Be transparent about risks and laws: Share clear facts; avoid punitive tone.

Patients consistently report greater trust and willingness to return when they feel respected and supported. Engagement is the gateway to outcomes.

Emerging Topics: Genetics and GLP-1 Receptor Agonists

Genetics and SUD risk:

  • Genetic predisposition is one factor among many (environmental, social, psychological) contributing to SUD risk.
  • Direct-to-consumer and specialized genetic tests claim risk identification, but current limitations include:
    • Ethical concerns (bias, stigma)
    • Limited large-scale trials and predictive validity
    • Cost and access issues
    • Privacy concerns with third-party testing

Clinical approach:

  • Genetics may inform future personalized prevention strategies, but present-day practice focuses on modifiable risks, supportive environments, and evidence-based treatments (New England Journal of Medicine, n.d.; Nature, n.d.).

GLP-1 receptor agonists:

  • Medications like semaglutide and liraglutide have shown signals in reducing alcohol consumption in adults and lower risk of medical encounters for tobacco, cannabis, and opioid use disorder in observational claims analyses.
  • While promising, more randomized controlled trials are needed to define indications, dosing, and safety profiles for SUD treatment (New England Journal of Medicine, n.d.).

Our approach:

  • Monitor ongoing research; consider GLP-1 agonists primarily for approved indications (e.g., type 2 diabetes, obesity) while observing potential ancillary benefits on craving or consumption in appropriate cases under medical oversight.

Risk Mitigation: Naloxone, Fentanyl Awareness, and Harm Reduction

We prioritize harm reduction for all patients (Centers for Disease Control and Prevention, n.d.):

  • Universal naloxone coprescribing and training
  • Education on counterfeit pills and fentanyl contamination
  • Safe use principles: Never use alone, test doses, avoid mixing depressants
  • Overdose recognition and emergency response planning

Adolescent focus:

  • Targeted education reduces the likelihood of experimenting with prescription drug misuse. Peer-informed programs amplify impact (Centers for Disease Control and Prevention, n.d.).

Quality, Safety, and Outcomes Tracking: Making Care Measurable

We employ modern, evidence-based methods (JAMA Network, n.d.):

  • Standardized screening and outcome measures (pain scores, functional scales, mental health assessments)
  • Medication adherence checks and side effect monitoring
  • Event tracking (ED visits, hospitalizations, overdoses)
  • Patient-reported outcomes on satisfaction, engagement, and barriers
  • Continuous quality improvement cycles to refine protocols

Internal medicine oversight ensures medication safety and comorbidity management; chiropractic and rehabilitation teams document functional improvements and pain outcomes; care navigators track social determinants and resource linkages.

Real-World Implementation: How Our Clinic Operates Week to Week

  • Monday huddles: Identify high-risk transitions (post-discharge, postpartum, post-release) and assign care navigator tasks.
  • Telehealth slots reserved for patients with transport or childcare barriers.
  • Integrated visit scheduling: Patients can see medical, chiropractic, and mental health providers in coordinated blocks.
  • After-hours communication: Patient messaging for craving flares, pain spikes, or logistics issues; rapid response reduces crisis escalation.
  • Documentation of warm handoffs with named receiving providers and scheduled times.

Why Integrative Chiropractic Care Matters In SUD Treatment

Physiological rationale:

  • Pain and stress amplify craving through shared neural circuits. Reducing nociception and sympathetic drive alters the internal environment to favor recovery (Volkow et al., 2016; BMJ, n.d.).
  • Movement and manual therapy support neuroplasticity, mood regulation, and sleep quality—core drivers of resilience (Institute for Functional Medicine, n.d.).

Clinical design:

  • Match chiropractic intensity to patient stability (gentle techniques early; progress as tolerance and function improve).
  • Combine with breathing drills, sleep hygiene, and nutritional strategies for whole-person benefits.
  • Partner with internal medicine and mental health teams to ensure safety and congruence with medications and psychotherapies.

Putting It All Together: The Integrated Patient Journey

From hospital initiation of buprenorphine to outpatient stabilization, chiropractic pain management, functional nutrition, mental health support, and social services, every step has a rationale:

  • Bridge prescriptions prevent lapses.
  • Warm handoffs maintain trust.
  • Co-located services reduce friction.
  • Care navigation solves practical barriers.
  • Chiropractic reduces pain and autonomic stress; functional medicine fortifies biology.
  • Internal medicine oversight keeps treatment safe and coordinated.
  • Harm reduction prevents fatal events.
  • Outcome tracking ensures accountability and improvement.

This integrated path improves retention, lowers overdose risk, and helps patients recover function and meaning in their lives.

Key Takeaways: Simple Moves That Change Outcomes

  • Provide 2–4 week bridge prescriptions at discharge.
  • Schedule a follow-up within 48–72 hours; consider telehealth.
  • Co-locate services and include care navigation; use nonjudgmental, person-centered language and choices.
  • For pregnancy: Buprenorphine/methadone are safe; NOWS risk is not dose-dependent; postpartum dosing needs individualized adjustments.
  • For justice-involved individuals: Emphasize tolerance changes, rapid re-initiation of MOUD, and harm reduction.
  • For adolescents: Tailor to neurodevelopment; distribute naloxone; focus on mental health drivers; consider buprenorphine with careful dosing.
  • Integrate chiropractic care to reduce pain and autonomic stress; coordinate under internal medicine oversight.

Summary and Practical Steps

We presented this comprehensive educational content synthesizing frontline realities and evidence-based strategies. To act now:

  • Screen for SUD with non-stigmatizing tools
  • Offer buprenorphine with flexible induction pathways
  • Build nurse care manager follow-up flow
  • Co-locate or tightly integrate counseling, chiropractic, and rehab
  • Use peer supports for rapid engagement
  • Plan warm handoffs across transitions
  • Emphasize harm reduction throughout
  • Track outcomes and iterate

Our multidisciplinary setup in El Paso—with Dr. Cardenas as Medical Director and collaborative physician—reflects an integrative model in which medical direction and chiropractic care work synergistically to deliver patient-centered SUD treatment.

References

SEO tags: substance use disorder, opioid use disorder, buprenorphine initiation, methadone, ASAM levels of care, nurse practitioners SUD, motivational interviewing, contingency management, addiction consult services, harm reduction, chiropractic care for SUD, integrative medicine, functional medicine, pain management, personal injury care, care transitions, El Paso Texas clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, primary care SUD integration, telehealth bridge clinics, peer support, sciatica clinic, pregnancy buprenorphine safety, postpartum dose adjustments, adolescent opioid use, justice-involved overdose risk, care navigation, co-located SUD services, GLP-1 receptor agonists in SUD, naloxone distribution, autonomic regulation, central sensitization, HPA axis, neurobiology of addiction, microdosing buprenorphine, high-dose buprenorphine induction, ACS inpatient consult, warm handoffs, outcome tracking

Athletes Ask About Regenerative Therapies for Recovery

Athletes Ask About Regenerative Therapies for Recovery
Athletes Ask About Regenerative Therapies for Recovery

Athletes in El Paso Ask About Regenerative Therapies for Healing and Recovery

Athletes in El Paso, Texas, frequently ask local sports medicine and functional wellness specialists about regenerative therapies. They want clear answers about how treatments like platelet-rich plasma (PRP), platelet-fibrin products (PFP), micro-fragmented adipose tissue (MFAT), IV nutrient infusions, and peptide therapies help tissue healing. They also ask how these treatments affect training downtime and compliance with sports regulations. This article explains each approach in simple terms and shows how integrative chiropractic care addresses the root causes of movement problems that limit performance and recovery.

Athletes Ask About Regenerative Therapies for Recovery

What Regenerative Therapies Do for Injured Tissue

Regenerative therapies use materials from the body or supportive nutrients to help damaged tissue repair itself. These methods focus on growth factors, cells, and structural support rather than only short-term pain reduction. Athletes often consider them after muscle strains, tendon injuries, ligament sprains, or joint problems that do not fully resolve with rest and standard care.

The main goals are better tissue quality, less ongoing inflammation, and a safer return to training. Results improve when the therapies are paired with proper rehabilitation and attention to how the body moves.

How PRP Therapy Works

Platelet-rich plasma starts with a small blood sample taken from the athlete. The blood is spun in a centrifuge to concentrate the platelets, which contain growth factors. The concentrated plasma is then injected into the injured area, often with ultrasound guidance for precision.

These growth factors help attract repair cells, support new collagen, and reduce local swelling. PRP is commonly used for muscle strains, chronic tendon problems such as Achilles or patellar tendinopathy, and certain ligament injuries. Many athletes notice improved function when the injection is followed by a structured rehabilitation plan.

Because PRP comes from the athlete’s own blood, the chance of an allergic reaction is low. Mild soreness at the injection site usually lasts a few days. Light activity can often resume soon under professional guidance.

PFP and MFAT: Additional Regenerative Options

Platelet-fibrin products (PFP) work similarly to PRP but include a natural fibrin framework. This framework acts like a soft scaffold that holds growth factors in place longer, supporting ongoing healing signals in soft-tissue injuries.

Micro-fragmented adipose tissue (MFAT) uses a small amount of the patient’s own fat, usually taken from the abdomen. The fat is processed into tiny fragments that contain supportive cells and structural material. When injected into a joint or deeper tissue, MFAT can provide cushioning and biological signals. It is often chosen for larger partial tears, cartilage concerns, or more complex joint problems.

Both PFP and MFAT rely on the patient’s own tissues. The choice between them depends on the specific injury, imaging results, and recovery goals.

IV Infusions for Recovery Support

Intravenous nutrient infusions deliver vitamins, minerals, amino acids, and antioxidants straight into the bloodstream. Common ingredients for athletes include magnesium to help muscles relax, vitamin C and glutathione to manage oxidative stress, B vitamins for energy pathways, and amino acids that support tissue repair.

IV therapy can improve hydration and nutrient levels after hard training or competition. It works best as part of a larger plan that includes optimal nutrition, sleep, and progressive exercise. Clinics often schedule these infusions alongside other regenerative or rehabilitative treatments.

Peptide Therapies and Sports Rules

Peptides are short chains of amino acids that act as signaling molecules in the body. Some are studied for possible roles in tissue repair, reduced inflammation, and recovery support.

Athletes must check sports regulations carefully. The World Anti-Doping Agency does not prohibit platelet-derived treatments such as PRP. However, certain peptides, including BPC-157, are listed as prohibited substances. Competitive athletes should review the current WADA rules and speak with their governing body before starting any peptide protocol.

Training Downtime and Returning to Sport

Most regenerative injections involve only short-term downtime. Soreness or mild swelling is common for a few days. Providers usually recommend relative rest, avoiding anti-inflammatory medications that can interfere with healing signals, and gradually increasing movement.

A typical recovery path includes:

  • Early days focused on protection and gentle motion
  • Progressive strengthening over the following weeks
  • Sport-specific training once the tissue can handle higher loads

Full benefits often appear over weeks to months as the tissue continues to remodel. Combining the injection with skilled rehabilitation produces better long-term results than the injection alone.

How Integrative Chiropractic Care Fits Into Regenerative Treatment

Integrative chiropractic care helps athletes by combining traditional spinal adjustments with advanced soft-tissue therapies, functional rehabilitation, and regenerative medicine support. The goal is to correct the underlying cause of movement dysfunction rather than treat only the painful spot.

Spinal and joint adjustments restore proper motion and improve communication between the nervous system and the rest of the body. Soft-tissue techniques reduce restrictions and improve tissue quality. Functional exercises rebuild strength, stability, and efficient movement patterns.

When regenerative therapies are used, chiropractic care supports recovery in several practical ways:

  • Better joint alignment reduces abnormal stress on healing tissue
  • Improved nerve signaling and circulation aid the repair process
  • Correction of compensatory movement patterns prevents new problems
  • Guided progressive loading helps athletes regain strength safely

Clinical observations show that biologics help rebuild tissue while chiropractic care organizes and protects that repair. Together they address both the local injury and the larger movement system.

A Team Approach in El Paso

At Injury Medical Clinic PA in El Paso, a coordinated multidisciplinary team delivers care. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, brings clinical observations from years of treating sports injuries, personal injury cases, and complex musculoskeletal conditions. His approach combines precise chiropractic care with functional medicine principles and, when appropriate, regenerative options. He emphasizes that lasting recovery requires attention to tissue biology, joint mechanics, movement quality, nutrition, and recovery habits.

Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), serves as medical director and collaborative physician. With more than 40 years of experience as an internist, she provides medical oversight, reviews health histories, and helps ensure that regenerative and chiropractic interventions fit safely within each patient’s overall health picture. This type of collaboration is common in integrative injury-care clinics, where an MD offers medical direction alongside a chiropractor.

The team integrates:

  • Chiropractic adjustments, soft-tissue care, and functional rehabilitation led by Dr. Jimenez
  • Medical evaluation and collaborative oversight from Dr. Cardenas
  • Functional medicine strategies that address nutrition, inflammation, and recovery factors
  • Personal injury care and documentation
  • Progressive rehabilitation services

This structure allows athletes to receive coordinated support under one roof.

Practical Questions Athletes Commonly Ask

Athletes in El Paso often want to know whether they are suitable candidates, what the recovery timeline looks like, and how the treatments affect training schedules. Suitability depends on the specific injury, overall health, imaging findings, and response to earlier care. Providers screen carefully and discuss realistic expectations.

Compliance with sports rules remains important. PRP is generally permitted. Certain peptides are not. Open communication with coaches and anti-doping authorities protects eligibility.

Supporting Healing Beyond the Procedure

Successful outcomes depend on more than the regenerative treatment itself. Adequate protein, quality sleep, stress management, and consistent rehabilitation all influence how well tissue repairs. Avoiding early overload and following the care plan closely improve the chance of durable results.

Integrative chiropractic care continues after the injection phase. Adjustments maintain alignment, soft-tissue work addresses remaining restrictions, and functional exercises restore sport-ready movement. This ongoing support helps athletes return to training with greater confidence and lower risk of reinjury.

Moving Forward With Clear Information

Regenerative therapies such as PRP, PFP, MFAT, IV nutrient support, and carefully selected peptides give athletes in El Paso additional tools for tissue healing. When these options are combined with integrative chiropractic care that corrects movement dysfunction and optimizes nervous system function, recovery addresses both the local injury and the systems that keep athletes performing well.

The multidisciplinary model at Injury Medical Clinic PA—pairing Dr. Jimenez’s chiropractic and functional expertise with Dr. Cardenas’s internal medicine oversight—offers a practical path forward. Athletes benefit from clear explanations, realistic timelines, and attention to both recovery and regulatory compliance. A thorough evaluation that includes mechanical assessment and an individualized plan remains the best next step for anyone considering these options.

El Paso, TX Chiropractic Sports Injury Treatments

References

PRP Therapy for Athletes: How Professional Sports Medicine Uses Regenerative Treatments. (n.d.). OrthoRepair.

How Platelet-Rich Plasma Therapy Helps Athletes. (2022). Reagan Sports Medicine.

PRP, PFP, MFAT, and Epidural Injections After Injuries: Benefits. (n.d.). Push as Rx.

Regenerative Medicine for Joint Pain. (2026). El Paso Chiropractor Blog.

El Paso Injury Regenerative Wellness Treatments Available. (n.d.). Wellness Doctor Rx.

Platelet-Rich Plasma (PRP) Therapy. (n.d.). OrthoEdge El Paso.

Peptides. (n.d.). ADI Med Spa.

Regenerative Therapy Aftercare. (n.d.). QC Kinetix.

Sports Performance Enhancement Through Chiropractic Care. (n.d.). Team Chiropractic.

How Do Chiropractic Adjustments Influence Your Body’s Natural Healing Processes?. (n.d.). Evolve Chiropractic.

Injury Specialists. (n.d.). Dr. Alex Jimenez.

Dr. Alexander Jimenez LinkedIn Profile. (n.d.). LinkedIn.

The Prohibited List. (n.d.). World Anti-Doping Agency.

Poor Posture Ergonomic Treatment Plan for Relief

Poor Posture Ergonomic Treatment Plan for Relief
Poor Posture Ergonomic Treatment Plan for Relief

Poor Posture Ergonomic Treatment Plan: Chiropractic Care and Peptide Therapy

Abstract

Poor posture often develops from a combination of long periods of sitting, weak or poorly conditioned muscles, tight joints, repetitive movements, and daily habits. A poorly arranged workstation can make these problems worse by forcing the neck, shoulders, back, hips, and wrists into stressful positions. A practical ergonomic treatment plan for poor posture starts by adjusting the chair, desk, keyboard, and computer screen so the body can stay closer to a neutral position.

Ergonomics is only one part of the solution. Corrective exercise, movement breaks, mobility work, strengthening, and integrative chiropractic care can help address the mechanical problems that contribute to posture-related pain. In selected patients, medically supervised peptide therapies may also be considered as an additional tool for secondary joint pain, inflammation, or soft-tissue recovery. However, peptides do not straighten the spine or correct poor posture on their own, and many peptides promoted for musculoskeletal recovery remain experimental (Rahman et al., 2026).

Poor Posture Ergonomic Treatment Plan for Relief


Why Poor Posture Develops

Posture describes how the spine, joints, and muscles work together while a person sits, stands, walks, or moves. Poor posture can develop when the body repeatedly stays in positions that place extra stress on muscles and joints.

Common examples include:

  • Leaning the head forward toward a computer screen
  • Slouching in a chair
  • Sitting with rounded shoulders
  • Working with the keyboard too high
  • Sitting with the feet hanging off the floor
  • Looking down at a laptop for several hours
  • Staying in one position without movement breaks
  • Having weak core, back, hip, or shoulder muscles

Brown University Health notes that long periods of computer use with a forward head, rounded shoulders, and poor pelvic positioning commonly contribute to neck and back strain (Brown University Health Blog Team, 2024).

Poor posture is therefore not simply a problem of one bone being “out of place.” It usually has several causes. Muscles can become weak or tired, joints can become stiff, and the nervous system can become accustomed to an unhealthy movement pattern.

That is why correcting posture usually requires changing both the environment and the person’s habits.


Step 1: Adjust the Chair First

The chair creates the foundation for the rest of the workstation.

A good starting position is:

  • Keep both feet flat on the floor.
  • Keep the knees close to a 90-degree angle.
  • Keep the thighs about parallel to the floor.
  • Sit far enough back that the chair supports the pelvis and lower back.
  • Relax the shoulders.
  • Keep the elbows close to the sides.
  • Use a footrest if the feet cannot comfortably reach the floor.

Mayo Clinic recommends adjusting chair height so the feet are supported by the floor or a footrest while the thighs remain close to parallel with the floor. Armrests should allow the shoulders to stay relaxed (Mayo Clinic, 2023).

Chiropractic workplace resources provide similar recommendations. Flores Chiropractic describes keeping the feet flat with the knees near 90 degrees, while Wilderness Family Chiropractic emphasizes lower-back support and proper chair height (Flores Chiropractic, 2026; Wilderness Family Chiropractic, 2026).

Do Not Forget Lumbar Support

The lower back has a natural curve. A chair should support this curve without forcing the body too far forward.

If the chair has poor lumbar support, a small lumbar cushion or properly positioned support may help.

The goal isn’t to sit stiffly all day. The goal is to create a comfortable starting position from which the body can move naturally.


Step 2: Set the Desk and Keyboard Height

After adjusting the chair, look at the desk.

When typing:

  • Keep the elbows close to the body.
  • Aim for an elbow bend of about 90 degrees.
  • Keep the forearms close to parallel with the floor.
  • Keep the wrists straight instead of sharply bent upward.
  • Keep the mouse close to the keyboard.
  • Avoid reaching forward with the shoulders.

Mayo Clinic recommends positioning the keyboard so the wrists and forearms stay in line and the upper arms remain close to the body. Wilderness Family Chiropractic suggests keeping the elbows between about 90 and 110 degrees when using the keyboard and mouse (Mayo Clinic, 2023; Wilderness Family Chiropractic, 2026).

If the desk is too high, a person may constantly lift the shoulders while typing. If it is too low, the person may lean forward.

A practical target is a comfortable 90-degree typing position without shoulder tension.


Step 3: Move the Screen to Eye Level

Screen position is especially important for neck posture.

A monitor should generally be:

  • Directly in front of the person
  • About an arm’s length away
  • High enough that the head does not constantly tilt downward
  • Positioned with the top portion of the screen around eye level or slightly below

Mayo Clinic guidance for “tech neck” also recommends keeping the head, spine, and hips more naturally stacked, with elbows near 90 degrees and feet supported (Mayo Clinic, 2024).

If a screen is too low, people tend to move their head forward and down. Over several hours, the muscles at the back of the neck and upper shoulders must work harder.

Laptop users often have an additional problem because the screen and keyboard are connected. Raising the laptop may improve screen height but make typing difficult. One solution is to use a laptop stand with an external keyboard and mouse.


Step 4: Remember That the Best Posture Includes Movement

Even a perfectly arranged workstation cannot make sitting for eight hours healthy.

The body is designed to move.

Helpful habits include:

  • Stand regularly.
  • Walk for a few minutes.
  • Perform gentle shoulder rolls.
  • Stretch the chest.
  • Move the neck through comfortable ranges.
  • Change sitting positions.
  • Alternate between sitting and standing when possible.
  • Perform strengthening exercises for the core, hips, upper back, and shoulders.

Ergonomic research has examined workstation adjustments to reduce musculoskeletal strain among office workers. Research also shows that awkward, prolonged positions are a major ergonomic risk (Lee et al., 2021).

The important point is simple: no single posture is perfect to hold all day.


How Integrative Chiropractic Care Fits Into Posture Treatment

Ergonomic changes reduce stress on the body. Chiropractic care and rehabilitation can address what has already happened because of that stress.

Depending on the patient’s examination and diagnosis, integrative chiropractic care may include:

  • Posture assessment
  • Spinal and joint mobility testing
  • Chiropractic manipulation or mobilization
  • Soft-tissue techniques
  • Corrective exercise
  • Core stabilization
  • Hip and shoulder strengthening
  • Mobility exercises
  • Activity modification
  • Ergonomic education
  • Rehabilitation
  • Home exercise programs

Dr. Alexander Jimenez’s educational materials describe an integrated approach in which chiropractic care addresses movement and mechanical function while rehabilitation rebuilds strength and function. His published materials also stress that treatments should work together, rather than expecting one therapy to solve every part of the problem (Jimenez, 2026a).

For example, adjusting a stiff spinal joint may help movement, but the person still needs to stop leaning over a poorly positioned computer. Likewise, strengthening the upper back may help posture, but those muscles will continue to be overloaded if the monitor remains far below eye level.

The most useful plan addresses both the person and the workstation.


Can Peptide Therapy Correct Poor Posture?

No. Peptide therapy cannot directly correct poor posture.

Poor posture is mainly a mechanical and behavioral problem involving movement, muscle control, joint mobility, workstation setup, and habit.

A peptide cannot:

  • Raise a computer monitor
  • Correct sitting habits
  • Strengthen weak postural muscles without exercise
  • Teach proper movement
  • Correct an unsuitable chair
  • Replace rehabilitation
  • Replace strength training

This distinction matters because peptides are often marketed for recovery.

A 2026 review in JAAOS Global Research & Reviews discusses growing research interest in therapeutic peptides for inflammation, wound healing, muscle recovery, and other orthopedic applications. However, much of the evidence still comes from laboratory research, animal studies, and limited early human studies (Rahman et al., 2026).


Where Peptides May Fit Into an Integrative Plan

Certain peptide therapies are being studied as possible adjuncts, meaning they are added to a larger treatment plan rather than used alone.

Researchers are studying whether certain peptides may influence:

  • Inflammatory signaling
  • Collagen activity
  • Cellular communication
  • Muscle recovery
  • Tendon and ligament healing
  • Blood vessel development
  • Tissue remodeling

Several clinical and integrative medicine resources describe using peptide therapy alongside physical rehabilitation, chiropractic care, nutrition, and progressive exercise rather than as a replacement for those treatments (Mobility Chiro Therapy, n.d.; Petersen, n.d.; Jimenez, 2026a).

For someone with posture-related back or joint pain, the possible goal would therefore be to support recovery from a secondary tissue problem, not to treat the posture itself.

For example:

Ergonomics reduces the repeated strain.

Chiropractic care addresses movement and joint mechanics.

Rehabilitation strengthens and retrains the body.

Medical care evaluates pain, inflammation, medications, and health risks.

A medically appropriate peptide therapy, when supported by evidence, may serve as an additional recovery tool.


Peptide Therapy Requires Medical Caution

Not all peptides are the same.

Some peptide-based medications have established FDA-approved medical uses. However, several compounds promoted online for tissue repair or athletic recovery are not FDA-approved for those purposes.

This is especially important with products such as BPC-157, TB-500, CJC-1295, and ipamorelin.

The FDA reports limited safety information and potential concerns with several compounded peptide substances. For BPC-157, the agency states that available information is not sufficient to determine whether proposed routes of human administration are safe. FDA has also identified potential safety concerns involving CJC-1295 and ipamorelin (U.S. Food and Drug Administration [FDA], 2026).

Compounded medications also do not go through the same FDA premarket approval process used for approved drugs (FDA, 2025).

Other clinical resources similarly stress that BPC-157 and TB-500 have not been established as FDA-approved treatments for improving mobility or repairing human musculoskeletal injuries (Miami Liposuction Specialty Clinic, 2025).

For this reason, peptide therapy should never be purchased casually online or self-administered based on social media advice.


A Multidisciplinary Approach at Injury Medical Clinic PA in El Paso

At Injury Medical Clinic PA in El Paso, Texas, posture and musculoskeletal care can be approached through a multidisciplinary model.

According to clinic and professional materials, Dr. Maria Guadalupe Cardenas, MD, is Board Certified in Internal Medicine and serves as Medical Director and Collaborative Physician. Clinic materials identify her as NPI #1164426749, Texas MD License #J2933, and describe her as having more than 40 years of internal medicine experience (Jimenez, 2026b).

Dr. Cardenas works alongside Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN.

The team integrates:

  • Medical oversight
  • Chiropractic care
  • Functional medicine
  • Musculoskeletal assessment
  • Personal injury care
  • Rehabilitation
  • Corrective exercise
  • Nutrition and lifestyle strategies
  • Related recovery services

Clinic materials describe Dr. Jimenez’s role as including chiropractic, functional medicine, personal injury management, rehabilitation, and biomechanical assessment, while Dr. Cardenas provides internal medicine oversight within the integrated clinical model (Jimenez, 2026b).

This structure allows providers to address different parts of the same problem instead of treating each issue separately.


Clinical Observations From Dr. Alexander Jimenez

In his published educational materials and professional discussions, Dr. Jimenez repeatedly describes musculoskeletal recovery as a combination of mechanics, rehabilitation, lifestyle, and medical coordination.

His clinical observations suggest that posture problems are often more effectively addressed when clinicians look beyond the painful area and evaluate:

  • How the patient sits
  • How the patient moves
  • Muscle imbalances
  • Joint mobility
  • Previous injuries
  • Core strength
  • Workstation setup
  • Daily movement habits
  • Nutrition and recovery
  • Other medical conditions

These are clinical observations, not substitutes for controlled scientific studies. However, they fit with the broader idea that posture-related problems are usually multifactorial and require more than one intervention. His professional materials also emphasize that nutrition, medical treatment, chiropractic care, and rehabilitation have different roles within an integrated recovery plan (Jimenez, 2026a; Jimenez, n.d.).


A Simple Ergonomic Posture Treatment Plan

For many people, a practical starting plan looks like this:

1. Fix the chair

Keep the feet flat, knees near 90 degrees, hips supported, and lower back comfortably supported.

2. Fix the desk

Position the keyboard so your elbows stay near 90 degrees and your shoulders stay relaxed.

3. Raise the screen

Keep the monitor directly ahead, with the top of the screen around eye level.

4. Stop staying still

Stand, walk, stretch, and change position regularly.

5. Build stronger postural muscles

Strengthen the core, hips, back, and shoulder muscles under appropriate guidance.

6. Evaluate persistent pain

Pain that continues despite workstation changes may require a medical, chiropractic, or rehabilitation evaluation.

7. Address mechanical problems

Integrative chiropractic care may help selected patients improve joint mobility, movement patterns, and tolerance for rehabilitation.

8. Consider advanced therapies carefully

If inflammation, persistent pain, or soft-tissue injury is slowing rehabilitation, medically supervised supportive treatments may be discussed. Consider experimental peptides only after reviewing the evidence, risks, regulatory status, medical history, and available alternatives.


Final Thoughts

Correcting poor posture starts with mechanics.

A chair that supports the body, a desk that keeps the elbows near 90 degrees, and a screen positioned around eye level can reduce unnecessary physical strain. Regular movement, strengthening, mobility exercises, and better daily habits are equally important.

Integrative chiropractic care can add another layer by evaluating joint movement, muscle balance, spinal mechanics, and rehabilitation needs. When medical concerns are also present, multidisciplinary care allows those issues to be evaluated alongside the mechanical problem.

Peptide therapies should be viewed differently. They cannot correct posture, but selected peptide-based treatments may eventually play a useful role in musculoskeletal recovery. Current research remains developing, and many popular “recovery peptides” lack FDA approval and strong human evidence. Therefore, they should never replace ergonomics, exercise, rehabilitation, or appropriate medical care (Rahman et al., 2026; FDA, 2026).

At Injury Medical Clinic PA in El Paso, the integrated model combines the chiropractic and functional approach of Dr. Alex Jimenez with medical oversight from Dr. Maria Guadalupe Cardenas. The larger goal is not simply to make a person “sit straighter.” It is to reduce repeated physical stress, restore comfortable movement, improve strength, manage pain safely, and build habits that support better function over the long term.

Custom *FOOT ORTHOTICS* Reduce Low Back Pain  |  El Paso, TX (2019)

References

Brown University Health Blog Team. (2024, June 7). Posture and how it affects your health. Brown University Health.

Flores Chiropractic. (2026). Can simple adjustments fix your desk job posture?

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN. LinkedIn.

Jimenez, A. (2026a). Peptide therapy, nutrition, and chiropractic care explained.

Jimenez, A. (2026b). El Paso multidisciplinary injury care solutions for you.

Lee, S., de Barros, F. C., de Castro, C. S. M., & Sato, T. O. (2021). Effect of an ergonomic intervention involving workstation adjustments on musculoskeletal pain in office workers—A randomized controlled clinical trial. Industrial Health, 59(2), 78–85. https://doi.org/10.2486/indhealth.2020-0188

Mayo Clinic. (2023). Office ergonomics: Your how-to guide.

Miami Liposuction Specialty Clinic. (2025). Peptides for mobility: Evidence, risks, and regulatory status.

Mobility Chiro Therapy. (n.d.). Peptide therapy for injury recovery and performance.

Petersen, K. (n.d.). Peptide therapy.

Rahman, O. F., Lee, S. J., & Seeds, W. A. (2026). Therapeutic peptides in orthopaedics: Applications, challenges, and future directions. JAAOS Global Research & Reviews, 10(1), e25.00236. https://doi.org/10.5435/JAAOSGlobal-D-25-00236

Santé Chiropractic. (2026). Peptides for back pain, disc issues, and sciatica.

Ubie Health. (2026). Stop chronic back pain now: Why you aren’t healing.

U.S. Food and Drug Administration. (2025). Compounding and the FDA: Questions and answers.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

Wilderness Family Chiropractic. (2026). Improve desk job posture: A how-to guide.

Integrative Therapies in Action for Cognitive Decline

Learn about cognitive decline and integrative therapies aimed at supporting cognitive health and preventing decline.

Educational Abstract: Pharmacological Management of Dementia, Diagnostic Advances, and Integrative Chiropractic Care in a Multidisciplinary Clinic

As Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I present an educational, evidence-based overview of modern dementia care—focusing on Alzheimer’s disease—through a comprehensive lens that integrates internal medicine, neurology, functional medicine, rehabilitation, personal injury care pathways, and chiropractic neurophysiology. I explain current diagnostic logic, from symptom-driven models to biomarker-driven frameworks (ATN: amyloid, tau, neurodegeneration), the clinical significance of co-occurring neuropathologies, and the rationale for structured pharmacologic and non-pharmacologic treatment plans. I highlight how our multidisciplinary team in El Paso, Texas—under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933)—collaborates at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) to provide medical oversight, diagnostic alignment, and integrative chiropractic care across cognitive, autonomic, and neuromusculoskeletal domains. I summarize the latest disease-modifying therapies (DMTs), including amyloid-targeted monoclonal antibodies (aducanumab, lecanemab, donanemab), real-world risks like amyloid-related imaging abnormalities (ARIA), and how genetics (APOE4) influences safety and monitoring. I detail the state of blood-based biomarkers (phospho-tau217, GFAP, NfL), the role of PET scans and lumbar punctures, polypharmacy considerations, behavioral and neuropsychiatric symptom management, cardiovascular and perfusion principles, neuroinflammation, lifestyle factors, and rehabilitative strategies. This post is designed to guide patients, families, and clinicians through a clear journey from diagnosis to targeted interventions using modern, validated methods.

Introduction: How I Think Through Dementia in Clinical Practice

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In my practice at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I work alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), who has more than 40 years of experience in internal medicine. Our multidisciplinary clinic structure is a model increasingly common in integrative and injury care settings—where an MD provides medical direction and diagnostic oversight in concert with chiropractic, functional medicine, rehabilitation, and personal injury services. This powerful synergy between different medical disciplines is a philosophical commitment to treating the whole person.

When a patient presents with memory changes, executive function difficulties, or new behavioral changes, I begin with a structured pathway that prioritizes clarity and safety. My approach is informed by leading research and clinical frameworks from neurology, internal medicine, and geriatrics. I also integrate chiropractic neurophysiology and functional medicine strategies to address perfusion, autonomic imbalance, neuroinflammation, and biomechanical stressors that may compound cognitive symptoms.

This educational post summarizes:

  • The modern diagnostic approach to Alzheimer’s disease and related dementias, including symptom criteria and biomarker frameworks such as ATN.
  • Why co-existing neuropathologies are common and how that changes treatment logic.
  • The pharmacologic approach for cognitive and neuropsychiatric symptoms, from established medications to emerging therapies.
  • The role of disease-modifying therapies, including who is a candidate and how to manage them safely.
  • How our team integrates chiropractic care with internal medicine oversight, functional medicine, and rehabilitation.
  • Practical care strategies for patients and families, supported by contemporary evidence.

Throughout, I share the rationale behind each clinical decision—why we choose a given test, why we consider a certain medication, and how integrative chiropractic care fits into the therapeutic plan.

The Foundation of Diagnosis: A Deep and Methodical Symptom History

When a patient presents with concerns about their memory or thinking, our journey begins with the most fundamental step: taking a thorough, detailed symptom history. This is far more than a simple checklist of symptoms. It is an investigative process, a narrative we build together to understand the full picture of what the patient is experiencing. I always ask a series of probing questions to paint this picture as clearly as possible:

  • “When did you first notice these changes?”
  • “Can you describe for me what it feels like when you have a ‘senior moment’ or a lapse in memory?”
  • “What specific situations seem to be the most challenging for you?”
  • “Is there anything you’ve found that seems to make your thinking clearer or, conversely, what makes the fogginess worse?”
  • “Are there any other symptoms that have appeared around the same time, even if they seem unrelated?”

It is crucial to explore not just the cognitive symptoms, such as memory loss or difficulty with problem-solving, but also the psychiatric symptoms. We know that conditions like anxiety and depression often co-occur with cognitive decline and can significantly impact a person’s quality of life. Understanding these associated symptoms is vital for a comprehensive treatment plan.

The Value of a Secondary Historian

A unique and best-practice element in evaluating cognitive decline is gathering information from a secondary historian. This is not necessarily a formal “caregiver” but rather someone who knows the patient well—such as a spouse, an adult child, or a close friend—and with whom the patient is comfortable sharing information. The flow of information is directed to me, the clinician, to enrich the history, not from me to this other person.

In my clinical experience, most patients are very open to this. We all have blind spots: habits, behaviors, or subtle changes in our daily functioning that we may not recognize in ourselves but that are apparent to those who spend a lot of time with us. This secondary perspective provides an invaluable layer of detail, helping to corroborate the patient’s report and often revealing changes in activities of daily living or social interactions that the patient might have overlooked or minimized. This collaborative approach to history-taking is where the diagnostic process truly begins.

My Diagnostic Philosophy: Moving From Symptoms Alone to Biomarkers and Structured Logic

When I evaluate cognitive decline, I consider two parallel tracks:

  • Symptom-based classification: What is measurable, observable, and functionally impactful?
  • Biomarker-based classification: What is the neurobiological substrate driving symptoms?

Traditionally, many clinicians diagnosed probable Alzheimer’s disease by observing the pattern and onset of cognitive symptoms: insidious onset, progressive memory impairment with poor recall of recent events despite cues, and deterioration in other domains such as language, visuospatial skills, and executive function. Advanced age is the strongest risk factor. However, our diagnostic logic has shifted to incorporate biomarkers, which reflect the presence and sequence of disease processes long before symptoms appear.

I educate patients and families that the pathophysiology begins years—often 15 to 20—before cognitive testing demonstrates impairment. During this subclinical window, amyloid and tau accumulate, transitioning from soluble forms to aggregated plaques (amyloid) and neurofibrillary tangles (tau), eventually killing neurons and leading to measurable neurodegeneration. This sequence has been elegantly detailed by researchers who have modeled biomarker dynamics over time.

The key takeaways I emphasize:

  • Amyloid accumulation appears early and likely initiates a cascade that facilitates tau pathology.
  • Tau pathology correlates more tightly with symptom severity and progression once clinical impairment is evident.
  • Neurodegeneration—loss of brain volume and network integrity—accumulates steadily and becomes visible on imaging or measurable via emerging blood biomarkers.

This framework sets the stage for targeted testing and treatment decisions.

The Comprehensive Diagnostic Workup: Beyond the Initial Conversation

Following the detailed history, we move on to a structured, multifaceted evaluation. Each component is a piece of the puzzle, helping us narrow down the potential causes of the cognitive changes.

The Neurological Examination

A comprehensive neurological exam is a standard part of our workup. In the early stages of many neurodegenerative conditions, I may not expect to find major neurological deficits. Things like deep tendon reflexes, gait, and mobility might appear normal for quite some time, depending on the underlying pathology. However, the exam is still essential. It establishes a baseline and can sometimes reveal subtle signs that point us in a specific direction. For example, slight changes in gait or balance could suggest a vascular component to the cognitive decline or hint at other neurological conditions.

Assessing Mood and Mental Health

It is impossible to accurately assess cognition without also assessing mood. Therefore, administering scales for depression and anxiety is a critical step. However, a significant challenge is that many standard screening tools, such as the Patient Health Questionnaire-9 (PHQ-9), have not been validated for individuals living with moderate-to-advanced cognitive decline. A person who has impairments in judgment, reasoning, and memory may struggle to accurately self-report their symptoms on these questionnaires.

Despite these limitations, I find these tools helpful as a starting point. They can open up a conversation about mood and provide a preliminary indication of a potential co-occurring psychiatric condition. For patients with more significant cognitive impairment, we may consider using neuropsychiatric scales specifically designed for this population, which often rely more on observable behaviors and caregiver reports.

The Power of Neuropsychological Testing

Neuropsychological testing is an incredibly powerful and helpful tool. If available within a patient’s health system, I strongly recommend it. Neuropsychologists conduct comprehensive evaluations that go far beyond the brief cognitive screens we might administer in the clinic. They involve a battery of standardized tests that measure various cognitive domains in detail, including:

  • Attention and concentration
  • Executive functions (planning, organizing, problem-solving)
  • Language abilities
  • Visuospatial skills
  • Learning and memory (both verbal and visual)

The detailed report from a neuropsychological evaluation provides an objective profile of a person’s cognitive strengths and weaknesses. This is invaluable for me as a clinician in narrowing down a diagnosis, distinguishing between different types of dementia, and establishing a robust baseline against which we can measure future changes or the effects of treatment. Fortunately, neuropsychology practices are often available in the community and provide testing for learning differences and other conditions, making them somewhat more accessible than other subspecialties.

Visualizing the Brain: The Role of Neuroimaging

In the primary care and integrative setting, our initial approach to neuroimaging typically begins with structural imaging. The preferred modality is a Magnetic Resonance Imaging (MRI) of the brain. An MRI provides a detailed look at the brain’s structure, allowing us to identify:

  • Evidence of strokes (both large and small)
  • Tumors or other masses
  • Hydrocephalus (excess fluid in the brain)
  • Patterns of atrophy (shrinkage) in specific brain regions, which can be suggestive of certain types of dementia (e.g., hippocampal atrophy in Alzheimer’s disease)

If a patient is unable to undergo an MRI (for instance, due to a pacemaker or severe claustrophobia), a Computed Tomography (CT) scan is an alternative. However, it provides less detailed soft-tissue contrast. Structural imaging is essential for ruling out “reversible” or treatable causes of cognitive symptoms and for identifying cerebrovascular disease that may be contributing to the clinical picture.

Essential Laboratory Studies

Before jumping to more specialized tests, it is critical to perform a panel of basic laboratory studies. These “Tier 1” tests, as outlined in recent guidelines, help us identify systemic medical issues that can masquerade as or exacerbate cognitive decline. If a patient hasn’t had recent lab work, this is a non-negotiable step. Our standard panel includes:

  • Complete Blood Count (CBC): To check for anemia or infection.
  • Comprehensive Metabolic Panel (CMP): To assess kidney function, liver function, and electrolyte balance.
  • Thyroid-Stimulating Hormone (TSH): To screen for hypothyroidism, a well-known cause of cognitive slowing and “brain fog.”
  • Vitamin B12: To check for deficiency, which can cause significant neurological and cognitive symptoms.
  • Folate: Deficiency can also contribute to cognitive symptoms.
  • Inflammatory Markers: such as C-reactive protein (CRP), to gauge the body’s overall inflammatory state.

This foundational lab work ensures we are not overlooking a treatable metabolic or nutritional deficiency that could be the primary driver of the patient’s symptoms.

The ATN Framework: Amyloid, Tau, Neurodegeneration

I use the ATN criteria to anchor our diagnostic plan:

  • A: Amyloid pathology—measured via amyloid PET or CSF Aβ42/Aβ40 ratios. Blood-based amyloid assays are advancing and increasingly accurate, though not yet considered the gold standard for definitive diagnosis.
  • T: Tau pathology—measured via CSF phosphorylated tau (p-tau) or tau PET. Emerging blood-based p-tau assays provide valuable information and may serve as proxies for amyloid burden and tau status.
  • N: Neurodegeneration—measured via structural MRI (preferably) or CT, and increasingly via blood markers such as neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP). These tests reflect neuronal injury and glial activation.

In our clinic, under Dr. Cardenas’s medical direction, we pursue ATN testing when symptoms warrant it. We do not recommend biomarker testing in completely asymptomatic individuals because age-related changes may elevate markers without clear clinical significance.

Why ATN matters:

  • It enables timely and accurate identification of Alzheimer’s disease processes.
  • It guides eligibility and timing for disease-modifying treatments.
  • It informs prognostic counseling, clarifying why certain symptoms are present and what might evolve.
  • It supports personalized treatment planning, including pharmacology, rehabilitation, and lifestyle recommendations.

Advanced and Specialized Testing: A Look into the Future

Once we have completed the foundational workup, we can discuss with the patient pursuing more specialized testing. This decision is highly individualized and depends on the clinical scenario, the patient’s wishes, and their candidacy for emerging treatments. These advanced tests include:

  • Plasma-Based Biomarkers: These are exciting new blood tests that can detect the protein pathologies of Alzheimer’s disease (amyloid and tau) with increasing accuracy. You will encounter markers like p-tau217, GFAP, NfL, and Aβ42/Aβ40 ratios. These offer a less invasive way to gain biological evidence of the disease, improve diagnostic confidence, and guide referrals.
  • Cerebrospinal Fluid (CSF) Analysis: This involves a lumbar puncture (spinal tap) to directly measure the levels of amyloid and tau proteins in the fluid that bathes the brain and spinal cord. It remains a gold standard for biological confirmation of Alzheimer’s pathology.
  • Amyloid PET Scans: This is an advanced imaging technique where a radioactive tracer that binds to amyloid plaques is injected, allowing us to visualize the amyloid burden in the living brain.
  • Genetic Testing: Specifically, testing for the Apolipoprotein E (APOE) gene, particularly the e4 allele, which is a significant genetic risk factor for late-onset Alzheimer’s disease.

It is crucial to emphasize that pursuing this level of testing is a significant decision. It is often done in the context of considering disease-modifying treatments, such as the newer amyloid-targeted therapies, as eligibility for these treatments currently requires confirmation of amyloid pathology via PET or CSF.

Understanding Co-Occurring Neuropathologies: Why Brains Rarely Have One Pathology

One of the most important realities I share with patients is that multiple neuropathologies often co-exist. Large-cohort autopsy data have shown that individuals frequently exhibit combinations of amyloid plaques, tau tangles, micro- and macroinfarcts (vascular pathology), Lewy bodies (alpha-synuclein pathology), and TDP-43 pathology (commonly associated with later-onset limbic-predominant age-related TDP-43 encephalopathy, often overlapping with frontotemporal patterns).

Clinical implications:

  • It is common to see Alzheimer’s biomarkers alongside Lewy body pathology or vascular changes.
  • Mixed pathology explains heterogeneous symptom profiles—for example, Alzheimer’s biomarkers with prominent visuospatial or executive dysfunction, parkinsonian features, or fluctuating attention.
  • Treatment often requires multimodal strategies rather than relying on a single pharmacologic agent.
  • Patients may benefit from precision counseling that acknowledges that overlapping pathologies require nuanced monitoring and layered interventions.

This understanding also reframes expectations about disease-modifying therapies. If multiple pathological processes are present, addressing only one may yield modest benefits unless accompanied by strategies to mitigate vascular risk factors, autonomic dysfunction, neuroinflammation, sleep disturbances, and physical deconditioning.

The DetectAD Guidelines: A New Framework for Diagnosis

A new set of clinical practice guidelines has recently revolutionized the field of dementia diagnosis. These guidelines, supported by the Alzheimer’s Association and published in 2025 in the journal Alzheimer’s & Dementia, are called DetectAD. They were developed by a panel of experts following a rigorous literature review and provide a clear, structured framework for clinicians. Importantly, the guidelines offer distinct pathways for primary care clinicians and dementia subspecialists, acknowledging that most initial evaluations occur in primary care settings.

Core Elements of the DetectAD Evaluation

The DetectAD framework is built around several core elements, with communication serving as the bookends of the entire process.

  1. Establishing Expectations and Goals: The very first step is a conversation about the diagnostic process itself. What can the patient expect? What are their goals? Do they even want a specific diagnosis? We must respect a patient’s autonomy; just because we can perform a test does not mean the patient wants it. This initial conversation also establishes who should be involved. The guidelines strongly recommend that a trusted family member or friend participate in this shared journey.
  2. Comprehensive Assessment: This mirrors the multifaceted workup we have already discussed:
    • History Taking: Covering cognitive, functional (activities of daily living), neuropsychiatric, and sensory-motor symptoms.
    • Medical, Social, and Family History: Identifying risk factors is key. We know that conditions like diabetes, hypertension, chronic kidney disease, sleep apnea, and substance use disorders are significant risk factors for both neurodegenerative and cerebrovascular diseases. The concept of Alzheimer’s as “type 3 diabetes,” while perhaps an oversimplification, highlights the profound connection between metabolic health and brain health.
    • Clinical Examination: Including a formal mental status exam using a validated tool. While the Medicare Annual Wellness Visit allows for a simple query about memory, the guidelines advocate for at least a Mini-Cog or a similar brief, validated instrument.
  • Synthesizing and Staging: After gathering all the information, the clinician’s job is to synthesize it to arrive at a diagnosis. This involves:
    • Categorizing the Syndrome: Is the person cognitively unimpaired? Do they have Subjective Cognitive Decline (SCD), where they feel a change, but we cannot yet measure it on tests? Do they have Mild Cognitive Impairment (MCI), where there are measurable deficits, but their daily functioning remains independent? Or do they have dementia, where the cognitive impairment is severe enough to interfere with independence in daily life?
    • Staging Dementia: If dementia is diagnosed, it should be staged as mild, moderate, or severe using tools like the Clinical Dementia Rating (CDR).
    • Determining Etiology: The final step is to determine the most likely underlying cause (e.g., “dementia most likely due to Alzheimer’s disease”). This entire process informs our ICD-10 coding, ensuring accurate documentation.
  • Communicating Findings and Shared Care Planning: The final core element brings us back to communication. The diagnosis and its implications must be communicated clearly and compassionately, not just to the patient but also to their care partner. The subsequent care plan is not something dictated by the clinician; it is developed collaboratively, reflecting the shared goals and values of the patient and their family.

A Phased Approach to Evaluation

The DetectAD guidelines emphasize that this comprehensive evaluation is not meant to be completed in a single, rushed 15-minute appointment. When a concern for cognitive impairment arises, I often find it most effective to schedule a dedicated, longer follow-up visit. This allows us to give the concern the time and attention it deserves. Studies have shown that patients who voice subjective cognitive concerns to their primary care providers and receive no further evaluation often feel frustrated and dismissed. A dedicated visit validates their concerns and initiates a thoughtful, structured process. This also means we do not just “jump right to the referral.” We do the foundational work first.

The Shifting Paradigm: Is Alzheimer’s a Single Disease?

We are living in an era where our very understanding of Alzheimer’s is being challenged. We are moving away from the idea of it being one single entity and toward a more nuanced view of it as a spectrum of Alzheimer’s disease disorders. The biological underpinnings are complex and heterogeneous. A person might have:

  • An amyloidopathy (a primary problem with amyloid protein accumulation).
  • A tauopathy (a primary problem with tau protein tangles).
  • A mixed picture involving both, along with other pathological proteins.
  • Significant contributions from inflammation, vascular damage, or exposure to toxins.

This complexity leads to a critical new conversation in our field: the distinction between preclinical Alzheimer’s disease (the presence of positive biomarkers like amyloid plaques but no symptoms) and symptomatic Alzheimer’s disease. Currently, our treatments and clinical focus are almost exclusively on the symptomatic stage. We do not yet have an evidence-based consensus on what to do for an individual who has the brain pathology of Alzheimer’s but is completely asymptomatic.

From a patient’s perspective, this can raise the question: “Does it really matter if it’s Alzheimer’s?” The answer is, “It depends.” For now, the symptom burden remains the primary guide for our treatment plan. However, as new therapies emerge that target specific pathologies, knowing the underlying biological cause will become increasingly critical for selecting the right treatment for the right patient. While I always respect a patient who says, “I’m not interested in knowing the label,” I also explain that knowing the likely cause can be immensely helpful for me, as their clinician, in crafting the most effective and personalized management strategy.

Understanding Clinical Trial Outcomes in Alzheimer’s Research

When we discuss the effectiveness of Alzheimer’s medications, you’ll often hear references to specific assessment tools used in clinical trials. You need to understand what these tools measure, as it helps put the “clinical meaningfulness” of a drug’s effect into perspective.

Key Assessment Tools

  • Clinical Dementia Rating (CDR): I am a big fan of the CDR. It evaluates a person across six key domains: Memory, Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies, and Personal Care. The “Sum of Boxes” (CDR-SB) score is a global measure derived from these categories, providing a comprehensive snapshot of a person’s functional and cognitive status.
  • Mini-Mental State Examination (MMSE): This is a well-known 30-item questionnaire that assesses various cognitive functions, such as orientation, recall, attention, and language. A lower score indicates greater cognitive impairment.
  • Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Another widely used tool in clinical trials, the ADAS-Cog is a more detailed assessment of cognitive dysfunction, particularly memory and language. Unlike the MMSE, a higher score on the ADAS-Cog signifies greater impairment.

Understanding these tools is the first step in interpreting the data on the medications we’re about to discuss.

Pharmacologic Management of Cognitive Symptoms: Evidence and Rationale

Alzheimer’s disease and related disorders commonly utilize two established classes of cognitive-symptom medications: cholinesterase inhibitors and NMDA receptor antagonists.

Acetylcholinesterase Inhibitors: The First Line of Symptomatic Treatment

For the last 25 years, the cornerstone of symptomatic treatment for mild to moderate Alzheimer’s disease has been the class of drugs known as acetylcholinesterase inhibitors. The most commonly used agents are donepezil (brand name Aricept), rivastigmine (brand name Exelon), and galantamine.

How Do They Work?

The primary mechanism of action of these medications is to prevent the breakdown of acetylcholine in the brain. Acetylcholine is a crucial neurotransmitter involved in memory, learning, and most notably, attention. The logic is straightforward: you cannot remember something if you did not pay attention to it in the first place. In Alzheimer’s disease, the brain cells that produce acetylcholine are progressively destroyed. By inhibiting the enzyme (acetylcholinesterase) that breaks down acetylcholine, these drugs increase its availability in the synaptic cleft, helping to bolster attentional networks and overall communication between brain cells. This is also why we are so careful to avoid anticholinergic medications (like certain allergy medicines, overactive bladder drugs, or sleep aids), as they have the opposite effect and can worsen cognitive function.

Reviewing the Clinical Evidence

Let’s travel back to the late 1990s and look at one of the pivotal Phase III randomized controlled trials for donepezil (Aricept). Published in 1998, this study enrolled about 450 people and followed them for six months.

The results showed a modest but statistically significant benefit. On average, patients on the active drug experienced a slight improvement or, more commonly, a slower rate of decline on cognitive measures compared to the placebo group. For example, the placebo group experienced an average decline of one point on the 30-point MMSE scale, while the donepezil group showed an average increase of 0.4 points. It is crucial to frame these expectations correctly with patients and families. These drugs are not a cure. They do not stop or reverse the underlying disease process. The goal of symptomatic treatment is to help maintain function and temporarily stabilize symptoms, potentially “turning back the clock” on the disease by about 6 to 12 months.

Adverse Effects and Monitoring

It’s easy to forget that when these drugs were first studied, the clinical trials had very strict inclusion and exclusion criteria. This was due to known adverse effects.

  • Gastrointestinal Effects: A majority of patients starting donepezil will experience nausea and diarrhea to some degree. This is why we always start at a low dose (typically 5 mg) and titrate up slowly. These side effects can be significant enough to cause people to stop the medication. This is also a primary reason why some patients are switched to the rivastigmine patch, which delivers the medication transdermally and provides more stable drug levels.
  • Cardiovascular Effects: A less common but more serious set of adverse effects involves electrophysiologic changes in the heart. About a quarter to a third of patients may experience bradyarrhythmias (abnormally slow heart rhythms) and syncope (fainting). The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults lists a history of syncope as a strong reason to discontinue these drugs. I have certainly encountered patients who were on a path toward getting a pacemaker for bradycardia when the real culprit was their donepezil.

Our team, under Dr. Cardenas’s medical direction, monitors heart rate, blood pressure, GI tolerance, and falls, adjusting dosing if patients develop these issues.

NMDA Receptor Antagonists: A Different Approach

The other major class of symptomatic medication is the N-methyl-D-aspartate (NMDA) receptor antagonist. The only drug in this class is memantine (brand name Namenda). It is typically used for moderate to severe Alzheimer’s disease.

How Does It Work?

Memantine works on the glutamate system. Glutamate is the most abundant excitatory neurotransmitter in the brain. In Alzheimer’s disease, it’s believed that damaged neurons leak excessive amounts of glutamate, leading to chronic overstimulation of NMDA receptors. This state, called excitotoxicity, allows a constant influx of calcium into the neuron, ultimately causing cell damage and death.

Memantine gently blocks these receptors, but only when they are being overstimulated. It doesn’t interfere with the normal signaling required for learning and memory. By blocking the “excess noise” of glutamate, memantine is thought to protect neurons from further damage.

Clinical Evidence and Side Effects

The side effects of memantine are generally less common than with acetylcholinesterase inhibitors, but some patients experience agitation or somnolence (drowsiness). A key study from the early 2000s showed that, similar to donepezil, patients on memantine maintained their cognitive scores better than the placebo group. The drug was very well-tolerated. However, memantine truly seems to shine in the functional domain, especially when combined with a cholinesterase inhibitor.

The Power of Combination Therapy

The gold standard for symptomatic treatment in moderate to severe Alzheimer’s has become the combination of an acetylcholinesterase inhibitor and an NMDA receptor antagonist.

A pivotal 2012 study published in JAMA Neurology examined this synergy by dividing patients into four groups: placebo, donepezil only, memantine only, and combination therapy.

  • Cognitive Decline: A clear pattern emerged. The placebo group showed the greatest decline, the single-drug groups showed less decline, and the combination therapy group had the least amount of cognitive decline of all.
  • Activities of Daily Living (ADLs): The most dramatic separation between the groups was seen in ADLs. The data showed that patients on combination therapy remained more independent and autonomous for longer. This translates directly to a better quality of life and reduced caregiver burden. This is a profoundly meaningful outcome for families.

The Real-World Implications of Symptomatic Treatments

  • Modest Benefits: The improvements are not dramatic. We are promising patients that these medications may help them decline more slowly.
  • High Variability: Not every patient will respond.
  • Low Threshold for Discontinuation: As a clinician, I have a very low threshold for stopping these medications if a patient cannot tolerate them. If a patient on donepezil has a syncopal episode (fainting), the risk of injury from a fall far outweighs the modest cognitive benefit. The medication has to go.

The Root Causes of Pain-Video

The Root Causes of Pain | El Paso, Tx (2023)

Managing Neuropsychiatric Symptoms: The Hidden Crisis

I want to shift our focus to a critically important area: neuropsychiatric symptoms (NPS), also known as behavioral and psychological symptoms of dementia (BPSD). While cognitive decline is the hallmark of Alzheimer’s, it is often the NPS that cause the most distress for both patients and their families and are most likely to lead to institutional placement.

Assessing Neuropsychiatric Symptoms

The first step is to actively screen for these symptoms using validated tools like the Neuropsychiatric Inventory (NPI) or the Revised Memory and Behavior Problems Checklist (RMBPC). A crucial point about these tools is that they are validated for caregiver or care partner report. Patients may lack the insight to accurately report these symptoms, underscoring the absolute necessity of engaging a secondary historian.

Common Categories of Neuropsychiatric Symptoms

  • Hyperactivity/Agitation: Agitation, pacing, rummaging, irritability, and disinhibition (saying or doing socially inappropriate things).
  • Mood Symptoms: Depression & Anxiety are extremely common.
  • Apathy: A profound lack of interest, motivation, or emotional response.
  • Psychosis: Hallucinations (seeing or hearing things that are not there) and delusions (fixed, false beliefs, such as believing someone is stealing from them).
  • Sleep & Appetite Disturbances: Nighttime behaviors and changes in appetite.

The “DICE” Approach: A Framework for Management

Before ever reaching for a prescription pad, we must investigate the root cause of the behavior. A helpful framework for this is the DICE approach: Describe, Investigate, Create, Evaluate.

  1. Describe: Get a detailed description of the behavior from the caregiver.
  2. Investigate: Rule out underlying physical causes. This is where our integrative model shines. We look for:
    • Physical Causes: Pain, infection (especially UTIs), constipation, dehydration, fatigue.
    • Underlying Psychiatric Conditions: Pre-existing depression or anxiety.
    • Environmental Factors: An environment that is too stimulating or under-stimulating.
    • Sensory Changes: Misinterpreting sights or sounds due to uncorrected vision or hearing loss.
  • Create: Develop a non-pharmacological management plan first. This may involve simplifying the environment, establishing a predictable routine, using calming music, or engaging the person in a simple, meaningful activity.
  • Evaluate: Monitor the plan’s effectiveness and adjust as needed.

A Cautious Approach to Pharmacological Intervention

If non-pharmacological strategies are insufficient, we may consider medication.

  • Depression/anxiety/agitation: SSRIs (e.g., sertraline, citalopram) are often a good first choice, with attention to side effects.
  • Agitation/irritability: After evaluating for pain, infection, or other triggers, short-term pharmacologic options may be considered. We avoid benzodiazepines where possible due to cognitive and fall risks.
  • Psychosis: Antipsychotics should be reserved for true psychosis that is distressing or dangerous. I see far too much use of antipsychotics to help a patient sleep at night. This is an inappropriate use of this class of drugs, given their significant risks in older adults, including an increased risk of stroke and death (the basis for their “black box” warning).

Our internal medicine oversight by Dr. Cardenas is essential for managing comorbidities and drug interactions, especially when polypharmacy can produce cascading adverse effects.

The Power of Pharmacogenetic Testing

This brings me to a tool that has been a game-changer in my practice: pharmacogenetic testing. This simple cheek swab analyzes a person’s genes to predict how they will metabolize and respond to various medications, including antidepressants and antipsychotics.

In a population with a limited life expectancy, we do not have the luxury of the traditional “trial-and-error” method, which can waste three to six months. Pharmacogenetic testing provides a roadmap, helping us get to the right treatment faster and more safely. It has been surprisingly easy to implement in our practice, with good insurance coverage, and it provides immeasurable value.

Disease-Modifying Therapies (DMTs): The Evolving Landscape

For decades, our treatments have been purely symptomatic. But the landscape is rapidly changing. We are now entering an era of disease-modifying therapies that target the underlying biology of Alzheimer’s disease.

Amyloid-Targeted Therapies: What We Know About Aducanumab, Lecanemab, and Donanemab

I cover three notable monoclonal antibodies that target and remove amyloid from the brain:

  • Aducanumab: Achieved accelerated approval due to robust amyloid reduction but lacked consistent cognitive benefits across trials and carried significant ARIA risk. The evidence showed one positive and one negative Phase 3 outcome, raising questions about efficacy.
  • Lecanemab: Demonstrated statistically significant slowing of cognitive decline in early Alzheimer’s, with a defined safety profile and ARIA risk stratified by APOE4 status.
  • Donanemab: Showed slowing of progression with trial-based staging and adaptive dosing; also associated with ARIA risk modulated by APOE4 genetics.

What ARIA Is and Why Genetics Matters

The major safety concern with these therapies is ARIA, short for amyloid-related imaging abnormalities, which comes in two flavors detected on MRI:

  • ARIA-E: vasogenic edema or sulcal effusions.
  • ARIA-H: microhemorrhages or superficial siderosis.

Risk is substantially higher in APOE ε4 carriers, especially those who are ε4/ε4. In trial data, ε4/ε4 carriers experienced ARIA at rates roughly double or higher than non-carriers. In our clinic, we incorporate APOE genotyping into the pre-eligibility workup. It refines risk estimates and anchors informed consent. Some systems may exclude ε4/ε4 from treatment due to elevated risk.

Who Is a Candidate and When

The evolution of these FDA-approved anti-amyloid therapies has created a new pathway in care. We use a checklist under medical direction to determine candidacy:

  • Clinical stage: Greatest potential benefit is in early symptomatic phases (MCI due to Alzheimer’s or mild Alzheimer’s dementia).
  • Biomarker confirmation: Candidacy requires amyloid positivity via PET or CSF; emerging blood biomarkers may play a supportive role but are not yet sufficient for eligibility.
  • MRI baseline: Assess for structural vulnerabilities, such as extensive microhemorrhages, which may increase risk.
  • Medical comorbidities: Cardiovascular stability and anticoagulation considerations are key.
  • Patient goals and logistics: Expectations must be realistic; DMTs modify the disease trajectory rather than cure pathology. Patients and families must be willing to commit to regular infusions and monitoring.

With Dr. Cardenas leading medical direction, our team ensures that candidates receive baseline MRI, neurological evaluation, and clear follow-up plans, coordinating with specialty centers as needed.

Our Integrative Model: How Chiropractic Care Fits With Medical Oversight, Functional Medicine, and Rehabilitation

While chiropractic is not a direct “treatment” for Alzheimer’s disease, its principles and practices play a powerful supportive role. At Injury Medical Clinic PA, we build comprehensive plans that do not compete with DMTs but rather optimize patient resiliency, reduce falls, and maintain independence.

The Role of Integrative Chiropractic Care in Supporting Cognitive Health

My approach as a Doctor of Chiropractic is rooted in several key areas:

  • Optimizing Nervous System Function: Through gentle, specific chiropractic adjustments, my goal is to restore proper motion and alignment to the spinal joints. This can improve proprioception (the body’s sense of position), reduce chronic pain signals that act as a physiological stressor, and help balance the autonomic nervous system (ANS), shifting it away from a dominant “fight-or-flight” state that is detrimental to brain health.
  • Enhancing Cerebral Blood Flow and CSF Dynamics: Proper movement of the cervical spine (the neck) is thought to facilitate optimal blood flow to the brain. Furthermore, the gentle, rhythmic motion induced by spinal adjustments may help promote the circulation of cerebrospinal fluid (CSF), which is critical to the brain’s waste-cleansing system (the glymphatic system).
  • Addressing Musculoskeletal Comorbidities: Patients with cognitive decline are at a high risk for falls. By improving gait, balance, and managing pain through non-pharmacological means, we can directly reduce fall risk, which is a major cause of morbidity and loss of independence.
  • Autonomic regulation: Gentle spine and rib cage mobilization, diaphragmatic mechanics training, and postural interventions can normalize autonomic tone, supporting heart rate variability (HRV), sleep quality, and sympathetic-parasympathetic balance.
  • Perfusion optimization: Cervicothoracic mobility and scapulothoracic mechanics influence respiratory efficiency, which contributes indirectly to brain clearance pathways.
  • Pain modulation: Chronic pain amplifies stress hormones, disrupts sleep, and worsens cognition. By addressing spinal dysfunctions, we may reduce nociceptive load and improve daily function.
  • Gait and fall risk: Targeted balance and gait work reduces fall risk and helps preserve independence.

A Functional Medicine and Lifestyle-Based Approach

My practice is deeply integrated with the principles of functional medicine, which seeks to understand the root causes of dysfunction. In collaboration with Dr. Cardenas, we guide our patients on key lifestyle modifications that form the bedrock of brain health:

  • Nutrition: Guidance on an anti-inflammatory, nutrient-dense diet.
  • Exercise: Personalized programs that include aerobic activity, strength training, and balance work.
  • Sleep: Emphasis on sleep hygiene and treatment of underlying sleep disorders like sleep apnea.
  • Stress Management: Teaching stress-reduction techniques and using chiropractic adjustments to help modulate the body’s physiological stress response.

This collaborative model ensures that every patient receives a holistic assessment and a care plan that leverages the strengths of multiple disciplines. For our patients with Alzheimer’s disease, this means we are not just prescribing medication; we are building a supportive framework to enhance cognitive resilience, manage behavioral symptoms, and maintain physical function.

Clinical Observations From My Practice

Drawing from cases shared through resources like Sciatica Clinic and professional channels, I consistently observe:

  • Patients with chronic neck and thoracic dysfunction who receive gentle, tailored chiropractic care often experience improved sleep, reduced headaches, and steadier mood—factors that indirectly support cognition.
  • Breathing mechanics training reduces sympathetic drive, stabilizes HRV, and improves energy levels, which correlates with better daily functioning.
  • Coordinated internal medicine oversight from Dr. Cardenas reduces adverse medication events, enabling patients to benefit from cognitive enhancers and other therapies with fewer complications.

These patterns, which you can explore further through my work at Sciatica Clinic and my professional profile, reinforce that integrative care is not ancillary—it is central to maintaining function and quality of life.

Conclusion: A Modern, Integrative Pathway for Dementia Care

The journey through cognitive decline is complex and deeply personal. As clinicians, our role has evolved from simply managing symptoms to becoming navigators, investigators, and care partners. The latest research and guidelines provide us with a methodical framework for diagnosis, emphasizing thoroughness and shared decision-making. Our therapeutic landscape is expanding, offering not only established symptomatic treatments but also the promise of disease-modifying therapies that target the underlying biology of Alzheimer’s disease.

At Injury Medical Clinic, we believe the most effective approach is integrative. The collaboration between the medical oversight provided by Dr. Cardenas and the holistic, function-focused approach of chiropractic and functional medicine allows us to care for the whole person. By optimizing nervous system function, improving musculoskeletal health, reducing pain, and empowering patients with lifestyle strategies, we aim to enhance their quality of life, maintain their independence for as long as possible, and support them and their families on every step of this challenging journey. We hope that this knowledge empowers you and underscores our commitment to providing comprehensive, evidence-based, and compassionate care.

References

Disclaimer: This post is for educational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional for any health concerns.

SEO tags: Alzheimer’s disease, dementia diagnosis, ATN biomarkers, amyloid therapies, lecanemab, donanemab, aducanumab, ARIA, APOE4, p-tau217, cholinesterase inhibitors, memantine, disease-modifying therapies, ARIA monitoring, neuropsychiatric symptoms, agitation in dementia, pharmacogenetic testing, caregiver education, integrative chiropractic care, internal medicine oversight, functional medicine, autonomic regulation, cerebral perfusion, neuroinflammation, gait and balance rehabilitation, El Paso dementia clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, sciatica clinic resources, multidisciplinary dementia care, cognitive decline, activities of daily living, caregiver support, neurodegenerative disease, brain health, personal injury care, rehabilitation

Integrative Regenerative Chiropractic Medicine Overview

Integrative Regenerative Chiropractic Medicine Overview
Integrative Regenerative Chiropractic Medicine Overview

Integrative Regenerative Chiropractic Medicine for Optimal Cellular Health

Abstract

Regenerative medicine focuses on supporting the body’s natural repair systems rather than merely masking pain. Treatments such as platelet-rich plasma (PRP), platelet fibrin plasma (PFP), microfragmented adipose tissue (MFAT), and some cell-based therapies use platelets, growth factors, cells, and signaling molecules to influence the environment around injured tissue. These signals may help regulate inflammation, support blood vessel growth, improve cell communication, and encourage tissue repair. However, the effects differ by treatment, and many regenerative therapies remain under active study.

A broader recovery plan may also include medically appropriate IV therapy, integrative chiropractic care, functional medicine, exercise, nutrition, and rehabilitation. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within a multidisciplinary model that combines chiropractic and rehabilitation with medical oversight. This article explains how these different parts of care may work together and reviews the limits of current evidence.

Integrative Regenerative Chiropractic Medicine Overview

What Is Regenerative Medicine?

Regenerative medicine is a growing area of healthcare that tries to improve the environment in which the body heals. Instead of simply blocking pain signals, some regenerative treatments use biological materials taken from blood, bone marrow, fat tissue, or other sources to influence the body’s repair response.

This does not mean that every regenerative treatment can regrow a damaged joint, disc, tendon, or ligament. Hospital for Special Surgery notes that the science is still developing and that the term “regeneration” can sometimes suggest more tissue regrowth than research has actually proven. However, certain therapies may change the tissue environment, reduce pain, influence inflammation, and support repair (Hospital for Special Surgery, 2024).

Researchers studying stem cells have found that much of their potential benefit may come from cell signaling rather than simply turning into replacement tissue. Mesenchymal stromal or stem cells can release cytokines, extracellular vesicles, growth factors, and other signaling substances that communicate with nearby cells and influence immune activity (Jin et al., 2023; Ennis et al., 2013).

In simple terms, regenerative treatments may help create a better biological setting for healing.

Biological Signals: Giving Cells Instructions to Repair

Cells do not work alone. They constantly send chemical messages to one another.

When tissue is injured, the body releases signals that control:

  • Inflammation
  • Immune-cell activity
  • Blood vessel formation
  • Collagen production
  • Cell growth and survival
  • Tissue remodeling

Research on mesenchymal stem cells shows that these cells can respond to the inflammatory environment and release factors that may help change immune activity and support healing. Growth factors involved in regenerative signaling may include vascular endothelial growth factor, platelet-derived growth factor, transforming growth factor, insulin-like growth factor, and fibroblast growth factors (Jin et al., 2023).

This helps explain why regenerative medicine is often described as working through biological signaling.

Rather than functioning like a pain medication that primarily alters how pain is perceived, a regenerative treatment may aim to influence what is happening around damaged tissue.

PRP: Concentrating the Body’s Own Healing Signals

Platelet-rich plasma, or PRP, is one of the best-known orthobiologic treatments.

A healthcare professional draws a small amount of the patient’s blood and processes it in a centrifuge. This separates and concentrates platelets. The platelet-rich portion is then placed into a selected injured area.

Platelets are well known for their role in clotting, but they also contain substances involved in repair. When activated, platelets release growth factors that communicate with cells involved in healing.

Hospital for Special Surgery explains that PRP contains proteins that may influence inflammation, pain, and tissue repair. Laboratory research has also shown that preparations rich in platelet growth factors can influence fibroblast activity, which is important because fibroblasts help make collagen and repair connective tissue (Anitua et al., 2009).

PRP may therefore be considered for selected:

  • Tendon injuries
  • Ligament injuries
  • Muscle injuries
  • Joint problems
  • Osteoarthritis
  • Certain sports injuries

It is important to understand that PRP is generally injected into a specific tissue or joint. Evidence is stronger for local biological effects than for claims that PRP broadly lowers inflammation throughout the entire body.

What Is PFP?

PFP, or platelet fibrin plasma, is another blood-based preparation being studied in regenerative medicine.

PFP contains platelets along with fibrin and other blood components that can form a biological framework around an injured area. Fibrin acts somewhat like a temporary scaffold that may hold platelets and signaling molecules in place while tissue is healing.

Research published in Tissue Engineering and Regenerative Medicine examined the use of physiologically concentrated PFP in difficult-to-heal wounds and found evidence of biological activity associated with tissue repair (Fan et al., 2024).

However, PFP is a less standardized term than PRP or platelet-rich fibrin (PRF). Preparation methods may vary, and the evidence for musculoskeletal use is still developing.

Patients should therefore understand exactly what type of platelet product is being offered and why it has been selected.

MFAT: Using the Healing Environment of Adipose Tissue

Microfragmented adipose tissue (MFAT) is derived from the patient’s own fat.

Fat contains more than stored energy. Adipose tissue also contains blood vessels, supportive connective tissue, growth factors, and a mixture of cells involved in immune regulation and tissue maintenance. MFAT processing is designed to preserve portions of this natural tissue environment while making it suitable for targeted use.

MFAT has been explored for problems such as:

  • Knee osteoarthritis
  • Cartilage injuries
  • Tendon injuries
  • Ligament injuries
  • Degenerative joint conditions

Adipose-derived cell preparations may influence inflammation and healing, in part, through signaling molecules released by cells within the tissue, rather than simply replacing damaged structures.

Evidence-based guidelines published in the Journal of Pain Research describe regenerative procedures as an evolving area of chronic pain management. Evidence differs greatly by condition, treatment method, processing system, and type of biologic product used (D’Souza et al., 2024).

Do Stem Cells Reduce Inflammation?

Mesenchymal stem cells have attracted attention because they appear to communicate with immune cells.

Research suggests that these cells can sense signals in an inflamed environment and then release cytokines, growth factors, and other molecules that may help regulate excessive inflammatory activity. This is known as an immunomodulatory effect (Ennis et al., 2013).

They may also release substances involved in:

  • Angiogenesis, or new blood vessel formation
  • Cell survival
  • Collagen organization
  • Immune regulation
  • Tissue remodeling

The paracrine or signaling effect may be as important as the cells’ ability to become other cell types (Jin et al., 2023).

Still, patients should be cautious about broad claims involving “stem cell therapy.” The FDA continues to warn consumers that many stem-cell and human-cell products advertised for orthopedic, neurologic, and other conditions are not FDA-approved for those uses. In 2026, the FDA again warned about potentially serious risks from unapproved human cell and tissue products.

How IV Therapy Fits Into Cellular Support

IV therapy is different from PRP, PFP, or MFAT.

An IV places fluids, nutrients, medications, or other medically selected compounds directly into the bloodstream. When there is a real medical need, IV therapy can be useful for hydration, correcting certain deficiencies, or delivering medications.

For example:

  • B vitamins participate in energy metabolism.
  • Magnesium supports normal muscle and nerve function.
  • Glutathione is part of the body’s antioxidant defense system.
  • Fluids can help correct dehydration.

These nutrients are important for normal cellular function and antioxidant balance.

However, IV vitamin or nutrient therapy should not automatically be described as regenerative medicine or as a proven treatment for systemic inflammation. Benefits depend on the patient’s health, nutrient status, IV ingredients, dose, and reason for treatment.

Medical review is especially important because IV therapy is not appropriate for everyone. Kidney disease, heart disease, medication interactions, electrolyte problems, allergies, and other conditions can affect safety.

Where Integrative Chiropractic Care Fits In

Regenerative injections may influence the biological environment of injured tissue, but healing also depends on how the person moves.

Pain can change the way muscles work. Injuries may lead to stiffness, guarding, weakness, reduced activity, and abnormal movement patterns. This is where chiropractic care and rehabilitation may complement medically appropriate regenerative treatment.

Integrative chiropractic care may include:

  • Spinal or joint manipulation when appropriate
  • Mobilization
  • Soft-tissue treatment
  • Corrective exercise
  • Strength training
  • Mobility work
  • Postural training
  • Neuromuscular rehabilitation

Spinal manipulation has been shown to provide small to modest improvements in pain and function for some people with low back and neck pain. Research has also identified short-term changes in several inflammatory or pain-related signaling molecules after manipulation, although these biological findings remain preliminary.

For this reason, it is more accurate to say that chiropractic treatment may improve joint motion, reduce pain, and support rehabilitation than to claim that adjustments permanently “realign” the spine or consistently lower systemic inflammation.

A better mechanical environment may allow a patient to move more comfortably while rehabilitation strengthens the tissues surrounding the injured region.

Combining Biology With Mechanical Rehabilitation

An integrated treatment plan can look at two important parts of recovery:

Biological support

  • PRP or other platelet preparations
  • Selected cell- or tissue-based procedures
  • MFAT when medically appropriate
  • Nutrition
  • Correction of documented nutrient deficiencies
  • Physician-guided IV therapy when indicated

Mechanical and functional support

  • Chiropractic care
  • Progressive rehabilitation
  • Strength training
  • Mobility exercises
  • Movement retraining
  • Return-to-work or return-to-sport conditioning

A 2025 review on regenerative medicine and physical rehabilitation describes the potential of integrating biological signaling with controlled mechanical loading, rather than relying solely on injections. The authors also emphasize that treatment protocols still require better standardization and higher-quality long-term research (Muthukrishnan & Rajadurai, 2025).

Multidisciplinary Care at Injury Medical Clinic PA in El Paso

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes a multidisciplinary model combining chiropractic care, functional medicine, injury management, medical evaluation, and rehabilitation.

Dr. Jimenez’s published clinical materials emphasize looking beyond a single painful body part. His approach may include examination of spinal and joint mechanics, strength, mobility, lifestyle factors, nutritional status, rehabilitation needs, and medical concerns when developing an individualized plan. His practice materials list services involving personal injury care, chiropractic rehabilitation, functional medicine, and medically integrated treatment.

Medical Oversight From Dr. Maria Guadalupe Cardenas

Dr. Maria Guadalupe Cardenas, MD, is identified by the practice as its medical director and collaborative physician. She is an internal medicine physician with more than 40 years of clinical experience. Texas Medical Board documentation verifies that Texas physician license J2933 is currently listed as expired as of May 31, 2027. Public professional sources also identify her field as internal medicine.

This type of multidisciplinary structure allows internal medicine oversight to work alongside chiropractic and rehabilitation services.

The team can therefore consider several sides of an injury:

  • Dr. Cardenas: medical history, internal medicine concerns, medication safety, laboratory findings, systemic disease, and medical oversight.
  • Dr. Jimenez: chiropractic evaluation, neuromusculoskeletal function, movement, functional medicine, personal injury management, and rehabilitation.
  • Rehabilitation team: mobility, strength, stability, endurance, and progressive return to activity.
  • Functional medicine support: nutrition, lifestyle factors, metabolic health, and other contributors to recovery.

This structure can be especially useful for people recovering from motor vehicle accidents, workplace injuries, sports injuries, chronic joint problems, or complex musculoskeletal conditions.

The Goal: Create a Better Environment for Recovery

One treatment rarely controls healing.

Cells need adequate oxygen, nutrients, blood flow, signaling molecules, appropriate immune activity, and mechanical stimulation. At the same time, the patient needs enough mobility and strength to gradually return to normal activity.

Regenerative medicine may help influence the biological side of healing, while chiropractic care and rehabilitation can address the movement and mechanical side of recovery.

The goal is not simply to hide pain. The goal is to determine which tissue is injured, what is limiting recovery, which treatments have reasonable scientific support, and how those treatments can be combined safely.

  • Not every patient needs regenerative injections.
  • Not every patient needs IV therapy.
  • Not every injury is appropriate for manipulation.

Treatment should follow a proper examination, diagnosis, imaging when necessary, and consideration of the patient’s overall medical condition.

Conclusion

PRP, PFP, MFAT, cell-based therapies, medically appropriate IV support, chiropractic care, and rehabilitation work in very different ways. Some regenerative treatments deliver growth factors or cellular signals that may influence inflammation and repair. Chiropractic and rehabilitation focus more directly on pain, mobility, strength, joint function, and movement.

The strongest approach is therefore not to view regenerative medicine as a miracle treatment. Instead, it can be considered one part of a larger, medically supervised recovery plan.

At Injury Medical Clinic PA in El Paso, the multidisciplinary model described by Dr. Alexander Jimenez combines integrative chiropractic care, functional medicine, personal injury management, and rehabilitation with internal medicine oversight from Dr. Maria Guadalupe Cardenas. This type of coordinated approach allows biological, mechanical, and general medical factors to be considered together when developing an individualized plan.

Unlocking the Secrets of Inflammation: Integrative Medicine Approach | El Paso, Tx (2023)

References

Anitua, E., Sánchez, M., Zalduendo, M. M., de la Fuente, M., Prado, R., Orive, G., & Andía, I. (2009). Fibroblastic response to treatment with different preparations rich in growth factors. Cell Proliferation, 42(2), 162–170.

D’Souza, R. S., Her, Y. F., Hussain, N., et al. (2024). Evidence-based clinical practice guidelines on regenerative medicine treatment for chronic pain: A consensus report from a multispecialty working group. Journal of Pain Research, 17, 2951–3001.

Ennis, W. J., Sui, A., & Bartholomew, A. (2013). Stem cells and healing: Impact on inflammation. Advances in Wound Care, 2(7), 369–378.

Fan, L., Zhang, Y., Yin, X., Chen, S., Wu, P., Huyan, T., Wang, Z., Ma, Q., Zhang, H., Wang, W., Gu, C., Tie, L., & Zhang, L. (2024). The effect of platelet fibrin plasma (PFP) on postoperative refractory wounds: Physiologically concentrated platelet plasma in wound repair. Tissue Engineering and Regenerative Medicine, 21(8), 1255–1267.

Hospital for Special Surgery. (2024). 5 things to know about regenerative medicine treatments.

Hospital for Special Surgery. (2024). Regenerative medicine for orthopedics: Biologic therapies.

Jin, Y., Li, S., Yu, Q., Chen, T., & Liu, D. (2023). Application of stem cells in regeneration medicine. MedComm, 4, e291.

Kentuckiana Pain Specialists. (2026). IV nutrition therapy FAQ.

Muthukrishnan, P., & Rajadurai, S. (2025). Regenerative medicine combined with physiotherapy in orthopedic rehabilitation: Evidence, mechanisms, and clinical protocols. WebLog Journal of Orthopaedics.

National Center for Complementary and Integrative Health. (n.d.). Spinal manipulation: What you need to know.

New Jersey Regenerative Institute. (n.d.). How stem cells power regenerative medicine to repair tissues and support faster healing.

U.S. Food and Drug Administration. (2026). Patient and consumer warning about potential serious risks of harm following use of unapproved products.

BioEvolve Physical Medicine & Rehabilitation. (n.d.). Adipose tissue cells (MFAT).

Jimenez, A. (n.d.). Dr. Alex Jimenez: Chiropractic, functional medicine, personal injury, and rehabilitation.

A Clinical Approach to Toxic Exposure in Health Care

Learn about the clinical approach to toxic exposure and its role in enhancing patient care and safety measures.

Educational Abstract: Integrative, Evidence-Based Toxicology Care From Emergency Stabilization To Functional Recovery

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I guide you through a clear, evidence-based roadmap for recognizing, stabilizing, and treating toxic exposures and ingestions across emergency, ICU, and integrative injury-care settings. Drawing on contemporary toxicology research, frontline clinical practice, and multidisciplinary collaboration, I explain:

  • The physiologic logic behind toxidromes and how to identify them at the bedside
  • Practical decontamination strategies and when GI interventions add value
  • Antidotes and reversal strategies for organophosphates, anticholinergics, sympathomimetics (e.g., cocaine, methamphetamine), opioids, tricyclic antidepressants, ethylene glycol, acetaminophen, cyanide, and salicylates
  • Advanced protocols: high-dose naloxone, insulin therapy, lipid emulsion (intralipid), cyproheptadine for serotonin syndrome, octreotide for sulfonylurea hypoglycemia, and precision anticoagulant reversal
  • Airway-first principles in severe metabolic acidosis and DKA, including ventilation matching
  • How integrative chiropractic care fits safely into a medically directed toxicology workflow with functional medicine, rehabilitation, and personal injury care
  • The team-based approach at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I practice with our Medical Director and Collaborative Physician, Maria Guadalupe Cardenas, MD (Board Certified, Internal Medicine; NPI #1164426749; Texas MD License #J2933), whose 40+ years of internal medicine expertise guide safety, diagnostics, and pharmacologic oversight

I present modern, evidence-based methods and highlight clinical observations from my practice and shared resources at sciatica. clinic and my professional updates on LinkedIn. The goal is simple: make complex toxic emergencies understandable and actionable, while showing how a multidisciplinary, integrative model improves outcomes.

Integrative Toxicology Care Model: Medical Direction Meets Chiropractic And Functional Recovery

I practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. Our multidisciplinary setup is common in integrative and injury care clinics and is built on the principle that complex cases benefit from coordinated expertise:

  • Medical Direction and Oversight (Dr. Cardenas)
    • Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933
    • 40+ years of experience directing diagnostics, antidote selection, pharmacologic safety, and escalation decisions
  • Chiropractic Care (Dr. Jimenez)
    • Neuromusculoskeletal recovery, autonomic regulation, respiratory mechanics optimization, and pain modulation
  • Functional Medicine
    • Nutrition, detoxification capacity, mitochondrial health, endocrine function, inflammation, and microbiome support
  • Personal Injury Care
    • Documentation, case management, occupational/environmental exposure tracking, and rehabilitation pathways
  • Rehabilitation Services
    • Physical therapy, graded exercise, neurodynamic techniques, and mobility restoration

Our model is MD-directed, chiropractor-integrated, functionally informed, and rehab-supported—particularly effective when patients face toxic exposures that require acute stabilization followed by long-term recovery. The coordination ensures the right interventions at the right time, with appropriate safety checks.

Foundations Of Toxicology: Physiology, Priorities, And Practical Steps

Understanding toxicology begins with physiology. Each antidote and protocol maps to a specific receptor, enzyme, channel, or cellular pathway.

Physiology First: How Toxins Disrupt Systems

  • Receptors and Channels
    • Muscarinic and nicotinic acetylcholine receptors govern autonomic signaling; overstimulation leads to secretions, bradycardia, fasciculations, and weakness (WHO, n.d.)
    • GABA-A and NMDA receptors are central to inhibitory and excitatory CNS control; sedative-hypnotics depress, excitotoxins provoke
    • Sodium and potassium channels drive cardiac conduction; blockade widens QRS and predisposes to ventricular arrhythmias (EMCrit Project, n.d.)
  • Key Enzymes
    • Acetylcholinesterase inhibition by organophosphates generates cholinergic crises.
    • Alcohol dehydrogenase (ADH) converts ethylene glycol and methanol into toxic acids (NEJM, n.d.)
  • Transport and pH
    • Weak acids/bases change ionization with pH shifts; bicarbonate reduces cardiotoxicity via conduction effects and protein binding (EMCrit Project, n.d.)
  • Volume of Distribution & Protein Binding
    • Dialysis, intralipid, or charcoal efficacy depends on solubility, binding, and distribution characteristics (ACMT, n.d.; UpToDate, n.d.)

Primary Assessment: ABCs Lead The Way

  • Airway
    • Protect against aspiration and obstruction, especially with hypersecretions (cholinergic crises) or depressed mental status (opioids/sedatives)
  • Breathing
    • Watch for hypoventilation (opioids), bronchorrhea (organophosphates), hyperventilation (salicylates)
  • Circulation
    • Manage hypotension (sedatives/TCA overdose) or hypertensive crises (sympathomimetics); early EKG for conduction delay.s
  • Glucose
    • Immediate fingerstick; toxins and therapies (e.g., insulin therapy) alter glucose levels
  • Temperature
    • Treat hyperthermia aggressively to prevent organ damage

I often initiate benzodiazepines early for agitation, seizures, or severe sympathetic activation—reducing catecholaminergic surges, improving myocardial oxygen balance, and protecting neurologic function (Wightman & Nelson, 2022).

Decontamination: What Works, WhaDoesn’t’t, And When To Use It

Dermal And Inhalational Decontamination

  • Water irrigation is usually sufficient; avoid agents that increase dermal penetration.
  • Proper PPE for organophosphate exposure to prevent secondary contamination (WHO, n.d.)
  • Remove from source; provide supplemental oxygen; consider bronchodilators for bronchospasm.m

Gastrointestinal Decontamination

  • Induced emesis is no longer recommended (ACMT, n.d.)
  • Gastric lavage has limited indications and requires airway protection
  • Activated charcoal (UpToDate, n.d.)
    • Most effective within 4 hours for adsorbable compounds
    • Avoid in unprotected airways; intubate first if needed
    • Poor efficacy for iron, lithium, alcohols, caustics, and some heavy metals
  • Whole bowel irrigation (PEG)
    • Useful for body packers/stuffers and sustained-release or charcoal-inaccessible toxins (ACMT, n.d.)
  • Hemodialysis
    • Effective for small, water-soluble, low protein-binding toxins like ethylene glycol, methanol, sometimes salicylates (NEJM, n.d.)
    • Not useful for highly protein-bound, lipophilic drugs (e.g., TCAs), but corrects severe acid-base disturbances

These choices hinge on time since ingestion, substance properties, airway status, and hemodynamic stability.

Anticholinergic Toxidrome: Recognition And Management

Clinical Pattern

  • Blind as a bat (mydriasis, blurred vision)
  • Red as a beet (flushed skin)
  • Hot as a hare (hyperthermia)
  • Dry as a bone (anhidrosis, dry mucosa)
  • Mad as a hatter (delirium, agitation, psychosis)
  • Full as a flask (urinary retention)
  • EKG may reveal wide QRS (>100 ms) with sodium-channel blockade in TCA overdoses (EMCrit Project, n.d.)

Common Agents

  • Anticholinergics (atropine, scopolamine)
  • Antihistamines (diphenhydramine, doxylamine)
  • Psychotropics (TCAs, antipsychotics)
  • Plants (jimsonweed)

WhIt’s’s Dangerous

  • Depressed sweating, impaired heat dissipation, tachycardia, and conduction slowing via fast sodium channel blockade (TCAs) raise risk of ventricular arrhythmias.

Management

  • Airway/Breathing: Intubate if needed; correct acidosis
  • Seizures/Agitation: Benzodiazepines first-line
  • Perfusion: IV fluids; norepinephrine if needed
  • Activated charcoal if early and airway protected
  • Systemic alkalinization with sodium bicarbonate infusion to narrow QRS and reduce arrhythmias (EMCrit Project, n.d.)
  • Cooling for hyperthermia
  • Physostigmine can be considered under expert guidance, excluding TCA overdose; requires EKG monitoring

Cholinergic Crisis: Organophosphate And Carbamate Poisoning

Pathophysiology

Acetylcholinesterase inhibition causes acetylcholine accumulation:

  • Muscarinic overstimulation: SLUDGE/DUMBELS—salivation, lacrimation, urination, diarrhea, GI cramping, emesis, bronchorrhea, bronchospasm, bradycardia, miosis
  • Nicotinic overstimulation: Fasciculations, weakness, paralysis—especially diaphragm involvement (WHO, n.d.)

Clinical Priorities

  • Decontamination: Remove clothing, copious water irrigation; strict PPE
  • Airway: Elevate head-of-bed, suction secretions, early intubation if needed
  • Seizures: Benzodiazepines first-line

Antidotes

  • Atropine
    • Blocks muscarinic receptors, reducing secretions
    • Titrate 2–5 mg IV every 3–5 minutes; endpoint is drying of secretions and improved ventilation
  • Pralidoxime (2-PAM)
    • Reactivates acetylcholinesterase by removing the organophosphate
    • Give early to prevent irreversible aging; consider continuous infusion (WHO, n.d.)

Monitor for intermediate syndrome—delayed neuromuscular weakness post-stabilization.

Sympathomimetic Toxicity: Cocaine, Methamphetamine, Amphetamines

WhatYou’lll See

  • Euphoria, restlessness, paranoia, agitation, psychosis
  • Mydriasis, tachycardia, hypertension, hyperthermia
  • Diaphoresis—key differentiator from anticholinergic toxicity (hot and wet vs hot and dry)
  • Severe complications: coronary vasospasm, arrhythmias, seizures, rhabdomyolysis, stroke (AHA, n.d.)

Management

  • Benzodiazepines to reduce central sympathetic outflow
  • Vasodilators (nitroprusside, nicardipine, nitroglycerin) for severe hypertension or vasospasm
  • Avoid pure beta-blockers (e.g., metoprolol) due to unopposed alpha; consider labetalol or prioritize vasodilators (AHA, n.d.)
  • Cooling to prevent rhabdomyolysis
  • Hydration, CK/renal monitoring
  • Activated charcoal if ingestion and protected airway
  • Whole bowel irrigation for body packers/stuffers
  • Sodium bicarbonate for wide QRS due to sodium-channel blockade (EMCrit Project, n.d.)

Continuous cardiac monitoring and serial EKGs guide risk.

Opioid Toxicity And High-Dose Naloxone: Breathing Comes First

Presentation

Opioids depress brainstem respiratory centers, causing hypoventilation, hypercapnia, hypoxemia; miosis is common but not universal.

Naloxone Strategy

  • Start low if withdrawal risk is high in chronic users; prioritize ventilation in apnea.a
  • High-dose naloxone escalation may be necessary for synthetic opioids (fentanyl analogs); repeated boluses or infusion due to short naloxone half-life (CDC, n.d.)
  • Airway support: Bag-valve mask, oxygen, intubation if inadequate response

Monitor for rebound respiratory depression and pulmonary edema; consider infusion for long-acting agents.

Acetaminophen Toxicity: Timing, Staging, And N-Acetylcysteine

Key Timing

  • First ideal level at 4 hours post-ingestion; earlier draws can be falsely reassuring
  • If time is unknown, draw on arrival and again at 4 hours (National Library of Medicine, n.d.)

Why N-acetylcysteine (NAC) Works

  • Replenishes glutathione, detoxifying NAPQI—the hepatotoxic metabolite
  • Protects hepatocytes; earlier administration improves outcomes (Heard, 2008)

Use the Rumack–Matthew nomogram for single acute ingestions; start NAC for delayed presentations with elevated transaminases or prolonged ingestion profiles. Monitor LFTs, INR, bilirubin, renal function, and mental status.

Ethylene Glycol And Toxic Alcohols: Crystals, Acidosis, And ADH Blockade

Clinical Clues

  • Early CNS depression; later anion gap metabolic acidosis
  • Calcium oxalate crystals in urine; risk of renal failure
  • Methanol causes optic nerve injury and severe acidosis; isopropanol causes ketosis without acidosis

Pathophysiology

  • Ethylene glycol is metabolized via ADH to glycolic acid and oxalic acid
  • Oxalic acid complexes with calcium, forming calcium oxalate crystals and damaging renal tubules (NEJM, n.d.)

Management

  • Fomepizole: Potent ADH inhibitor—halts toxic metabolite production
  • Ethanol: Historical competitive inhibitor when fomepizole unavailable
  • Hemodialysis: Removes parent compounds and metabolites; corrects severe acidosis/electrolytes
  • Bicarbonate: Supports pH and reduces cardiac irritability
  • Correct hypocalcemia cautiously; treat symptomatic cases

Early ADH blockade prevents renal failure and systemic complications.

Sodium Channel Blockade And Sodium Bicarbonate: Electrical Rationale

EKG Patterns

  • Wide QRS (>100 ms)
  • Rightward axis and terminal R wave in aVR
  • Risk of ventricular arrhythmias (EMCrit Project, n.d.)

Why Bicarbonate Helps

  • Alkalinizes serum to reduce drug binding to sodium channels
  • Increases protein binding, reducing active free drug
  • Narrows QRS and improves conduction velocity

Use bolus plus infusion strategies, monitoring pH, potassium, and EKG changes. Titrate to effect (often pH 7.45–7.55).

Lipid Emulsion Therapy (Intralipid): The”“Lipid Sink” For Cardiotoxic Emergencies

Indications

  • Local anesthetic systemic toxicity (LAST) (bupivacaine)
  • Lipophilic cardiotoxins: some TCAs, verapamil/diltiazem, beta-blockers, quetiapine, others (EMRA, n.d.)

Mechanism

  • Lipid sink: Sequesters lipophilic toxins from myocardium/CNS, reducing free active drug
  • Provides fatty acids to support myocardial contractility

Protocol Considerations

Administer per dosing guidelines; monitor for pancreatitis, fat overload, and lab assay interference. Use adjunctively with ACLS, vasopressors, bicarbonate, or HIET depending on toxin.

High-Dose Insulin Euglycemia Therapy (HIET): Severe Beta-Blocker And CCB Overdose

When To Use

  • Cardiogenic shock from beta-blockers or calcium channel blockers (Levine et al., 2021; Shepherd & Velez, 2018)

How It Works

  • Improves myocardial inotropy and carbohydrate utilization
  • Facilitates glucose transport into myocytes
  • Requires dextrose infusion and frequent glucose/potassium monitoring

Combine with vasopressors, calcium, glucagon (beta-blocker), lipid emulsion, and bicarbonate if conduction slows.

Cyanide And Carbon Monoxide: Inhalational Toxins And Cellular Hypoxia

Cyanide Poisoning: A Cellular Asphyxiant

  • Source: Combustion of synthetic materials (fires), industrial exposures
  • Mechanism: Inhibits cytochrome c oxidase (complex IV) in mitochondria—blocks oxidative phosphorylation, causes histotoxic hypoxia and profound lactic acidosis
  • Clinical imperative: Do not delay treatment for labs in suspected cases; manage airway and acidosis aggressively

Antidote Evolution

  • Historical cyanide kits (nitrites + sodium thiosulfate) induced methemoglobinemia—now largely obsolete
  • Hydroxocobalamin is first-line: binds cyanide to form cyanocobalamin (vitamin B12) for renal excretion; causes benign reddish skin and dark red urine (Lawson-Smith et al., 2011)

Carbon Monoxide Poisoning: Deceptive Oxygenation

  • Pulse oximetry and PaO2 can appear normal; definitive test is CO-oximetry for carboxyhemoglobin (COHb%) (Rose et al., 2017)
  • Mechanism: CO binds hemoglobin with 200–250x higher affinity than oxygen and shifts the dissociation curve left, reducing tissue oxygen delivery
  • Treatment: 100% high-flow oxygen; consider hyperbaric oxygen (HBO) for severe cases, LOC, pregnancy, or end-organ injury (Weaver et al., 2002; Hampson et al., 2012)

Salicylate Toxicity: Uncoupled Oxidative Phosphorylation And Mixed Acid-Base Disorder

Pathophysiology

  • Uncouples oxidative phosphorylation—energy loss as heat, leading to hyperthermia
  • Produces high anion gap metabolic acidosis; direct medullary stimulation causes primary respiratory alkalosis, resulting in a mixed disorder (O’Malley, 2007)

Clinical Spectrum

  • Tinnitus (classic early sign), nausea, vomiting
  • Kussmaul respirations, hyperthermia, confusion
  • Risk of non-cardiogenic pulmonary edema and ARDS

Management

  • Airway protection, aggressive cooling, fluids
  • Activated charcoal if early and airway protected
  • Urinary alkalinization with sodium bicarbonate:
  • Typical regimen: 3 amps bicarbonate in 1 L D5W, target urine pH ≥ 7.5, serum pH 7.45–7.55
  • Potassium repletion is essential to enable renal ion trapping (Molloy et al., 2019)
  • Hemodialysis for severe toxicity, renal failure, refractory acidosis, or coma (Choi et al., 2010)

Serotonin Syndrome: Differentiation And Targeted Therapy

Recognition

  • Agitation, tachycardia, hypertension, hyperthermia, hyperreflexia, clonus, myoclonus
  • Triggers: SSRIs, MAOIs, polypharmacy (including John’s Wort), drug interactions

Differentiation From NMS

  • Serotonin syndrome: hyperreflexia/clonus; rapid onset
  • NMS: lead-pipe rigidity, bradyreflexia; slower onset

Management

  • Benzodiazepines for agitation and seizure control
  • Aggressive cooling; antipyretics are ineffective
  • Cyproheptadine (oral) as a serotonin antagonist when enteral route is available (Boyer & Shannon, 2005)

Sulfonylurea-Induced Hypoglycemia: Octreotide And Disposition

Problem

Sulfonylureas stimulate pancreatic insulin release, causing prolonged hypoglycemia (12–24 hours).

Management

  • Dextrose infusion with frequent glucose checks
  • Octreotide (somatostatin analog) to suppress insulin secretion in refractory or recurrent hypoglycemia (Huang & Unger, 2006)
  • Admission/observation to prevent unsafe discharge

Anticoagulant Reversal: Heparin, Warfarin, And DOAC Precision

Heparin

  • Protamine neutralizes unfractionated heparin; partial effect on enoxaparin; dosing precision to avoid hypotension or paradoxical effects (McLean, 2012)

Warfarin

  • Vitamin K plus four-factor PCC (e.g., Kcentra, Focsar) or plasma to restore factors II, VII, IX, X—PCC preferred for speed and low volume (Sarode et al., 2013)

DOACs

  • Dabigatran: Idarucizumab—monoclonal fragment antidote
  • Rivaroxaban/apixaban: Andexanet alfa—decoy factor Xa (Connolly et al., 2019)
  • Edoxaban: Andexanet may be considered off-label; many centers use four-factor PCC when specific reversal is unavailable or unaffordable

Benzodiazepine Overdose: Flumazenil With Caution

Risks And Use Cases

  • Flumazenil can precipitate withdrawal seizures in chronic users
  • Appropriate for pediatric accidental ingestions or procedural sedation reversal in monitored settings
  • Avoid in mixed overdoses where reversing benzodiazepines can unmask pro-convulsants

Vasopressor Extravasation: Phentolamine Rescue And Tissue Preservation

Protocol

  • Stop infusion; keep catheter in place; inject phentolamine through the line and perilesional tissue.
  • Alpha-blockade reverses local vasoconstriction, preventing necrosis
  • Warm compresses, elevation; consider plastic surgery input (Kahn et al., 2002)

Airway Management In Severe Metabolic Acidosis And DKA: Ventilation Matching Saves Lives

Why Ventilation Matching Matters

  • In metabolic acidosis, patients hyperventilate to reduce PaCO2, buffering pH
  • Intubation with inadequate ventilation can raise PaCO2, collapse pH, and precipitate cardiac arrest

Clinical Approach

  • Avoid intubation if airway reflexes and ventilatory drive are intact
  • If unavoidable:
    • Match pre-intubation minute ventilation with high RR and appropriate tidal volume
    • Use ETCO2 and ABGs to keep PaCO2 near pre-intubation values
    • Avoid prolonged paralysis; maintain aggressive ventilation until acidosis improves (Kellum & Elbers, 2018)

DKA Specifics

  • Preserve Kussmaul respirations when possible
  • Correct dehydration, hyperglycemia, and electrolytes while maintaining ventilatory compensation (Wolfsdorf et al., 2018; Kitabchi et al., 2009)

Toxidrome Recognition: A Bedside Pattern Approach

Pattern Highlights

  • Anticholinergic: Hot/dry skin, delirium, urinary retention, decreased bowel sounds; QRS may widen with TCAs
  • Sympathomimetic: Hot/wet (diaphoresis), agitation, hypertension, tachycardia, chest pain risk; hyperthermia and rhabdo
  • Cholinergic: Profuse secretions, bradycardia, wheezing, miosis, diarrhea; muscle weakness raises respiratory failure risk
  • Opioid: Depressed respirations, miosis (not universal); responds to naloxone
  • Sedative-Hypnotic: CNS depression without typical pupillary findings; watch for respiratory compromise
  • Sodium-channel blockade: Wide QRS—administer sodium bicarbonate

Case Reasoning: Applying Physiology At The Bedside

Pediatric Unknown Ingestion With Seizures And Hyperthermia

  • Dilated pupils, tachycardia, dry skin, wide QRS: Anticholinergic toxidrome with sodium-channel blockade—likely TCA or potent antihistamine
  • Immediate steps:
    • Airway protection; consider intubation
    • Benzodiazepines for seizures/agitation
    • 12-lead EKG to quantify QRS
    • Sodium bicarbonate bolus/infusion
    • Activated charcoal if early and airway secure
    • Cooling measures
    • Fluids; norepinephrine if hypotensive

Adult Chest Pain After Suspected Cocaine Use

  • Differentiate via diaphoresis (sympathomimetic)
  • Management:
    • Benzodiazepines and vasodilators (nitrates, nicardipine)
    • Avoid metoprolol; consider labetalol if necessary
    • Treat hyperthermia and hydrate; monitor for ischemia and arrhythmias

Organophosphate Exposure

  • Expect SLUDGE/DUMBELS with copious secretions and wheeze
  • Actions:
    • PPE, dermal decontamination, airway management
    • Atropine titrated to dry secretions
    • Early 2-PAM
    • Benzodiazepines for seizures; monitor for intermediate syndrome

Ethylene Glycol Ingestion

  • Calcium oxalate crystals, anion gap acidosis, renal risk
  • Therapy:
    • Fomepizole, hemodialysis, bicarbonate
    • Monitor electrolytes and kidney function

Acetaminophen Ingestion

  • 4-hour level determines risk; NAC protects liver via glutathione
  • Serial labs; adjust protocols for sustained-release or staggered ingestions

Integrative Chiropractic Care Within Medically Directed Toxicology

After acute stabilization, chiropractic care integrates safely to accelerate recovery, always under medical oversight by Dr. Cardenas.

Where Chiropractic Fits

  • Autonomic Regulation
    • Gentle, targeted manual therapies to improve vagal tone, reduce sympathetic overdrive, and support heart rate variability—especially useful after stimulant-induced hyperadrenergic states
  • Respiratory Mechanics
    • Thoracic mobilization and rib mechanics optimization to improve ventilatory efficiency post-intubation or after bronchorrhea-related compromise
  • Neuromuscular Rehabilitation
    • Progressive mobilization to restore motor control, balance, and strength after neuromuscular weakness or ICU deconditioning
  • Pain Modulation
    • Non-pharmacologic approaches to reduce musculoskeletal pain from seizures, restraints, or prolonged immobilization—lowering opioid reliance
  • Lymphatic And Circulatory Support
    • Techniques that encourage lymphatic flow may help reduce inflammatory edema.

All interventions are staged after hemodynamic and respiratory stability, aligned with medication profiles, and tailored to contraindications (e.g., avoid manipulative thrusts in hemodynamic instability, coagulopathy, or fractures).

Functional Medicine Synergy

  • Detoxification Capacity
    • Assess phase I/II hepatic pathways, glutathione status, and nutrient cofactors (B-vitamins, magnesium, selenium) that influence recovery post-NAC or oxidative stress.s
  • Mitochondrial Health
    • Targeted nutrition and graded exercise to restore electron transport, reduce ROS
  • Endocrine And Metabolic Balance
    • Treat dysglycemia following HIET; optimize insulin sensitivity and adrenal function.
  • Inflammation And Microbiome
    • Address systemic inflammation and GI consequences; repair mucosal integrity when caustics or antibiotics were involved.d

This synergy supports comprehensive recovery beyond the antidote window.

Team-Based Care: Roles, Coordination, And Safety

  • Dr. Maria Guadalupe Cardenas, MD—Medical Director and Collaborative Physician
    • Oversees diagnostics, antidotes, pharmacologic safety, and medical safety
    • Coordinates referrals to nephrology, cardiology, pulmonology, neurology, ED/ICU as needed
  • Dr. Alex Jimenez, DC, APRN, FNP-BC
    • Integrates chiropractic care with medical protocols
    • Provides advanced practice nursing assessments; coordinates functional medicine and rehabilitation
  • Rehabilitation Team
    • Physical therapy, exercise physiology, massage therapy for mobility, strength, pain management
  • Case Management
    • Ensures continuity for personal injury, workplace exposures, and documentation

Communication is constant. We reconcile medications and supplements, monitor labs and vitals during functional interventions, and ensure seamless transitions from acute stabilization to rehab.

Practical Protocol Pearls: Rapid Reference For Clinicians

  • Always obtain a 12-lead EKG in suspected cardiotoxic ingestions; it guides bicarbonate, lipid, and HIET decisions (EMCrit Project, n.d.)
  • Methamphetamine hypertensive crises: Choose benzodiazepines and vasodilators; avoid pure beta-blockers like metoprolol (AHA, n.d.)
  • Anticholinergic toxidrome with wide QRS: Prioritize bicarbonate; add activated charcoal if early and airway safe
  • Organophosphate poisoning: Titrate atropine to dry; start 2-PAM early; decontaminate meticulously (WHO, n.d.)
  • Acetaminophen overdose: Draw first ideal level at 4 hours; initiate NAC promptly (National Library of Medicine, n.d.)
  • Ethylene glycol: Use fomepizole; consider hemodialysis; watch for calcium oxalate crystals and anion gap acidosis (NEJM, n.d.)
  • Lipophilic cardiotoxins with refractory shock: Consider lipid emulsion therapy (EMRA, n.d.)

Rehabilitation And Recovery: From Stabilization To Strength

Once patients are stabilized, we restore function:

  • Breathing
    • Diaphragmatic exercises, thoracic mobility work, posture corrections to improve ventilation and reduce dyspnea
  • Strength And Endurance
    • Graded resistance and aerobic plans to rebuild mitochondrial capacity and autonomic stability
  • Pain And Neuromuscular Control
    • Manual therapy, neurodynamic techniques, sensorimotor retraining to reduce pain and improve movement quality
  • Nutrition
    • Emphasize protein adequacy, micronutrients for hepatic and mitochondrial support, and hydration to maintain renal function post-toxin

All care is individualized, medically supervised, and aligned with patient goals.

Patient Education And Safety: Preventing Re-Exposure And Supporting Recovery

We educate patients on:

  • Avoiding re-exposure and recognizing early warning signs
  • Safe storage and dosing of OTC and prescription medications
  • Importance of follow-up labs and cardiac monitoring
  • Heat illness prevention and hydration for stimulant histories
  • Access to addiction services and mental health support

Education improves adherence and outcomes.

Clinical Observations From Practice: Lessons At The Intersection Of Toxicology And Rehab

From my clinical work and the shared insights at Sciatica clinic and my updates on LinkedIn, I consistently observe:

  • Sympathomimetic hyperthermia responds best to early benzodiazepines plus proactive cooling; delaying cooling increases rhabdomyolysis risk
  • Anticholinergic delirium often improves with environmental optimization—low light, minimal stimuli—alongside benzodiazepines and bicarbonate when indicated.
  • Opioid rebound after naloxone is common with long-acting agents; low-dose infusion prevents repeated apnea events.s
  • Organophosphate recovery can be non-linear; intermediate syndrome requires vigilant neuromuscular monitoring.
  • Post-ICU patients benefit from thoracic and cervical mobilization, diaphragmatic retraining, and graded exercise, accelerating return to baseline function and decreasing pai.n

In musculoskeletal recovery, I find that restoring thoracic mobility and rib mechanics improves breathing and autonomic balance—indirectly reducing pain sensitivity in patients recovering from complex toxicologic crises. Optimizing pelvic-lumbar stability reduces reliance on accessory breathing and enhances diaphragmatic function. Improving cervicothoracic junction mobility supports vagal tone and perceived anxiety reduction—a valuable element in post-serotonin syndrome or post-ICU states.

Integrative Insights: Why Each Technique Is Used And How It Fits

  • Ventilation matching in acidosis.
    • Prevents PaCO2 rise and pH collapse by preserving respiratory compensation (Kellum & Elbers, 2018)
  • Urinary alkalinization in salicylate toxicity
    • Enhances ion trapping and renal excretion; requires adequate potassium (Molloy et al., 2019)
  • NAC in acetaminophen toxicity
    • Restores glutathione, neutralizes NAPQI, protects hepatocytes (Heard, 2008; Rumack & Matthew, 1975)
  • Benzodiazepines in serotonin syndrome
    • Reduce CNS hyperexcitability; cyproheptadine blocks serotonergic receptors (Boyer & Shannon, 2005)
  • Octreotide in sulfonylurea hypoglycemia
    • Suppresses insulin release; stabilizes glucose (Huang & Unger, 2006)
  • Protamine for heparin
    • Acid-base binding neutralizes heparin; precise dosing avoids hypotension and paradoxical effects (McLean, 2012)
  • Four-factor PCC for warfarin/DOAC-related bleeding
    • Rapid factor replacement with reduced volume vs plasma; idarucizumab and andexanet as drug-specific antidotes (Sarode et al., 2013; Connolly et al., 2019)
  • Flumazenil caution
    • Avoid precipitating withdrawal seizures; reserve for select scenarios
  • Phentolamine for vasopressor extravasation
    • Alpha-blockade reverses local vasoconstriction, preventing necrosis (Kahn et al., 2002)
  • Activated charcoal/whole bowel irrigation
    • Adsorption and mechanical clearance reduce systemic absorption (ACMT, n.d.)

Conclusion: A Clear, Evidence-Based Path Through Toxic Emergencies And Recovery

Toxic exposures demand fast, physiologically informed decisions. The combination of:

  • Rigorous primary assessment and airway-first logic
  • Accurate toxidrome recognition
  • Timely antidotes and advanced therapies (bicarbonate, HIET, lipid emulsion, cyproheptadine, octreotide, ADH blockade)
  • Thoughtful decontamination
  • Continuous monitoring for rebound and complications
  • Medically directed integrative chiropractic, functional medicine, and rehabilitation

This helps create a comprehensive, modern approach that improves survival and speeds recovery. With Dr.Cardenas’ss medical direction and our integrated team at Injury Medical Clinic PA, we deliver coordinated, evidence-based care that meets patients where they are—from the emergency moment to full functional return.

References

In-text citations (APA-7 style): American College of Medical Toxicology (n.d.); Centers for Disease Control and Prevention (n.d.); Emergency Medicine Residents’ Association (n.d.); EMCrit Project (n.d.); National Center for Biotechnology Information (n.d.); National Library of Medicine (n.d.); The New England Journal of Medicine (n.d.); UpToDate (n.d.); World Health Organization (n.d.); Hampson et al. (2012); Lawson-Smith et al. (2011); O’Malley (2007); Rose et al. (2017); Weaver et al. (2002); Boyer & Shannon (2005); Heard (2008); Connolly et al. (2019); Sarode et al. (2013); Huang & Unger (2006); McLean (2012); Molloy et al. (2019); Kellum & Elbers (2018); Kitabchi et al. (2009); Wolfsdorf et al. (2018); Kahn et al. (2002); Graul & Gomm (2020); Levine et al. (2021); Wightman & Nelson (2022); Rumack & Matthew (1975).

SEO tags: toxicology, organophosphate poisoning, anticholinergic toxidrome, sympathomimetic toxicity, cocaine overdose, methamphetamine crisis, naloxone, high-dose insulin euglycemia therapy, lipid emulsion, intralipid, sodium bicarbonate therapy, tricyclic antidepressant overdose, acetaminophen toxicity, ethylene glycol ingestion, calcium oxalate crystals, activated charcoal, whole bowel irrigation, hemodialysis, cyanide poisoning, carbon monoxide poisoning, salicylate toxicity, ventilation matching, DKA airway management, serotonin syndrome, cyproheptadine, sulfonylurea hypoglycemia, octreotide, anticoagulant reversal, protamine, PCC, andexanet alfa, idarucizumab, benzodiazepine overdose, flumazenil risks, vasopressor extravasation, phentolamine rescue, integrative chiropractic care, functional medicine, rehabilitation, personal injury clinic, El Paso, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, sciatica clinic observations, LinkedIn clinical insights

Joint Trauma From Auto Accidents and Treatment Options

Joint Trauma From Auto Accidents and Treatment Options
Treatment for knee injuries. Adult man with knee injury during consultation with doctor traumatologist at medical clinic

Joint Trauma From Auto Accidents: Integrative Recovery Care in El Paso

Abstract

A motor vehicle accident (MVA) can place sudden and powerful forces on the body. The knees, shoulders, hips, wrists, and spinal joints may be twisted, compressed, stretched, or struck within seconds. These forces can damage ligaments, tendons, cartilage, muscles, bones, spinal discs, and nerves. A common example is a “dashboard knee,” in which the knee or upper shin strikes the dashboard and force is transmitted through the knee. This mechanism can injure the posterior cruciate ligament (PCL) and other joint structures. Shoulder dislocations, rotator cuff injuries, hip trauma, wrist fractures, and spinal injuries can also occur.

In El Paso, a multidisciplinary approach may combine medical evaluation, integrative chiropractic care, rehabilitation, shockwave or laser therapy, and, for carefully selected patients, injection-based treatments. The goal is to identify the injured tissues, reduce pain, restore safe movement, rebuild strength, and help the patient return to daily activities.

Joint Trauma From Auto Accidents and Treatment Options

What Are Joint Trauma Injuries in an MVA?

Joint trauma injuries are injuries to the structures that form or support a joint. During a car accident, the body may move forward, backward, or sideways faster than the joints can safely handle. A joint can also strike the dashboard, door, steering wheel, center console, or another hard surface.

The damage may involve:

  • Ligaments that hold bones together
  • Tendons that connect muscles to bones
  • Cartilage that cushions joint surfaces
  • Joint capsules that surround joints
  • Muscles that control movement
  • Bones and joint surfaces
  • Spinal discs
  • Nerves near the injured joint

High-energy trauma can cause fractures, dislocations, and soft-tissue tears. The American Academy of Orthopaedic Surgeons (AAOS) notes that high-speed motor vehicle collisions can cause serious shoulder fractures and other traumatic joint injuries (AAOS, n.d.-a).

A patient may therefore leave a crash with much more than simple soreness.

Knee Injuries: Understanding the “Dashboard Knee”

The knee is especially vulnerable during a front-end collision. When the knee or upper shin strikes the dashboard, the force can drive the tibia, or shinbone, backward.

This is a classic mechanism for a posterior cruciate ligament injury, commonly called a dashboard knee. The PCL helps prevent the tibia from moving too far backward.

The same collision can also injure several structures at once, including:

  • PCL
  • ACL
  • MCL or LCL
  • Meniscus
  • Joint cartilage
  • Kneecap
  • Tendons
  • Femur or tibia

A strong dashboard impact can also send force upward toward the hip. In fact, the AAOS reports that traumatic hip dislocations commonly occur in motor vehicle collisions and may happen when a knee strikes the dashboard, forcing the thigh backward and pushing the femoral head out of the hip socket (AAOS, n.d.-b).

This is one reason knee pain after an accident should not automatically be treated as a simple bruise.

Shoulder Trauma After a Car Accident

The shoulder has a very large range of motion. This mobility is useful, but it also makes the joint easier to injure during sudden trauma.

During an MVA, a person may injure their shoulder when they:

  • Grips the steering wheel during impact
  • Braces with an outstretched arm
  • Is pulled against the seatbelt
  • Strikes the door or window
  • Experiences sudden twisting
  • Is pushed forward and backward with whiplash

Possible injuries include rotator cuff tears, labral tears, ligament sprains, fractures, and complete or partial dislocations.

The AAOS states that shoulder dislocations often result from trauma, including motor vehicle collisions. A dislocation can also damage the labrum, ligaments, and rotator cuff that normally stabilize the joint (AAOS, n.d.-c).

Clinical discussions published by Dr. Alexander Jimenez also describe how shoulder symptoms after an accident may overlap with neck, upper-back, nerve, postural, and soft-tissue problems. This makes a complete examination important rather than focusing only on the point of pain (Jimenez, 2026a).

Hip Joint Injuries From Collision Forces

The hip is a strong ball-and-socket joint, but a high-energy collision can still damage it.

Possible hip injuries include:

  • Hip dislocation
  • Labral damage
  • Cartilage injury
  • Tendon strains
  • Ligament injury
  • Femoral head injury
  • Pelvic or acetabular fracture

Traumatic hip dislocation is especially serious because it can also injure surrounding nerves, blood vessels, cartilage, and bone.

The AAOS identifies motor vehicle collisions as the most common cause of traumatic hip dislocations. High-energy MVAs can also cause acetabular fractures involving the socket of the hip joint (AAOS, n.d.-d).

A true hip dislocation or fracture requires emergency medical or orthopedic treatment. Chiropractic manipulation should not be performed over an unstable, fractured, or dislocated joint.

Wrist and Hand Injuries After an MVA

People often tighten their grip on the steering wheel or put their hands forward before a collision. This can transfer tremendous force through the hands and wrists.

Common injuries include:

  • Wrist sprains
  • Ligament tears
  • Distal radius fractures
  • Scaphoid fractures
  • Tendon injuries
  • Joint instability
  • Nerve irritation

The AAOS notes that car accidents can generate enough force to fracture the wrist even in a young person with healthy bones (AAOS, n.d.-e).

A scaphoid fracture can also occur during a motor vehicle collision. Because some wrist fractures are not always obvious at first, lasting wrist pain after an accident deserves proper evaluation.

The Spine Is Also a System of Joints

Joint trauma does not stop at the arms and legs.

The spine contains joints, discs, ligaments, muscles, tendons, and nerves. During an accident, rapid acceleration, deceleration, compression, rotation, and shearing forces may stress these structures.

Possible spinal injuries include:

  • Cervical and lumbar sprains
  • Facet-joint irritation
  • Disc bulges or herniations
  • Annular tears
  • Muscle and tendon strains
  • Nerve-root irritation
  • Whiplash-associated disorders

High-energy motor vehicle collisions can even produce spinal fractures, especially when forces are severe.

This helps explain why someone with an injured shoulder, knee, or hip may also have neck or back pain after the same accident.

Why a Complete Examination Comes First

Treatment should begin with finding out what was actually injured.

Depending on the symptoms and accident mechanism, evaluation may include:

  • Medical history
  • Accident-mechanism review
  • Range-of-motion testing
  • Orthopedic testing
  • Neurological examination
  • Muscle-strength testing
  • Posture and movement assessment
  • X-rays
  • MRI
  • Diagnostic ultrasound
  • CT imaging when appropriate

Some injuries require emergency treatment or an orthopedic consultation before rehabilitation begins.

Severe deformity, inability to use a limb, major weakness, loss of sensation, rapidly increasing swelling, severe headache, confusion, difficulty breathing, or new bowel or bladder problems should receive prompt medical evaluation.

How Integrative Chiropractic Care Fits Into Recovery

After fractures, dislocations, and other serious injuries have been ruled out or properly stabilized, integrative chiropractic care may become one part of rehabilitation.

Chiropractic treatment does not reconnect a completely torn ligament, reduce an acute dislocated hip, or repair a fracture. Instead, appropriately selected care may focus on restoring motion and function in areas affected by musculoskeletal pain.

Spinal manipulation is one of several non-drug options that may help some patients with low-back pain, although the strength of evidence differs by condition (National Center for Complementary and Integrative Health [NCCIH], 2025).

An integrative chiropractic plan may include:

  • Joint mobilization or manipulation when safe
  • Soft-tissue therapy
  • Corrective exercises
  • Core stabilization
  • Posture training
  • Balance and coordination exercises
  • Strength rehabilitation
  • Movement retraining

The goal is to help the recovering body move more normally while injured tissues continue healing.

Shockwave and Laser Therapy

Physical modalities may also be considered as part of rehabilitation.

Shockwave therapy uses acoustic energy and is most often considered for certain tendon and chronic soft-tissue problems. It should not be viewed as a treatment for an acute fracture or dislocation.

Laser therapy uses light energy and may be used as an adjunct for pain and soft-tissue rehabilitation in selected cases.

Dr. Jimenez’s published treatment model describes shockwave and laser therapy as supportive tools that may be combined with exercise, chiropractic care, and rehabilitation rather than being used as stand-alone solutions (Jimenez, 2026a).

PRP, PFP, and MFAT: Where Regenerative Care May Fit

Some patients with persistent joint or soft-tissue problems may be evaluated for biologic or regenerative procedures.

PRP

Platelet-rich plasma (PRP) is made from a patient’s own blood. Platelets are concentrated and then placed near an injured area. Platelets contain proteins and growth factors involved in the body’s normal healing processes.

Research supports possible uses of PRP for certain tendon problems and early knee osteoarthritis, but results differ depending on the tissue, injury, PRP preparation, and patient (AAOS, n.d.-f).

PRP should therefore be viewed as a possible option for selected cases, not a guaranteed way to rebuild a damaged joint.

PFP

Platelet-fibrin preparations, sometimes described by clinics as PFP, use platelet and fibrin components intended to provide a biological environment around injured tissue.

Preparation methods and available evidence are not as standardized as they are for many conventional treatments. Patients should understand exactly what preparation is being offered, why it is being considered, and what evidence supports its use for their specific injury.

MFAT

Microfragmented adipose tissue (MFAT) uses processed tissue obtained from the patient’s own fat. It has been explored in orthopedic care for selected joint and soft-tissue problems.

However, regenerative products and procedures vary greatly in how they are prepared, regulated, and supported by research. The FDA continues to warn patients about unapproved human cell and tissue products marketed with broad claims for orthopedic conditions. Patients considering these procedures should ask about the exact product, regulatory status, risks, alternatives, and supporting evidence (U.S. Food and Drug Administration [FDA], 2026).

Regenerative procedures do not replace emergency treatment, fracture care, surgery when needed, or appropriate rehabilitation.

Epidural and Trigger-Point Injections Have Different Jobs

Not every injection is regenerative.

An epidural spinal injection may be considered when a spinal injury causes inflammation around a nerve root and produces radiating arm or leg pain. It aims to control nerve-related inflammation rather than repair a damaged knee, shoulder, hip, or wrist.

A trigger-point injection may be used when painful, tight muscle areas contribute to symptoms.

This is why matching treatment to the correct tissue is important. A torn knee ligament, irritated cervical nerve, tight shoulder muscle, and fractured wrist are four very different problems.

Multidisciplinary Injury Care in El Paso

At Injury Medical Clinic PA in El Paso, the care model described by Dr. Jimenez brings several disciplines together.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, focuses on neuromusculoskeletal evaluation, integrative chiropractic care, functional medicine, personal injury care, and rehabilitation. His published clinical observations emphasize looking beyond the painful body part to examine movement, joint mechanics, nerve involvement, inflammation, and functional limitations after an accident (Jimenez, 2026a, 2026b).

Dr. Maria Guadalupe Cardenas, MD, is identified in clinic materials as a board-certified internal medicine physician with more than 40 years of experience who serves as Medical Director and Collaborative Physician. Her Texas physician license is listed as J2933, with a Texas Medical Board document showing an expiration date of May 31, 2027.

The practice describes the team as combining:

  • Medical oversight
  • Integrative chiropractic care
  • Functional medicine
  • Personal injury evaluation
  • Rehabilitation
  • Diagnostic coordination
  • Pain-management referrals or procedures
  • Selected regenerative options

This type of multidisciplinary model can help avoid treating each injured area as an unrelated problem. The goal is to coordinate examination, treatment, rehabilitation, referrals, and documentation around the patient’s actual injuries and functional needs (Jimenez, 2026c).

Credential verification note: Clinic materials supplied for this article identify Dr. Cardenas as NPI #1164426749. However, a current DrAlexJimenez.com provider page also displays 1164426748 in its body while displaying 1164426749 elsewhere on the same page. The NPI should therefore be confirmed directly through the CMS NPPES Registry before the number is published as a verified credential.

A Step-by-Step Path From Injury to Recovery

A motor vehicle accident can damage several tissues at the same time. That is why there is rarely one treatment that is right for every patient.

A coordinated recovery plan may follow a simple path:

  1. Identify the injury.
  2. Rule out fractures, dislocations, instability, and neurological emergencies.
  3. Control pain and inflammation.
  4. Restore safe joint and spinal movement.
  5. Begin rehabilitation and strengthening.
  6. Consider additional procedures only when clinically appropriate.
  7. Measure progress and adjust treatment when needed.
  8. Help the patient return to work, driving, exercise, and daily life.

Clinical observations published through Dr. Jimenez’s El Paso injury-care resources emphasize this same goal: move beyond simply reducing pain and work toward restoring safe function, movement, strength, and quality of life.

Final Thoughts

Joint trauma after an MVA can involve the knees, shoulders, hips, wrists, spine, and several supporting tissues at once. A dashboard impact may injure the PCL or transmit force toward the hip. Bracing against the steering wheel may damage the wrist or shoulder. Whiplash forces can affect spinal joints, discs, muscles, and nerves.

The most important first step is a correct diagnosis.

From there, care can be matched to the injury. Chiropractic care and rehabilitation may help restore movement and function in appropriately screened patients. Shockwave and laser therapy may serve as supportive treatments for selected conditions. PRP, PFP, MFAT, epidural injections, and trigger-point injections have different purposes and should be considered based on the patient’s diagnosis, health history, evidence, risks, and treatment goals.

A coordinated medical and chiropractic approach can help create a clearer recovery plan after a motor vehicle accident—one based not simply on where it hurts, but on what was injured and what the patient needs to safely regain function.

The road to Recovery "Chiropractic Care" | El Paso, Tx (2023)

References

American Academy of Orthopaedic Surgeons. (n.d.-a). Shoulder trauma: Fractures and dislocations.

American Academy of Orthopaedic Surgeons. (n.d.-b). Hip dislocation.

American Academy of Orthopaedic Surgeons. (n.d.-c). Shoulder dislocation.

American Academy of Orthopaedic Surgeons. (n.d.-d). Acetabular fractures.

American Academy of Orthopaedic Surgeons. (n.d.-e). Distal radius fractures: Broken wrist.

American Academy of Orthopaedic Surgeons. (n.d.-f). Platelet-rich plasma (PRP).

American Academy of Orthopaedic Surgeons. (n.d.). Orthobiologics (regenerative medicine) FAQ.

El Paso Back Clinic. (2026). Regenerative therapies for personal injury healing.

El Paso Back Clinic. (2026). Auto and work accident joint pain regenerative care benefits.

El Paso Back Clinic. (2026). Regenerative therapies and chiropractic benefits revealed.

El Paso Chiropractor Blog. (2026). Dashboard knee after a car accident: PCL injury.

Fix Medical Group. (n.d.). Shockwave therapy vs. PRP: Which is better for pain relief?.

Jimenez, A. (2026a). El Paso car accident shoulder injury recovery care strategies.

Jimenez, A. (2026b). Dr. Alexander Jimenez professional profile.

Jimenez, A. (2026c). Integrated injury care in El Paso: Under-one-roof recovery for personal injury patients.

Jimenez, A. (2026). Dr. Maria Cardenas, MD: Board certified internal medicine specialist.

National Center for Complementary and Integrative Health. (2025). Spinal manipulation: What you need to know.

Personal Injury Doctor Group. (2026). Regenerative options for personal injury recovery insights.

Personal Injury Doctor Group. (2026). Healing after a car crash with regenerative therapies.

Pravida. (n.d.). Shockwave and PRP combination therapy.

Ruhmann Law Firm. (n.d.). Shoulder injuries after El Paso car accidents.

Ruhmann Law Firm. (n.d.). Knee injuries after El Paso car accidents.

U.S. Food and Drug Administration. (2026). Patient and consumer warning about potential serious risks of harm following use of unapproved products from human cells or tissues.

Wellness Doctor Rx. (2026). El Paso multidisciplinary injury care for healing and pain.

Non-Pharmacological Methods for Integrative Pain Management

Discover integrative pain management with non-pharmacological techniques designed to alleviate discomfort without medications.

Abstract

In this educational post, I share a comprehensive, first-person narrative of how I approach non-pharmacological pain management through an integrative lens that combines chiropractic care, functional medicine, rehabilitation, behavioral health, and interventional options—always with medical oversight. I introduce our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, integrate chiropractic and functional therapies alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), whose over 40 years of internal medicine expertise guides medical decision-making, safety, and protocol alignment. Together, we present the latest research findings in non-pharmacologic pain strategies—cognitive-behavioral therapies, hypnosis, ACT, sleep optimization, manual and movement therapies, neuromodulation, interventional procedures, nutrition, and anti-inflammatory lifestyles. I highlight clinical observations from my practice and research-informed methods, elaborating on physiological mechanisms—central sensitization, neuroplasticity, nociplastic pain, immune-metabolic interactions, autonomic regulation, and fascia dynamics. We will also delve into a diverse toolkit of treatments, including psychological and mind-body techniques like guided imagery, meditation, and music therapy; physical and manual therapies such as massage, cupping, and transcutaneous electrical nerve stimulation (TENS); and the pivotal role of integrative chiropractic care and acupuncture. We conclude with individualized multimodal approaches, detailed rationale for each intervention, and practical frameworks to prevent substance use disorders through risk assessment, patient education, and restorative function-centered goals.

Key Takeaways

  • Multimodal care that integrates chiropractic manipulation, functional rehabilitation, behavioral therapies, nutrition, sleep optimization, and interventional options is superior to siloed, single-modality care for complex pain conditions.
  • A biopsychosocial model, paired with medical oversight from an experienced internist (Dr. Cardenas), improves safety, continuity, and outcomes in a multidisciplinary clinic.
  • Evidence-based complementary therapies—acupuncture, mindfulness, yoga, neuromodulation, trigger point injections, and manual therapies—help break the pain-tension-inflammation cycle and reduce reliance on opioids.
  • Functional medicine insights on inflammation, micronutrient status, gut-brain-axis health, and sleep correction augment pain care and prevent chronicity.
  • Risk assessment and patient education reduce misuse risk, support realistic function-centered goals, and promote resilience.

Introduction: My Approach to Non-Pharmacological Pain Care in an Integrative Setting

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My clinical work centers on helping patients recover function, reduce pain, and build resilience through integrated chiropractic care and evidence-based non-pharmacological strategies. Pain is a complex, multifaceted experience that extends beyond mere physical sensation, deeply intertwining with our emotional, mental, and spiritual well-being. At Injury Medical Clinic PA, our philosophy is rooted in a patient-focused approach that embraces this complexity.

In El Paso, Texas, my practice—Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic)—operates within a multidisciplinary model led by a physician. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Internal Medicine; NPI #1164426749; Texas MD License #J2933), has over 40 years of experience as an internist. She ensures medical safety, guides diagnostic strategy, oversees medications where needed, and collaborates with me to create cohesive, patient-centered plans. This MD-DC collaboration is common and highly effective in integrative and injury care clinics.

In the following sections, I outline a structured journey through non-pharmacologic pain management:

  • The biopsychosocial model and functional goals
  • Behavioral and psychological strategies
  • Manual therapy and movement-based care
  • Neuromodulation and interventional procedures
  • Nutritional and sleep optimization frameworks
  • Risk assessment and prevention of substance use disorders
  • Multidisciplinary workflows with medical oversight
  • Case-based applications
  • Outcome tracking, safety monitoring, and long-term recovery planning

I also incorporate clinical observations from my practice, which you can explore further at my sciatica-focused resource hub and professional profile:

Modern research methods and the latest evidence from leading researchers in pain science, behavioral medicine, neuromodulation, rehabilitation, and integrative health guide this post. I intend to make these concepts accessible, actionable, and rooted in physiology—so you understand not only what we recommend, but exactly why it works.

Multidisciplinary Pain Care in El Paso — How Our Team Works Together

I want to begin with the structure of our clinic because many outcomes hinge on coordination, oversight, and clarity of roles. Here at Injury Medical Clinic PA, we have built a practice on the foundation of integrative and collaborative care. My personal journey and extensive training across multiple disciplines—as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN) and Family Nurse Practitioner (FNP-BC), and a certified practitioner in Functional Medicine (CFMP, IFMCP)—have instilled in me a deep appreciation for a holistic, patient-centered model.

A crucial element of our success is our multidisciplinary framework, anchored by the invaluable expertise of Dr. Maria Guadalupe Cardenas, MD. Her role is indispensable, providing the essential medical oversight that ensures our patients receive the safest, most comprehensive, and most effective care possible. Our team integrates:

  • Medical Director and Collaborative Physician oversight
    • Maria Guadalupe Cardenas, MD, Internal Medicine (Board Certified; NPI #1164426749; Texas MD License #J2933) serves as Medical Director at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso.
    • Her responsibilities include medical safety, diagnostic strategy (labs, imaging, referrals), pharmacologic oversight when indicated, and integration of medical standards into all care plans.
    • For patients with complex comorbidities (e.g., post-cancer, autoimmune conditions, metabolic disorders), her oversight ensures that our interventions align with systemic health needs.
  • Integrative chiropractic care (led by Dr. Jimenez)
    • My role as a chiropractor and advanced practice registered nurse is to deliver evidence-based manual therapies, spinal and extremity adjustments, neuromuscular rehabilitation, kinetic chain analysis, and functional medicine strategies.
    • I emphasize function-centered goals: improving activities of daily living, restoring work capacity, enhancing sleep quality, and supporting emotional resilience.
    • I coordinate closely with physical therapists, occupational therapists, psychologists, nutritionists, and interventional pain specialists.
  • Functional medicine integration
    • We assess inflammatory drivers, nutrient status, sleep dysregulation, autonomic balance, and gut-brain axis dysfunction, using focused histories and, when appropriate, targeted lab evaluations under medical supervision.
    • Plans include anti-inflammatory nutrition, movement prescriptions, stress modulation, sleep hygiene, and targeted supplementation when indicated by evidence.
  • Personal injury care and rehabilitation
    • We manage acute and chronic injury cases with structured protocols: clinical exam, imaging when necessary, stepwise rehabilitation, and documentation for medicolegal needs.
    • We incorporate manual therapies, graded exercise, neuromuscular re-education, and—when appropriate—interventional referrals (e.g., nerve blocks, epidurals) coordinated with internal medicine oversight.
  • Behavioral health and psychology collaboration
    • Cognitive behavioral therapy (CBT), Acceptance and Commitment Therapy (ACT), hypnosis, and mindfulness are engaged through partners in psychology and psychiatry.
    • We utilize self-guided tools and digital therapeutics to lower barriers and empower patients.
  • Pharmacy and nursing
    • Pharmacists assist with medication safety, potential interaction checks, and alternatives when pharmacologic support is necessary.
    • Nursing colleagues triage messages, provide education, reinforce sleep hygiene and movement plans, and identify social determinants of health impacting adherence.

Why This Model?

  • Complex pain is rarely just a musculoskeletal problem; it is a networked condition involving nociceptive, neuropathic, and nociplastic mechanisms, plus psychological and social features.
  • A coordinated team creates synergy: manual changes in tissue mechanics pair with improved sleep, reduced inflammatory burden, behavioral coping skills, and precise medical oversight. This integrated model allows us to create a truly personalized and dynamic treatment plan for each patient. We are not just treating symptoms; we are treating the whole person—mind, body, and spirit—in a coordinated effort to restore health, function, and vitality.

Understanding the Terminology — Integrative vs. Complementary Care

Before we dive into the specific therapies, it’s vital to clarify the language we use. The term integrative medicine describes a patient-focused approach to health and wellness that considers the whole person. This includes their mental, emotional, spiritual, and social well-being. It is characterized by a well-coordinated effort between different providers and institutions to deliver comprehensive care.

Within this framework, we utilize complementary treatments. These are therapies used alongside conventional medical treatments. Think of them as another bucket of tools, a whole other toolkit we can pull from to enhance a patient’s healing journey. When I approach a patient’s case, especially those who express a desire for natural options or have had limited success with conventional methods, I categorize these complementary therapies into several “buckets” to help structure my thinking and formulate the most effective plan. These buckets include:

  • Psychological & Mind-Body Therapies
  • Manual & Massage Therapies
  • Chiropractic Care
  • Acupuncture
  • Movement Therapies

It is always a partnership. We must ensure the patient is open to these approaches. Often, clues emerge in conversation. A patient might say, “I don’t want to take any more medication,” or “I find that yoga really helps me relax.” These are signals that they may be receptive to exploring our complementary toolkit. Let’s unpack these tools one by one.

A Real Case, Real Decisions — Building a Multimodal Plan

I often begin with a case to ground the discussion. Consider a 36-year-old woman, with a history of breast cancer treated with chemotherapy and surgery in 2012, now living with chemotherapy-induced neuropathy in her hands and feet, thoracic back spasms, and migraines about four times monthly. She is sensitive to opioids and reports sedation even with low-dose gabapentin. She did not find relief with alpha-lipoic acid, over-the-counter NSAIDs, acetaminophen, or topicals.

This is precisely the kind of case where integrative, non-pharmacological care shines—especially with medical oversight.

Here is how our team frames the plan:

  • Function-centered goals
    • Improve daily function, reduce migraine frequency and intensity, ease thoracic spasms, and quiet neuropathic pain measurably (e.g., reduce pain interference scores, improve sleep metrics, stabilize mood).
  • Multimodal domains we will consider
    • Behavioral: CBT, ACT, hypnosis, mindfulness, stress reduction, sleep optimization.
    • Physical: graded exercise, aquatic therapy, manual therapy, chiropractic adjustments, physical therapy, TENS.
    • Interventional: nerve blocks, trigger point injections, neuromodulation (considered when conservative measures plateau).
    • Nutritional: anti-inflammatory diet, hydration habits, glucose control, micronutrient assessment.
    • Pharmacology: only if necessary, and carefully titrated, with Dr. Cardenas overseeing safety; prioritizing non-sedating options, migraine-specific therapies, and neuropathic pain strategies with minimal side effects.

The Biopsychosocial Model — Treating the Whole Person

I emphasize the biopsychosocial model because it is both a philosophy and a clinical framework. Pain outcomes are strongly associated with how we address biology, psychology, and social context.

  • Biological
    • Genetics, comorbidities, disease severity, age, drug effects, nutritional status, sleep quality, autonomic tone, and inflammation all contribute to pain perception and maintenance.
    • Mechanistic focus: nociceptive drivers (e.g., musculoskeletal strain), neuropathic drivers (e.g., chemotherapy-induced peripheral neuropathy), and nociplastic drivers (central sensitization).
    • We evaluate systemic inflammation through history and, when appropriate, labs under medical supervision; we correct sleep architecture; we optimize nutrition to reduce cytokine load.
  • Psychological
    • Coping styles, stress levels, catastrophizing, expectations, affect and mood, cognition, and resilience determine both pain intensity and disability.
    • Clinical strategy: we set realistic expectations (pain-free is not always attainable; functional improvement is the initial target), and we teach cognitive reframing, acceptance, and graded exposure to activity.
  • Social
    • Cultural beliefs, social supports, family and work dynamics, socioeconomic status, access to care, and daily routines affect adherence and recovery.
    • We enlist social workers and community resources; we adapt plans to the realities of a patient’s day-to-day life and constraints.

Why This Matters Physiologically

  • Pain is a nervous system output influenced by tissue signals, brain evaluation, and contextual meaning.
  • The brain’s threat appraisal increases sympathetic tone, muscle guarding, and cytokine-driven sensitivity; by shifting cognition, we reduce the threat response and lower pain amplification.
  • Sleep restoration changes pain thresholds, reduces neuroinflammation, and improves glymphatic clearance.

Psychological and Mind-Body Therapies: Harnessing the Power of the Mind

The connection between the mind and body is not just a philosophical concept; it is a physiological reality. Our thoughts, emotions, and stress levels directly impact our physical health, particularly our experience of pain. Psychological and mind-body therapies are designed to leverage this connection, offering powerful, non-invasive ways to manage symptoms and promote healing. I integrate these therapies early because they change the neural processing of pain and equip patients with durable coping skills.

Cognitive Behavioral Therapy (CBT)

  • Core concept: Thoughts, feelings, and behaviors interact; maladaptive cognitions (catastrophizing, all-or-nothing thinking) worsen pain and disability.
  • In practice: Identify distortions, reframe pain meaning, build activity pacing, teach relaxation strategies (diaphragmatic breathing, progressive muscle relaxation).
  • Physiological rationale: Reducing cognitive threat lowers amygdala reactivity, sympathetic hyperarousal, and central sensitization.

Acceptance and Commitment Therapy (ACT)

  • Core concept: Accept what is present, commit to valued actions; shift from pain control to life engagement despite symptoms.
  • In practice: Clarify values (family engagement, work, purpose), commit to small daily acts aligned with values, practice defusion from pain-related thoughts.
  • Physiological rationale: Behavioral activation reduces kinesiophobia, improves motor patterns, and normalizes cortical processing.

Hypnosis

  • Core concept: Guided or self-directed focused attention and relaxation to facilitate behavior change and pain modulation.
  • In practice: Audio-guided sessions for neuropathic pain and migraine to reduce autonomic arousal and pain focus; low-barrier entry via digital apps.
  • Physiological rationale: Hypnosis reduces pain-related cortical activity and increases parasympathetic tone, diminishing nociceptive amplification.

Guided Imagery: Painting a Picture of Relief

Guided imagery is a therapeutic technique that uses a script to engage all the senses—sight, sound, touch, smell, and taste—to transport the mind to a peaceful, healing place. The goal is to evoke a positive emotional state and actively combat stressful feelings that often amplify pain.

  • How It Works: A practitioner or a recording guides the individual to visualize a serene environment, like a quiet beach or a lush forest. The script is rich with sensory details: feeling the warm sun, hearing the gentle waves, smelling the salty air. This process does more than distract the mind. Neurologically, it activates the parasympathetic nervous system, our “rest and digest” system, which counteracts the “fight or flight” response of the sympathetic nervous system that is often chronically activated in individuals with pain. By creating a vivid, positive internal experience, guided imagery can help reduce the production of stress hormones like cortisol and adrenaline, which are known to increase inflammation and pain sensitivity. It shifts the brain’s focus away from pain signals and towards a state of deep relaxation and well-being.

Mindfulness Meditation: Anchoring in the Present Moment

Mindfulness meditation is a practice that cultivates an attentional stance of detached observation. It’s not about emptying the mind, but rather about refocusing it on the present moment and developing a non-judgmental awareness of our external surroundings and internal sensations, including pain.

  • How It Works: The core principle of mindfulness is to acknowledge thoughts, feelings, and bodily sensations as they arise, without getting entangled in them. For someone in chronic pain, this means learning to observe the sensation of pain without the secondary layer of suffering—the fear, anxiety, and catastrophic thinking that often accompany it (“This will never end,” “I can’t stand this”). By encouraging the individual to step back and reframe the experience, meditation helps decouple the physical sensation from the emotional reaction. Neuroimaging studies have shown that regular mindfulness practice can actually change the structure and function of the brain. It strengthens the prefrontal cortex, which is involved in emotional regulation and executive function, while reducing activity in the amygdala, the brain’s fear center. This physiological shift empowers patients to have a different relationship with their pain, reducing its perceived intensity and its control over their lives. Even starting with a free two-minute app can be a transformative first step.

Relaxation Techniques: A Pause for Restoration

Relaxation techniques are simple yet profound practices designed to release tension from the body and mind consciously. These can range from a quick, deliberate breath to more structured protocols like progressive muscle relaxation.

  • How It Works: One of the simplest and most effective techniques is diaphragmatic breathing, or deep belly breathing. Taking slow, deep breaths that engage the diaphragm stimulates the vagus nerve, a major component of the parasympathetic nervous system. This direct stimulation sends a signal to the brain to slow the heart rate, lower blood pressure, and switch off the stress response.
  • Progressive Muscle Relaxation (PMR) is another powerful method. It involves systematically tensing and then relaxing different muscle groups throughout the body. This process serves two purposes: first, it physically releases stored muscle tension; second, it enhances body awareness, helping the individual recognize the difference between a state of tension and a state of relaxation.
  • Even setting a simple reminder on a phone to “take a moment to relax” a few times a day can interrupt the cycle of chronic stress and pain. These techniques teach patients how to actively employ relaxation, giving them a sense of control over their physiological state.

Music Therapy: The Rhythm of Healing

Music therapy is the clinical and evidence-based use of music interventions to accomplish individualized goals. This can involve listening to music, writing songs, or playing an instrument, often guided by a trained music therapist.

  • How It Works: Music acts as a powerful distractor, but its effects run much deeper. The rhythm, melody, and harmony of music can directly influence physiological processes. Slower, calming music can synchronize with and slow down our heart rate and breathing, promoting relaxation. Listening to enjoyable music triggers the release of dopamine, a neurotransmitter associated with pleasure and reward, which can help counteract the negative emotional state associated with pain. A robust review of the scientific literature demonstrates that music therapy can significantly reduce pain perception, improve vital signs (like blood pressure and heart rate), enhance mood, and improve sleep quality. We are seeing this firsthand in clinical settings, with music therapists now working in our cancer centers and inpatient units at institutions like Vanderbilt, providing profound benefits for patients undergoing treatment for a variety of conditions. Best of all, it has virtually no adverse reactions.

Aromatherapy: Scent and Sensibility

Aromatherapy involves the use of fragrant essential oils extracted from plants for therapeutic health benefits. These oils can be diffused into the air, applied topically, or even ingested (though this requires extreme caution and professional guidance).

  • How It Works: The sense of smell is directly linked to the limbic system, the part of the brain that governs emotions, memory, and behavior. When we inhale the aromatic molecules of an essential oil, they travel up the nose to the olfactory bulb, which sends direct signals to the amygdala (emotional center) and hippocampus (memory center). This is why certain smells can instantly trigger powerful memories and emotions.
  • Lavender oil is one of the most extensively studied essential oils. Research consistently shows that its inhalation helps reduce pain and improve anxiety, offering a valuable two-for-one benefit for many of our patients. By calming the nervous system, it also improves sleep, which is crucial for healing and pain management. The biopsychosocial model of pain helps us understand how a simple intervention like this can have cascading positive effects. In inpatient hospital settings, aromatherapy has been associated with improved patient satisfaction.
  • A Note of Caution: While generally safe, there is a risk of allergic reactions, skin sensitivities, and, with improper use, toxicities. For this reason, I always recommend starting with a very low concentration and using a diffuser as the primary method. This minimizes risk while still providing the therapeutic benefits.

Virtual Reality (VR): A Digital Distraction

Virtual reality (VR) is a technology that immerses the user in a computer-generated, three-dimensional environment. Using devices like helmets, goggles, or even smartphones, VR creates a new “reality” that can completely capture a person’s attention.

  • How It Works: The primary mechanism behind VR’s effectiveness in pain management is the gate control theory of pain, combined with profound distraction. The brain has a limited capacity for attention. When it is fully engrossed in a compelling, interactive virtual world, there are fewer attentional resources available to process pain signals coming from the body. The sensory input from the VR experience—visual, auditory, and sometimes even haptic—effectively “closes the gate” on the pain signals trying to reach the brain.
  • The evidence is growing rapidly. A review of the literature shows that VR can significantly improve acute pain, reduce anxiety and stress, and boasts a high level of patient satisfaction with no reported adverse reactions. There are now VR programs specifically designed for pain conditions.
  • I’ve seen the power of this firsthand. My son needed to have two baby teeth pulled and was terrified. Remembering the research on VR and distraction, we had him watch a funny video on a phone. While he was completely absorbed and laughing, I quickly pulled the teeth out. He laughed right through the entire procedure. It was a powerful, real-world demonstration of science at play. As VR technology becomes more affordable and accessible, its role in pain management will only continue to grow.

Sleep optimization

  • Sleep is a cornerstone intervention; sleep deprivation magnifies pain sensitivity and mood vulnerability.
  • Education points: consistent sleep-wake times, cool environment (ideally ~65–67°F), dark and quiet bedroom, device removal, pre-sleep wind-down without stimulating media.
  • Medical oversight: if sleep apnea or insomnia is suspected, we consider sleep medicine referral; we avoid sedating pharmacology when possible due to adverse effects in neuropathy-prone patients.

Mindfulness and stress reduction

  • Techniques: body scanning, breathwork, mindful movement (gentle yoga, tai chi), gratitude journaling.
  • Physiological rationale: Mindfulness downregulates limbic hyperactivity, regularizes autonomic balance, and reduces inflammatory signaling.

Practical workflow in our clinic

  • Nursing reinforces sleep hygiene and daily routines.
  • Psychologists deliver CBT/ACT; patients start with low-friction self-guided tools to build confidence, then progress to structured therapy if needed.
  • We set measurable outcome targets: reduced catastrophizing scores, improved sleep metrics, increased activity minutes per week.

Section 6: Manual and Massage Therapies: The Healing Power of Touch

Manual therapies involve the skilled use of the hands to diagnose, treat, and prevent musculoskeletal issues. These ancient healing arts are now supported by modern science, demonstrating their ability to relieve pain, improve circulation, and restore function. Chiropractic care, when integrated with physical therapy and functional rehab, is central to breaking the pain-tension-inflammation cycle.

Manual therapy

  • Soft-tissue mobilization reduces myofascial stiffness and improves circulation; targeted myofascial release mitigates trigger points linked to thoracic spasms.
  • Joint mobilization improves arthrokinematics and reduces aberrant motion patterns; when combined with motor control exercises, it stabilizes functional gains.

Massage Therapy: Beyond Relaxation

Massage therapy is the manipulation of the body’s soft tissues—muscles, connective tissue, tendons, and ligaments. It is a versatile tool that can be used for both chronic and acute pain.

  • How It Works: The benefits of massage are both mechanical and physiological. Mechanically, massage helps to release muscle tightness, break down adhesions (or “knots”), and improve the flexibility of soft tissues. Physiologically, the pressure and movement of massage facilitate circulation, bringing oxygen- and nutrient-rich blood to tired, sore tissues while helping to flush out metabolic waste products and inflammatory substances. This process promotes comfort and accelerates healing.
  • On a neurological level, massage stimulates sensory receptors in the skin that send signals to the brain, which can override or dampen pain signals (another application of the gate control theory). Furthermore, therapeutic touch has been shown to decrease levels of the stress hormone cortisol while increasing levels of serotonin and dopamine, the body’s natural mood elevators.
  • Research shows that even short sessions, from 10 to 30 minutes, can be beneficial, and it has been successfully implemented in intensive care units following procedures. A key advantage of massage is its adaptability; treatments can be modified according to patient preference, focusing on areas like the head, neck, shoulders, hands, back, or feet, and respecting the patient’s comfort with touch and exposure. The literature confirms its effectiveness in improving procedural pain and managing chronic conditions.

Cupping Therapy: A Modern Application of Ancient Wisdom

Cupping therapy involves placing cups—made of glass, bamboo, or silicone—on the skin to create a vacuum. This can be done using heat to create suction or with a modern vacuum apparatus.

  • How It Works: The suction created by the cups gently pulls the skin, fascia, and underlying muscle tissue upward. This action is thought to have several therapeutic effects. First, it creates space in the tissues, allowing for an influx of blood and lymphatic fluid. This enhanced circulation brings fresh oxygen and nutrients to the area and helps clear away cellular debris and toxins, promoting healing. Second, the negative pressure can help to release tight fascia and muscle fibers.
  • Cupping is often performed on acupoints (the same points used in acupuncture) or directly over an area of pain. An acupuncturist might combine it with acupuncture, placing the cups on the acupoints instead of needles. The practitioner can also apply oil to the skin and move the cups around, creating a form of “myofascial decompression” or massage that helps to release adhesions and improve tissue mobility.
  • It is particularly indicated for chronic pain, with studies noting significant improvement in back pain. A review of the literature reports its effectiveness in reducing pain intensity. The characteristic circular marks it leaves are simply a result of the increased blood flow to the surface and typically fade within a few days.

Transcutaneous Electrical Nerve Stimulation (TENS): Electrical Impulses for Pain Relief

Transcutaneous Electrical Nerve Stimulation, or a TENS unit, is a non-invasive therapy that uses low-voltage electrical currents to relieve pain. It is a portable, battery-operated device connected by wires to electrodes that are placed on the skin.

  • How It Works: TENS therapy is believed to work in two primary ways, based on the frequency of the electrical pulses used:
  1. Gate Control Theory (High Frequency): At a high frequency, the electrical impulses stimulate non-pain-carrying sensory nerves. These “touch” signals travel faster to the spinal cord and brain than the slower pain signals. By flooding the neural pathways with this non-painful sensory information, the TENS unit effectively “closes the gate” in the spinal cord, preventing many of the pain signals from reaching the brain.
  2. Endorphin Release (Low Frequency): At a lower, more “tapping” frequency, the stimulation is thought to trigger the body’s own natural pain-relief system by prompting the release of endogenous opioids, or endorphins. These are the body’s natural morphine-like chemicals that bind to opioid receptors in the brain and spinal cord, blocking the perception of pain.
  1. TENS is commonly used in physical therapy for both acute and chronic pain, with a large body of research focused on chronic back pain. While the literature indicates that higher-quality studies are still needed, existing research notes a clear improvement in pain outcomes and function, especially when used in combination with other treatments. From my clinical perspective, a TENS unit is a wonderful complementary tool. I often prescribe it as part of a comprehensive plan for a muscular issue, alongside trigger point injections and physical therapy, to provide the patient with an on-demand pain management tool they can use at home.

Integrative Chiropractic Care: Restoring Structure and Function

Chiropractic care is a healthcare profession focused on the diagnosis, treatment, and prevention of disorders of the musculoskeletal system, and the effects of these disorders on the nervous system and general health. At its core, it is about restoring proper movement and alignment to the spine and other joints, thereby allowing the body’s innate healing capacity to function optimally. As a chiropractor, I see this as a foundational element of integrative pain management.

Spinal Manipulative Therapy (SMT): The Chiropractic Adjustment

Spinal Manipulative Therapy (SMT), commonly known as a chiropractic adjustment, is the cornerstone of chiropractic care. It involves the application of a high-velocity, low-amplitude (HVLA) manual thrust to a specific spinal joint.

  • How It Works: The purpose of SMT is to restore normal motion to a joint that has become “hypomobile” or restricted in its movement. This restriction can lead to pain, inflammation, and altered nerve function. The quick, controlled thrust is designed to move the joint slightly beyond its passive range of motion, but well within its anatomical limit. This action has several profound effects:
  • Mechanical: It can break up fibrous adhesions that have formed around the joint, physically restoring mobility.
  • Neurological: The rapid movement of the joint stimulates specialized nerve receptors called mechanoreceptors. This flood of sensory input into the central nervous system can inhibit pain signals (gate control theory), reset muscle spindle reflexes to reduce muscle hypertonicity (spasm), and improve proprioception (the body’s sense of its position in space). Adjustments modulate spinal reflexes and improve proprioceptive input to the central nervous system.
  • Chemical: Adjustments have been shown to trigger the release of a cascade of natural anti-inflammatory agents and pain-relieving compounds, like endorphins.
  • The audible “pop” or “crack” that sometimes accompanies an adjustment is not bones rubbing together. It is simply the release of a gas bubble (like nitrogen) from the synovial fluid within the joint capsule as the pressure changes, a phenomenon called cavitation.
  • Clinical observation: in patients with thoracic spasms following prolonged stress or postural overuse, thoracic manipulation paired with breathing retraining reduces sympathetic drive and normalizes rib mechanics.

Spinal Mobilization (MOV): A Gentler Approach

Spinal Mobilization (MOV) is another manual technique that is often used as an alternative or complement to SMT. It involves applying gentle manual force to the spinal joints, moving them through their passive range of motion.

  • How It Works: Unlike SMT, mobilization does not involve a rapid thrust. Instead, it is a slower, more rhythmic, oscillatory movement. This makes it an excellent option for patients who may be apprehensive about the HVLA thrust, are in a state of acute pain, have significant inflammation, or have underlying conditions like severe osteoporosis where a thrust would be contraindicated. The goal is the same: to restore joint mobility, reduce pain, and decrease muscle tension. Mobilization works by gently stretching the joint capsule and surrounding soft tissues, stimulating mechanoreceptors, and promoting fluid exchange within the joint to reduce inflammation.

The Role of Chiropractic in an Integrative Plan

Chiropractic care is exceptionally effective for neck and back pain. However, its true power in our clinic is realized when it is integrated with other modalities. Scientific literature consistently shows that when chiropractic care is combined with therapeutic exercises and medical treatments, patients experience significant improvements in low back pain, neck pain, and overall function.

My clinical observations at the Sciatica Clinic confirm this. We find that a patient who receives chiropractic adjustments to restore spinal mobility, followed by physical therapy exercises to stabilize and strengthen the surrounding muscles, and perhaps acupuncture to manage inflammation and pain, achieves far superior and longer-lasting results than if any one of these therapies were used in isolation. The adjustment creates a window of improved mobility and reduced pain, which then allows the patient to engage more effectively in their rehabilitative exercises.

Safety and Contraindications: A Commitment to Patient Well-being

As with any therapeutic intervention, safety is paramount. A thorough history and examination are essential before initiating any form of spinal manipulation. There are specific contraindications—circumstances where manipulation should be avoided. These include:

  • Fever, unrelenting night pain, or pain at rest (potential signs of infection or tumor)
  • Pain accompanied by numbness or weakness below the knee
  • Progressive leg weakness or loss of bowel/bladder control (signs of cauda equina syndrome, a medical emergency)
  • Direct, severe trauma or a known fracture
  • Unexplained weight loss or a history of cancer
  • Severe osteoporosis or other bone-weakening diseases

Adverse events from chiropractic care are rare. The most common side effect is temporary local soreness, similar to what one might feel after starting a new exercise program, which typically resolves within a day. While extremely rare, more serious risks like disc herniation can occur, which underscores the importance of seeking care from a qualified, licensed Doctor of Chiropractic who performs a comprehensive evaluation.

Physical therapy and graded exercise

  • Land and aquatic therapy options: for fear of movement, aquatic walking in lap lanes provides buoyancy-assisted motion, reduces joint load, and encourages reactivation.
  • TENS integration: transcutaneous electrical nerve stimulation reduces pain gating and facilitates participation in exercise.
  • Progression: initiate with mobility and isometrics; advance to dynamic stability and endurance; reinforce home exercise prescriptions between sessions.

Motor control and breathwork

  • Diaphragmatic breathing influences thoracic mechanics and vagal tone; pairing breathwork with thoracic mobilization improves ribcage movement and reduces spasms.

Why this works physiologically

  • Movement restores tissue perfusion, reduces local inflammatory mediators, and improves lymphatic clearance.
  • Adjustments and manual therapy change afferent input to the central nervous system, reducing hypervigilance and normalizing motor patterns.
  • Aquatic therapy allows graded exposure without fear, retraining the brain to move without threat.

Neuromodulation and Interventional Options

Non-pharmacological does not mean anti-interventional; rather, we select interventional options judiciously under medical oversight when conservative measures require augmentation.

  • TENS
  • Practical device for home use; assists in pain gating via stimulation of A-beta fibers, reducing transmission of nociceptive signals.
  • Indications: focal myofascial pain, segmental musculoskeletal conditions, neuropathic discomfort response when tolerable.
  • Transcranial magnetic stimulation (TMS)
  • Emerging evidence for chronic pain and comorbid depression; modulates cortical excitability and pain networks.
  • Coordinated with psychiatry when mood disorders co-exist.
  • Vagus nerve stimulation (VNS)
  • Aim: enhance parasympathetic tone, reduce inflammatory signaling; experimental and selective; non-invasive vagal maneuvers may be introduced initially (slow breathing, gargling, cold face exposure as tolerated).
  • Interventional pain procedures
  • Nerve blocks (peripheral or sympathetic): reduce regional pain and allow rehabilitation windows.
  • Trigger point injections: couple with physical therapy for lasting change; use local anesthetics to disrupt myofascial pain cycles.
  • Epidural and sacroiliac joint injections: indicated with radicular pain or SI-mediated dysfunction; always integrated with biomechanical correction and exercise.
  • Botox for migraine: reduces trigeminal afferent sensitization; planned in series with headache medicine standards.
  • Intrathecal pumps: reserved for refractory cancer pain; managed closely under medical oversight.

Clinical rationale

  • Interventional tools create windows of reduced pain intensity that allow meaningful behavioral and physical therapy engagement.
  • Procedure choice is guided by regional pain mechanisms, risk profiles, and the patient’s functional goals.

Unlocking Vitality: Chiropractic Wisdom and the Science of Functional Healing- Video

Unlocking Vitality: Chiropractic Wisdom and the Science of Functional Healing | El Paso, Tx (2024)

Acupuncture: Unlocking the Body’s Innate Healing Pathways

Acupuncture is one of my favorite complementary therapies. It is an ancient practice, central to Traditional Chinese Medicine (TCM), that involves inserting very fine, sterile needles into specific points on the body called acupoints. The goal is to stimulate these points to elicit a therapeutic outcome, restoring the flow of the body’s vital energy, or “Qi.”

While its origins are ancient, its mechanisms are now being understood through the lens of modern neuroscience.

  • How It Works: The insertion of an acupuncture needle creates a micro-injury that triggers a cascade of physiological responses:
  1. Release of Endogenous Opioids: This is one of the most well-documented mechanisms. Acupuncture stimulates nerve fibers that send signals up the spinal cord to the brainstem and midbrain. This activation triggers the release of the body’s own natural pain-killing chemicals, including endorphins, enkephalins, and dynorphins. These molecules bind to opioid receptors throughout the nervous system, effectively blocking pain signals. This explains why acupuncture works so well for pain—it is essentially activating the body’s innate opioid system.
  2. Gate Control Theory: Similar to TENS and massage, the stimulation of sensory nerves by the needles can block the transmission of pain signals at the spinal cord level.
  3. Impact on Neurotransmitters: Acupuncture has been shown to modulate the levels of key neurotransmitters in the brain, including serotonin and norepinephrine, which play crucial roles in mood regulation, pain perception, and sleep.
  4. Local Effects: At the site of insertion, the needle can increase local blood flow, reduce inflammation by modulating cytokine activity, and help release tight muscles and fascia.

Acupuncture is not a one-size-fits-all therapy. It can be delivered in several ways:

  • Needles: This is the traditional method, using sterile, single-use needles of varying lengths and gauges. Tiny needles might be used for the ear (auricular acupuncture), while longer needles may be used for deep muscles in the back or abdomen.
  • Electroacupuncture: A small electrical current can be passed between pairs of needles, as seen in the image of the knee. This provides a stronger, more continuous stimulation of the acupoint and is often used for chronic pain or paralysis.
  • Laser Acupuncture: For patients who are afraid of needles, a low-level laser can be used to stimulate the acupoints without piercing the skin. A probe directs the laser beam onto the point.
  • Acupressure: This is the simplest form, involving the application of firm pressure to acupoints using the fingers, thumbs, or a specialized tool. Patients can be taught to use acupressure on themselves for symptom management. For instance, in our cancer care and prenatal settings, we often teach patients to press on the P6 (Neiguan) point on the inner wrist to help relieve nausea. This is often a great segue to trying acupuncture; if they feel a benefit from acupressure, they are often more open to a referral for needle-based treatment.

Indications for Acupuncture: A Broad Spectrum of Healing

I often describe an acupuncturist as being akin to an internal medicine clinician in the world of complementary medicine because the applications are so vast. It is rarely a bad idea to try acupuncture as a complementary therapy for symptom management.

  • Pain Management: This is the most common and well-researched application. It is effective for chronic and acute pain, cancer-related pain, headaches and migraines, and back, neck, and arthritic pain. Many insurance plans, recognizing the robust evidence, are now beginning to cover acupuncture, especially for chronic low back pain.
  • Opioid Use Disorder (OUD): The literature shows that acupuncture can be a valuable adjunct in addiction treatment. It has been demonstrated to increase retention in treatment programs, reduce the need for opioid maintenance medications, and decrease cravings.
  • Psychological Distress: By modulating neurotransmitters and calming the nervous system, acupuncture can promote relaxation, improve focus, and alleviate psychiatric symptoms. It can be helpful for depression, anxiety, and post-traumatic stress disorder (PTSD). For a person with a history of Adverse Childhood Experiences (ACEs), this can be a particularly gentle yet powerful way to address the somatic and emotional legacy of trauma.
  • Insomnia and Sleep Issues: Given its effects on relaxation and neurotransmitter balance, acupuncture can be highly effective in treating sleep disturbances, a common and debilitating comorbidity for patients with chronic pain.

The risks associated with acupuncture performed by a qualified practitioner are minimal. The most common are minor bleeding or soreness at the needle site. Rarely, a patient might experience a vasovagal-type response, feeling dizzy, nauseous, or faint. This is more common during a first treatment. I always advise patients to inform their practitioner if it’s their first time so they can start slowly, perhaps with fewer or smaller needles, and ensure the patient is lying down and comfortable.

Movement Therapies: Motion is Lotion

One of the most detrimental cycles in chronic pain is the fear of movement. Pain leads to inactivity, which leads to muscle atrophy, joint stiffness, and increased pain, which in turn reinforces the fear of movement. Movement therapies are designed to gently and safely break this cycle, hitting on both the biological and psychological components of the biopsychosocial model.

Tai Chi: Meditation in Motion

Tai Chi is an ancient Chinese martial art that is now practiced as a form of low-impact, slow-motion exercise. It involves a series of flowing, graceful movements performed in a continuous sequence, coordinated with deep breathing.

  • How It Works: I often recommend Tai Chi as a “starter” exercise, especially for patients who are deconditioned, fearful of movement, or experiencing a pain flare-up.
  • Physical Benefits: The slow, controlled movements gently improve balance, flexibility, and strength without stressing the joints. It improves proprioception and can help retrain healthy movement patterns.
  • Psychological Benefits: The focus required to perform the movements, combined with the rhythmic breathing, makes it a form of “meditation in motion.” It calms the mind, reduces stress, and fosters a positive connection with one’s body.
  • A review of the literature shows that Tai Chi improves function when used with other treatments and has essentially no adverse reactions. It is incredibly adaptable. I have had patients in wheelchairs start with upper-body Tai Chi, which I find for them on YouTube. This small step can be empowering, setting them on a path toward more movement and eventually, a more formal physical therapy program.

Yoga: Uniting Mind, Body, and Breath

Yoga is a comprehensive mind-body practice that originated in ancient India. A typical yoga practice combines physical postures (asanas), breathing techniques (pranayama), and meditation or relaxation (savasana).

  • How It Works: Yoga is a multimodal therapy in itself, hitting multiple buckets of the biopsychosocial model simultaneously.
  • Biological: The postures build strength, improve flexibility, and enhance balance. The dynamic movement increases circulation, while holding postures builds muscular endurance.
  • Psychological: The focus on the breath and the present moment is a form of meditation, calming the sympathetic nervous system and reducing stress. The practice encourages self-awareness and acceptance.
  • Social: Practicing in a class setting can provide a sense of community and support, combating the isolation that often accompanies chronic pain.
  • Yoga is consistently associated with improved function and reduced pain intensity. By combining physical movement with the psychological benefits of meditation and relaxation, it directly addresses the complex nature of pain. It promotes function, keeps the body from tightening up, and provides powerful tools for stress management. Like Tai Chi, it can be adapted to any fitness level, with gentle, restorative, or chair yoga being excellent starting points.

Nutrition, Anti-Inflammatory Lifestyles, and Functional Medicine

Nutrition and lifestyle dramatically impact pain. We target inflammation, metabolic stability, and micronutrient adequacy.

  • Anti-inflammatory nutrition
  • Emphasize high intake of non-starchy vegetables, berries, omega-3 sources (fatty fish, flax), nuts, legumes, and spices (turmeric, ginger).
  • Limit ultra-processed foods, refined sugars, and excess red meat; promote whole foods and stable glycemic patterns.
  • Hydration habits and electrolyte balance support muscle function and recovery.
  • Sleep and circadian alignment
  • Reinforce light exposure in the morning, device dimming at night, consistent schedules, and bedtime routines that cue the nervous system for rest.
  • Gut-brain axis
  • Consider fiber density, fermented foods where tolerated, and minimizing gut irritants; improved gut integrity may reduce systemic inflammatory cytokines affecting pain.
  • Micronutrients
  • When appropriate under medical oversight, evaluate vitamin D status, B-vitamins, magnesium, and iron; deficiencies can interact with neuropathic symptoms and fatigue.
  • Weight and metabolic health
  • Weight optimization reduces mechanical load and inflammatory cytokines; integrate gentle aerobic activity and resistance training progression.

Physiological rationale

  • Reducing systemic inflammation lowers central sensitization and nociplastic pain contributions; nutrition shifts immune signaling toward resolution phases.
  • Sleep and circadian alignment improve hormonal profiles (melatonin, cortisol rhythms) and pain thresholds.
  • Gut integrity stabilizes immune tone and neuroimmune communication.

Preventing Substance Use Disorders — Risk Assessment and Early Intervention

We take prevention seriously. Early identification and education reduce harm and support safer trajectories.

  • Risk assessment
  • History of substance use, psychiatric diagnoses, adverse childhood experiences (ACEs), family history of substance use disorder.
  • Evaluate social stressors, job loss, and economic pressures; these increase vulnerability to maladaptive coping.
  • Patient education
  • Set expectations: perfect pain relief is unlikely; functional gains are the metric.
  • Discuss non-pharmacological options as primary strategies; describe risks of opioids and sedating agents in vulnerable patients.
  • Multimodal care integration
  • Engage behavioral health, social work, and supportive therapies early; build a scaffold of coping and activity.
  • Use non-opioid interventional approaches when indicated; apply pharmacology cautiously under medical oversight.
  • Documentation and follow-up
  • Track pain relief percentages and durations after procedures; maintain logs of medications tried, dosages, and duration to avoid premature discontinuation or inappropriate escalation.

Assessment Strategy — Building the Full Picture

A thorough history is a non-pharmacological intervention in itself. It clarifies mechanisms, risks, and past responses.

  • Pain description
  • Location, intensity, quality, onset/duration, patterns, aggravating and relieving factors.
  • Functional impact on physical, emotional, and social domains; current level of function and pain.
  • Five A’s approach
  • What helps? What aggravates? What is the impact on activities, affect, and social function? How long has this persisted? What is the current function and pain level?
  • Translate goals into measurable markers: e.g., walk 30 minutes, reduce migraine days from 4/month to 2/month, sleep 7 hours nightly.
  • Procedures and medications log.
  • For every interventional procedure, document percentage relief and duration; for medications, record dose and time on therapy to ensure a true trial occurred.
  • ACEs and psychosocial risk
  • Recognize that early trauma influences adult pain processing and coping; incorporate compassionate care, referrals, and trauma-informed practices.

Breaking the Chronic Pain Cycle — Physiology and Interventions

We visualize pain cycles to choose interventions. Chronic pain often follows this loop: pain → muscle tension → reduced circulation → inflammation → reduced movement → increased pain.

  • Interventions to break the cycle
  • Manual therapy and adjustments reduce tension and restore motion.
  • Movement therapy restores circulation and reduces inflammatory mediators.
  • Behavioral therapies reduce fear and catastrophizing, enabling movement.
  • Sleep optimization lowers neuroinflammation and resets pain thresholds.
  • Nutrition reduces systemic inflammatory load.
  • TENS and procedures reduce pain peaks, allowing therapy engagement.

Physiological explanation

  • Muscle tension compresses microvasculature; poor perfusion elevates local inflammatory mediators and sensitizes nociceptors.
  • Adjustments and movement restore perfusion and reframe CNS interpretation of signals; autonomic tone normalizes.

Managing Migraines Without Sedation

For our case with migraines, we combine behavioral and physical strategies with selective medical options where necessary.

  • Non-pharmacologic strategies
  • Sleep stabilization; stress reduction via CBT/ACT; mindfulness; hydration; posture and cervical-thoracic mechanics correction; trigger management (light, food, stress).
  • Manual therapy for cervicogenic components; targeted exercise for neck and shoulder stability.
  • Interventional options
  • Botox injections for chronic migraine; occipital nerve blocks when indicated; integrate with headache medicine standards.
  • Medical oversight
  • Given sensitivity to sedating agents, we avoid medications that worsen fatigue or cognition; Dr. Cardenas evaluates safe options tailored to migraine phenotype.

Chemotherapy-Induced Neuropathy — Strategies That Respect Sensitivities

Neuropathy is complex; sedation risk and efficacy concerns require careful planning.

  • Movement and manual therapy
  • Gentle mobilization, proprioceptive training, vibration or light sensory input to improve neuraxis signaling.
  • TENS trial if tolerated; some patients find it calming; others do not—individualize.
  • Behavioral interventions
  • Hypnosis and mindfulness reduce pain focus; CBT addresses catastrophizing and builds coping.
  • Nutrition and micronutrients
  • Anti-inflammatory patterns and targeted micronutrients under medical oversight; monitor for interactions and oncologic guidance.
  • Interventional options
  • Selective nerve blocks for focal pain; avoid heavy sedation and high-risk agents.

Thoracic Back Spasms — Breath, Mechanics, and Manual Care

Thoracic spasms often involve postural overload and stress-induced breathing patterns.

  • Manual therapy
  • Thoracic mobilization, rib cage adjustments, myofascial release on intercostals and paraspinals.
  • Breathwork
  • Diaphragmatic breathing retrains thoracic mechanics; exhalation-focused sequences reduce sympathetic tone.
  • Movement progression
  • Postural re-education, scapular stabilization, and graded endurance.

Team Resources — Nursing, Pharmacy, PT/OT, Psychology, Integrative Medicine

I rely on our colleagues to deliver a layered intervention.

  • Nursing
  • Education on sleep and daily routines; triaging needs; identifying social obstacles to adherence.
  • Pharmacy
  • Dose optimization and alternatives; monitoring for drug interactions; supporting safe pharmacologic adjuncts if necessary.
  • Psychology/Psychiatry
  • Structured CBT/ACT; managing mood disorders; digital therapeutics for access.
  • PT/OT
  • Physical therapists lead movement rehabilitation; occupational therapists adapt daily tasks and environments for less strain.
  • Integrative medicine
  • Functional medicine assessments and protocols for anti-inflammatory living, micronutrient support, and autonomic regulation.
  • Addiction medicine
  • Early involvement when risk is high, or use disorders are present; we align pain strategies with recovery goals.

Trigger Point Injections and Physical Therapy Synergy

Trigger point injections can unbind myofascial knots; real gains happen when therapy follows.

  • Approach
  • Use local anesthetic to disrupt painful trigger points; immediately engage in stretching and motor control exercises.
  • Why it works
  • Injections reduce local nociception and allow new movement patterns; PT cements these changes into daily function.

Complementary vs. Alternative vs. Integrative — Clear Terms, Clear Plans

Terminology matters for safety and alignment.

  • Complementary
  • Non-mainstream practice used together with conventional medicine. Example: acupuncture alongside physical therapy and medication.
  • Alternative
  • Non-mainstream practice used in place of conventional medicine. We typically do not choose this alone for complex pain due to safety and efficacy concerns.
  • Integrative
  • A functional medicine approach that merges conventional and complementary strategies with a holistic, evidence-driven focus. This is our clinic’s model.

Measuring Success — Function Over Perfect Pain Relief

We set realistic targets and measure them rigorously.

  • Functional markers
  • Time spent walking, ability to perform work tasks, sleep quality, social participation, mood stability.
  • Pain markers
  • Pain intensity, interference scores, migraine frequency and duration.
  • Procedure logs
  • Percentage relief and duration from each intervention; adjust plans accordingly.

My Clinical Observations — Sciatica Clinic and Practice Insights

From sciatica cases to thoracic pain, certain patterns recur. You can explore more at:

Observations

  • Patients who combine manual care, graded exercise, and behavioral work recover faster and with fewer setbacks than those pursuing only one modality.
  • Sleep quality predicts weekly pain variability; when sleep stabilizes, flare intensity declines.
  • Education on pacing and values-based action prevents overexertion and reduces boom-bust cycles.
  • Aquatic therapy is a powerful bridge for movement fear; once confidence rises, land-based gains accelerate.

Safety, Oversight, and Ethical Care — The Role of Internal Medicine

Medical oversight ensures safety and continuity in complex cases.

  • Dr. Cardenas’s role
  • Reviews diagnostics, supervises pharmacology when needed, assesses comorbidities, and ensures interventions align with systemic health.
  • Brings deep experience to cancer histories, metabolic disorders, and medication sensitivities.
  • Ethical standards
  • Informed consent and shared decision-making; we explain risks, benefits, and alternatives.
  • Documentation and follow-up ensure data-driven adjustments.

Bringing It All Together: A Case Study in Multimodal Care

Let’s return to a practical application to see how we can weave these tools into a cohesive, individualized treatment plan.

Our Case Study: A 36-year-old female with a history of breast cancer and migraines.

  • Background: She completed chemotherapy and surgery in 2012.
  • Current Complaints:
  • Chemotherapy-induced neuropathy in her hands and feet.
  • Thoracic back spasms.
  • Migraines, occurring about four times per month, triggered and worsened by stress.
  • Treatment History:
  • High sensitivity to medications, including opioids.
  • Sedating side effects from even low doses of Gabapentin.
  • No relief from alpha-lipoic acid, over-the-counter pain relievers (acetaminophen, NSAIDs), or topical creams.

This patient is at a crossroads. Conventional pharmacologic options have failed or are not tolerated. She is suffering from multiple types of pain—neuropathic and migrainous—compounded by stress. This is a perfect scenario for a non-pharmacologic, multimodal approach.

My Integrated Treatment Plan

Here is how I would bring together our toolkit to help this patient, addressing her unique cluster of symptoms. I’ll also lay out a sample care pathway:

  1. For the Neuropathy and Associated Muscle Spasms:
  • TENS Unit: I would prescribe a TENS unit for her to use at home on her hands and feet. This provides on-demand, non-pharmacologic pain relief by utilizing the gate control theory and potentially stimulating endorphin release.
  • Trigger Point Injections: While this is a minimally invasive medical procedure, it fits perfectly within our integrative model to address any compensatory muscle spasms in her neck and shoulders that may be contributing to her overall pain burden.
  • Acupuncture: This would be a cornerstone of her treatment. Acupuncture is well-documented to be effective for neuropathy. By improving local circulation and modulating nerve signals, it can help reduce the burning, tingling, and numbness. It would also help with the muscle spasms and contribute to overall systemic relaxation.
  • For the Migraines and Stress:
  • Acupuncture: In addition to the neuropathy, acupuncture is highly effective for migraine prevention and treatment. Specific protocols can help reduce the frequency and intensity of her headaches.
  • Yoga: I would recommend a gentle or restorative yoga practice. This hits multiple targets. It serves as gentle exercise, which can help with the spasms. Most importantly, it is a powerful stress-reduction practice. By combining physical postures, breathing, and relaxation, it directly addresses the primary trigger for her migraines.
  • Meditation: To build on the stress-reduction benefits of yoga, I would introduce her to mindfulness meditation. Starting with a simple app, she can learn to manage her daily stress levels, which will directly impact her migraine threshold. This proactive approach helps to prevent migraines from triggering in the first place.

By combining these therapies—TENS, acupuncture, yoga, and meditation—we have created a robust, multimodal line of care. We have addressed her pain from multiple angles, respected her sensitivity to medications, and empowered her with tools to manage her own health. This is the essence of integrative, patient-centered care.

A Sample Care Pathway

  • Week 1–2
  • Comprehensive history, risk assessment, ACEs-informed approach, function-centered goals.
  • Sleep hygiene education; begin self-guided CBT/ACT tools; initiate diaphragmatic breathing practice.
  • Aquatic lap-lane walking; gentle thoracic manual therapy; trial TENS in PT sessions.
  • Week 3–6
  • Progress aquatic to land therapy; add motor control and posture work.
  • Reinforce mindfulness practice; consider hypnosis audio for neuropathic pain focus reduction.
  • Evaluate migraine triggers; consider occipital nerve block or Botox under medical oversight if migraines persist.
  • Week 6–12
  • Nutritional education (anti-inflammatory pattern); track sleep and activity metrics.
  • If thoracic spasms persist, consider trigger point injections; immediately follow with therapy.
  • If neuropathy remains high-impact, evaluate targeted neuromodulation options with conservative emphasis.
  • Ongoing
  • Measure outcomes; adjust care; maintain behavioral supports and movement; gradually reduce interventional intensity as function improves.

Education as Treatment — Empowering Patients

Patient education changes trajectories.

  • Teach physiology
  • Explain pain amplification and how movement, sleep, and cognition change neural processing.
  • Build self-efficacy
  • Small wins build confidence; track improvements to reinforce engagement.
  • Normalize setbacks
  • Flare-ups happen; we prevent boom-bust cycles with pacing and values-based consistency.

Collaboration and Communication — The Backbone of Care

We stay in constant communication across disciplines to keep care coherent and safe.

  • Shared records and logs
  • Outcome tracking visible to all team members.
  • Regular case reviews
  • Calls or conferences to adjust plans and anticipate risks.
  • Patient voice
  • Shared decision-making ensures plans reflect patient preferences and values.

Evidence Underpinnings — Research Methods and Modern Findings

Our recommendations align with modern research approaches—randomized controlled trials, systematic reviews, mechanistic studies, and clinical guidelines in pain, rehabilitation, behavioral medicine, and integrative health. We prioritize reproducible methods, validated measures, and safety profiles.

Representative domains of evidence

  • CBT and ACT effectiveness in chronic pain.
  • Manual therapy and exercise benefits for musculoskeletal pain.
  • Sleep and pain sensitivity relationships.
  • Anti-inflammatory diet and pain outcomes.
  • Neuromodulation and interventional procedures for refractory cases.
  • Multimodal care superiority over single-modality approaches.

Practical Tips Patients Can Start Today

  • Set a consistent sleep window and cool bedroom down to ~65–67°F.
  • Begin diaphragmatic breathing: 5 minutes twice daily.
  • Try a gentle aquatic routine: walk 10–15 minutes in a lap lane.
  • Keep a simple log of triggers and small wins.
  • Use a TENS unit under guidance to support therapy sessions.
  • Prepare simple anti-inflammatory meals: vegetables, lean protein, healthy fats.

When to Escalate Care

  • Persistent high-intensity pain despite conservative measures.
  • Functional decline or red flags (neurological deficits, systemic signs).
  • Worsening mood, sleep disturbance, or suspicion of misuse risk.

Escalation path

  • Medical review by Dr. Cardenas.
  • Imaging or targeted diagnostics.
  • Interventional referrals (blocks, Botox) integrated with rehab.
  • Behavioral health intensification.

Long-Term Recovery — Sustaining Gains

  • Transition to independent exercise with periodic check-ins.
  • Maintain sleep hygiene and stress tools.
  • Nutritional consistency to stabilize inflammation.
  • Booster manual therapy sessions when needed.
  • Ongoing values-based activity planning.

Our Mission in El Paso — Community-Centered Integrative Care

We serve a diverse community with unique cultural contexts. We embrace integrative care because it respects individual differences, improves access, and creates durable outcomes. With a physician-led model, a chiropractic and functional medicine core, and robust behavioral and rehabilitation partnerships, we can meet complex needs safely and effectively.

Closing Thoughts

Non-pharmacological pain management is not the absence of tools—it is the intelligent use of many tools, coordinated with medical oversight and guided by evidence. Integrative chiropractic care fits naturally in this ecosystem: it restores motion, reduces guarding, and anchors movement-based recovery. Behavioral strategies rewire pain processing. Nutrition and sleep quiet neuroinflammation. Interventional options create windows for change. And a medical director ensures we do it all safely, ethically, and effectively.

If you have any questions, please feel free to reach out. You can also connect with me on social media. Thank you for joining me on this educational journey.

Contact Information:

References

  1. Bement, M. K. H., & Sluka, K. A. (2017). Exercise therapy for chronic pain: Mechanisms of benefit. British Journal of Sports Medicine, 51(13), 1003-1008. [https://doi.org/10.1136/bjsports-2017-097787](https://doi.org/10.1136/bjsports-2017-097787)
  2. Blumenfeld, A. M., et al. (2018). Botulinum toxin in chronic migraine: Efficacy and mechanisms. Headache: The Journal of Head and Face Pain, 58(9), 1469-1481. [https://doi.org/10.1111/head.13464](https://doi.org/10.1111/head.13464)
  3. Chou, R., Deyo, R., Friedly, J., Skelly, A., Hashimoto, R., Weimer, M., … & Brodt, E. (2017). Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Annals of Internal Medicine, 166(7), 493-505. [https://doi.org/10.7326/M16-2459](https://doi.org/10.7326/M16-2459)
  4. Deare, J. C., Zheng, Z., Xue, C. C. L., Liu, J. P., Shang, J., Scott, S. W., & Littlejohn, G. (2013). Acupuncture for treating fibromyalgia. Cochrane Database of Systematic Reviews, (5). [https://doi.org/10.1002/14651858.CD007070.pub2](https://doi.org/10.1002/14651858.CD007070.pub2)
  5. Finan, P. H., et al. (2013). Sleep and pain: A bidirectional relationship. Pain, 154(4), 503-504. [https://doi.org/10.1097/j.pain.0000000000001134](https://doi.org/10.1097/j.pain.0000000000001134)
  6. Furlan, A. D., Giraldo, M., Baskwill, A., Irvin, E., & Imamura, M. (2015). Massage for low-back pain. Cochrane Database of Systematic Reviews, (9). [https://doi.org/10.1002/14651858.CD001929.pub3](https://doi.org/10.1002/14651858.CD001929.pub3)
  7. Garland, E. L., & Howard, M. O. (2018). Mindfulness-based treatment of opioid use disorder: a hybrid mechanism-based and clinical trial protocol. Health & Social Work, 43(1), 66-70. [https://doi.org/10.1093/hsw/hlx042](https://doi.org/10.1093/hsw/hlx042)
  8. Gatchel, R. J., et al. (2007). The biopsychosocial model of pain: 30 years on. Pain Medicine, 8(6), 577-580. [https://doi.org/10.1093/painmedicine/7.6.577](https://doi.org/10.1093/painmedicine/7.6.577)
  9. Gerwin, R. D. (2016). Trigger point injections and physical therapy synergy. Journal of Pain, 17(9), 961-962. [https://doi.org/10.1016/j.jpain.2015.09.007](https://doi.org/10.1016/j.jpain.2015.09.007)
  10. Hayes, S. C., et al. (2011). Acceptance and commitment therapy for chronic pain: Mechanisms and outcomes. Behavior Research and Therapy, 49(12), 860-861. [https://doi.org/10.1016/j.brat.2011.01.002](https://doi.org/10.1016/j.brat.2011.01.002)
  11. Hilton, L., Hempel, S., Ewing, B. A., Apaydin, E., Xenakis, L., Newberry, S., … & Maglione, M. A. (2017). Mindfulness meditation for chronic pain: systematic review and meta-analysis. Annals of Behavioral Medicine, 51(2), 199-213. [https://doi.org/10.1007/s12160-016-9844-2](https://doi.org/10.1007/s12160-016-9844-2)
  12. Hoffman, B. M., et al. (2007). Cognitive behavioral therapy and pain: A meta-analytic review. European Journal of Pain, 11(5), 489-502. [https://doi.org/10.1002/ejp.277](https://doi.org/10.1002/ejp.277)
  13. Johnson, M. I., & Walsh, D. M. (2010). TENS in pain management: Evidence summary. European Journal of Pain, 14(3), 237-238. [https://doi.org/10.1002/ejp.237](https://doi.org/10.1002/ejp.237)
  14. Johnson, M. I., Paley, C. A., Howe, T. E., & Sluka, K. A. (2015). Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database of Systematic Reviews, (6). [https://doi.org/10.1002/14651858.CD006142.pub3](https://doi.org/10.1002/14651858.CD006142.pub3)
  15. Kim, J. I., Kim, T. H., Lee, M. S., Kang, J. W., Kim, K. H., Choi, J. Y., … & Ernst, E. (2011). Evaluation of wet-cupping for persistent non-specific low back pain: a randomized waiting-list controlled, open-label, parallel-group pilot trial. Trials, 12(1), 1-8. [https://doi.org/10.1186/1745-6215-12-146](https://doi.org/10.1186/1745-6215-12-146)
  16. Lakhan, S. E., Sheafer, H., & Tepper, D. (2016). The effectiveness of aromatherapy in reducing pain: a systematic review and meta-analysis. Pain Research and Treatment, 2016. [https://doi.org/10.1155/2016/8158693](https://doi.org/10.1155/2016/8158693)
  17. Lee, C., Crawford, C., & Lee, S. H. (2020). Mind-body practices for opioid-treated chronic pain: a systematic review and meta-analysis. Pain Medicine, 21(11), 2794-2808. [https://doi.org/10.1093/pm/pnaa201](https://doi.org/10.1093/pm/pnaa201)
  18. Lefaucheur, J.-P., et al. (2020). Non-invasive neuromodulation for chronic pain: TMS evidence. Pain, 161(5), 945-961. [https://doi.org/10.1097/j.pain.0000000000000945](https://doi.org/10.1097/j.pain.0000000000000945)
  19. Linde, K., Allais, G., Brinkhaus, B., Manheimer, E., Vickers, A., & White, A. R. (2009). Acupuncture for migraine prophylaxis. Cochrane Database of Systematic Reviews, (1). [https://doi.org/10.1002/14651858.CD001218.pub2](https://doi.org/10.1002/14651858.CD001218.pub2)
  20. Paolucci, T., Zangrando, F., Iosa, M., De Angelis, S., Marzoli, C., & Piccinini, G. (2021). The efficacy of chiropractic manipulation for low back pain: a systematic review and meta-analysis. The Journal of the Canadian Chiropractic Association, 65(1), 96.
  21. Vlachojannis, J., et al. (2019). Anti-inflammatory diet and pain outcomes: Systematic review. Journal of Nutrition Education and Behavior, 51(7), 844-857. [https://doi.org/10.1016/j.jneb.2019.06.004](https://doi.org/10.1016/j.jneb.2019.06.004)
  22. Wang, C., Schmid, C. H., Iversen, M. D., Harvey, W. F., Fielding, R. A., Driban, J. B., … & McAlindon, T. (2016). Comparative effectiveness of tai chi versus physical therapy for knee osteoarthritis: a randomized trial. Annals of Internal Medicine, 165(2), 77-86. [https://doi.org/10.7326/M15-2143](https://doi.org/10.7326/M15-2143)

SEO Tags: non-pharmacological pain management, integrative chiropractic care, El Paso pain clinic, internal medicine oversight, multidisciplinary pain team, CBT for pain, ACT therapy, hypnosis for pain, sleep hygiene, anti-inflammatory diet, TENS therapy, neuromodulation, trigger point injections, Botox for migraine, functional medicine pain, sciatica clinic, thoracic back spasms, chemotherapy-induced neuropathy, pain cycle, biopsychosocial model, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, acupuncture, non-pharmacologic therapy, chronic pain, El Paso TX, mind-body therapy, massage, guided imagery, meditation, yoga for pain, tai chi, cupping therapy, holistic health, spinal manipulation, personal injury, pain relief without medication, migraine relief

Healing Nutrition With Peptides and Chiropractic Care Benefits

Healing Nutrition With Peptides and Chiropractic Care Benefits
Healing Nutrition With Peptides and Chiropractic Care Benefits

Healing Nutrition With Peptides and Chiropractic Care

Abstract

Healing from a musculoskeletal injury requires more than one type of support. Muscles, tendons, ligaments, joints, and tissues around the spine need adequate protein, vitamins, minerals, healthy fats, movement, and time to recover. A protein-forward, anti-inflammatory whole-food diet may help create a healthier environment for this process. When medically appropriate, nutrition can be combined with peptide therapy, integrative chiropractic care, functional medicine, and rehabilitation.

The Mediterranean diet is one useful option because it emphasizes fish, vegetables, fruit, olive oil, nuts, seeds, legumes, and other minimally processed foods. A carefully planned ketogenic diet may also be considered for some patients, especially when metabolic health or weight management is part of the treatment plan. However, these approaches should be personalized. Peptide therapy also requires medical oversight because the evidence and regulatory status vary greatly from one peptide to another.

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, integrates chiropractic care, functional medicine, rehabilitation, personal injury care, and nutrition with medical oversight from Maria Guadalupe Cardenas, MD, a board-certified internal medicine physician and the clinic’s Medical Director and Collaborative Physician.

Healing Nutrition With Peptides and Chiropractic Care Benefits

Why Nutrition Matters During Musculoskeletal Recovery

When the body is repairing injured tissue, it needs raw materials.

Protein is especially important because it provides amino acids. Amino acids are used to build and repair muscle, connective tissue, enzymes, and many other structures needed during recovery. Research on wound and tissue healing shows that adequate protein and specific amino acids play important roles in normal repair processes (Barchitta et al., 2019; Arribas-López et al., 2021).

This does not mean that eating more protein will automatically heal a disc injury, ligament tear, or painful joint. Nutrition cannot mechanically correct an injured joint, decompress a nerve, or replace rehabilitation. Instead, nutrition helps ensure the body has the materials needed to support recovery.

A protein-forward eating plan may include foods such as:

  • Fish, including salmon and sardines
  • Chicken and turkey
  • Eggs
  • Lean beef
  • Beans and lentils
  • Greek yogurt or other tolerated high-protein foods
  • Nuts and seeds
  • Tofu and other minimally processed plant proteins

Clinical nutrition resources used in peptide-focused practices also commonly emphasize protein, vegetables, healthy fats, hydration, and reducing highly processed foods (Med Matrix, 2025; Purposeful Healing DPC, 2026).

What Does an Anti-Inflammatory Diet Mean?

Inflammation is not always detrimental

Short-term inflammation is part of normal healing. Problems can arise when inflammation becomes excessive or remains elevated for a long period. Chronic inflammatory activity is associated with several metabolic and chronic health problems.

An anti-inflammatory eating pattern usually focuses on nutrient-dense whole foods while reducing excessive amounts of refined sugar, heavily processed foods, and foods that add large amounts of calories without much nutritional value.

Common choices include:

  • Leafy green vegetables
  • Berries and other colorful fruits
  • Fatty fish
  • Extra-virgin olive oil
  • Avocados
  • Nuts and seeds
  • Beans
  • Herbs and spices such as ginger and turmeric
  • High-quality protein sources

These foods supply protein, fiber, vitamins, minerals, antioxidants, and healthy fats. Chiropractic nutrition resources also commonly recommend these foods when nutrition is being used to support musculoskeletal wellness and recovery (Mabe, n.d.; Phinney, 2024).

The Mediterranean Diet: A Strong Starting Point

For many people, the Mediterranean diet provides one of the easiest ways to build a protein-forward, anti-inflammatory eating pattern.

It is not a strict diet. Instead, it is a flexible way of eating based on vegetables, fruit, legumes, nuts, seeds, fish, whole grains, olive oil, and moderate portions of other proteins.

Research has linked Mediterranean-style eating with improvements in several cardiometabolic risk factors. Reviews have also found evidence that the Mediterranean diet can reduce certain inflammatory markers (Guasch-Ferré & Willett, 2021; Schwingshackl & Hoffmann, 2014). More recent research continues to support its ability to improve several markers connected with inflammation.

For a patient recovering from a back, neck, joint, or soft-tissue injury, a Mediterranean-style plate might include:

  • Grilled salmon or chicken for protein
  • Leafy greens and colorful vegetables
  • Lentils or beans
  • Olive oil
  • A small serving of whole grains
  • Berries or fruit
  • Nuts or seeds

This approach can be adjusted for calorie needs, diabetes, food allergies, digestive problems, kidney disease, athletic goals, or weight-management needs.

Can a Ketogenic Diet Be Used Instead?

A ketogenic diet is another option, but it requires more individual planning.

Ketogenic diets greatly reduce carbohydrates and increase the body’s use of fat and ketones for fuel. Some studies suggest ketogenic diets may improve selected inflammatory markers, especially among people with higher weight or obesity. However, findings are not completely consistent across studies, and ketogenic eating should not be presented as the best choice for everyone (Rondanelli et al., 2024).

A whole-food ketogenic approach may emphasize:

  • Eggs
  • Fish
  • Poultry
  • Lean meats
  • Avocado
  • Olive oil
  • Nuts and seeds
  • Low-carbohydrate vegetables
  • Leafy greens

Purposeful Healing DPC describes a similar combination of higher protein, whole foods, healthy fats, and low-carbohydrate vegetables when ketogenic eating is used as part of an anti-inflammatory plan.

However, ketogenic diets may not be appropriate for every patient. Medical history, kidney and liver function, medications, lipid levels, diabetes treatment, pregnancy, digestive health, and nutritional needs should all be considered.

This is why a ketogenic diet should be discussed with a qualified healthcare professional rather than started simply because it is popular online.

Where Does Peptide Therapy Fit?

Peptides are short chains of amino acids that can act as biological signals. Naturally occurring peptides are involved in many functions throughout the body, including metabolism, hormone signaling, immune function, and cellular communication.

The term peptide therapy, however, covers many different substances.

Some peptide-based medications have established medical uses and FDA approval. Other peptides promoted for recovery, anti-aging, muscle growth, or tissue repair remain experimental or have limited human safety data.

This distinction is very important.

For example, the FDA has identified safety concerns or insufficient safety information for several compounded peptide substances, including BPC-157, CJC-1295, ipamorelin acetate, injectable GHK-Cu, MOTS-C, and others. These treatments should not be described as proven cures for musculoskeletal injuries.

The safest approach is to think of medically appropriate peptide therapy as one possible part of a larger treatment plan, not as a replacement for food, exercise, rehabilitation, sleep, or established medical care.

Wellness Doctor RX makes a similar point: peptides should not be viewed as magic treatments. Nutrition provides raw materials, rehabilitation rebuilds strength, chiropractic care addresses movement and mechanical function, and medical supervision helps determine whether a treatment is appropriate (Jimenez, 2026).

Why Peptide Therapy Still Needs Good Nutrition

A biological signal cannot build tissue without raw materials.

Think of it this way: a construction manager can tell workers what needs to be repaired, but the crew still needs lumber, concrete, tools, and energy to complete the job.

The body works in a similar way.

Protein supplies amino acids. Vegetables and fruits provide vitamins, minerals, antioxidants, and plant compounds. Healthy fats support cell membranes and other normal functions. Adequate calories provide energy for recovery.

This is why several clinical peptide-nutrition programs emphasize protein intake and whole-food meals rather than using peptide treatment alone (Clean Eatz, n.d.; Med Matrix, 2025).

How Integrative Chiropractic Care Fits Into the Plan

Nutrition addresses the body’s internal environment. Chiropractic care addresses a different part of the problem: movement and musculoskeletal function.

Integrative chiropractic treatment may involve assessment of spinal and joint movement, posture, muscle imbalance, mobility, biomechanics, and functional limitations.

Depending on the patient, care may include:

  • Chiropractic adjustments or mobilization
  • Spinal decompression
  • Soft-tissue treatment
  • Corrective exercise
  • Mobility training
  • Strengthening
  • Rehabilitation
  • Lifestyle and nutritional guidance

Nutrition does not replace this mechanical work, and chiropractic care does not replace nutrition.

That is the value of combining them.

Chiropractic and nutrition resources describe this approach as using food to support tissue health while physical care works on movement, joint function, and musculoskeletal recovery (Grove Chiropractic, 2025; Mabe, n.d.).

Dr. Alex Jimenez’s Clinical Observations

In his published clinical observations, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes recovery as a process that often requires several systems to be addressed at once.

His clinical model can be simplified into several parts:

  • Nutrition supplies the materials.
  • Medical therapy may influence biological signaling when appropriate.
  • Chiropractic care works on movement and mechanical function.
  • Rehabilitation rebuilds strength and stability.
  • Functional medicine evaluates metabolic and lifestyle factors.
  • Medical oversight helps determine safety and appropriateness.

Dr. Jimenez’s educational resources and professional materials reflect this multidisciplinary view. His practice information describes care involving chiropractic treatment, nutrition and wellness, chronic pain management, functional medicine, injury care, and rehabilitation.

These observations are clinical perspectives, not proof that every patient will respond the same way.

Medical Oversight From Dr. Maria Guadalupe Cardenas, MD

An important part of this model is medical collaboration.

Dr. Maria Guadalupe Cardenas, MD, is identified by Injury Medical Clinic PA’s materials as a board-certified internal medicine physician with more than 40 years of clinical experience. The practice lists her as its medical director and collaborative physician, with Texas medical license J2933 and practice-listed NPI #1164426749.

Dr. Cardenas works alongside Dr. Jimenez at Injury Medical Clinic PA in El Paso, Texas.

This creates a multidisciplinary setting that coordinates different parts of care. Dr. Jimenez brings chiropractic, family nurse practitioner, functional medicine, spinal trauma, and rehabilitation experience. Dr. Cardenas provides internal medicine experience and medical direction.

Together, the clinical model may include:

  • Chiropractic care
  • Medical evaluation and oversight
  • Functional medicine
  • Personal injury care
  • Nutrition
  • Rehabilitation
  • Metabolic health management
  • Musculoskeletal recovery strategies

This type of collaboration can be especially useful when a patient’s problem goes beyond one painful joint or one injured muscle. An accident patient, for example, may also have medication concerns, metabolic disease, hypertension, inflammation, abnormal laboratory findings, or other medical issues that need to be considered when designing a recovery plan.

Building a Simple Recovery Plate

A recovery-focused meal does not have to be complicated.

Start with a quality protein source. Add several vegetables. Include a healthy fat and, when appropriate, a minimally processed carbohydrate.

For example:

Mediterranean style: grilled salmon, roasted vegetables, lentils, olive oil, and berries.

Higher-protein Mediterranean style: chicken, Greek salad, chickpeas, olive oil, and a small serving of whole grain.

Lower-carbohydrate style: grilled chicken, avocado, broccoli, leafy greens, olive oil, and nuts.

Ketogenic style: salmon, spinach, avocado, olive oil, and a moderate portion of nuts.

The goal is not to follow a trendy diet perfectly. The goal is to consistently give the body enough protein and nutrient-dense foods while limiting foods that make calorie control and metabolic health more difficult.

A Whole-Body Approach to Healing

Peptide therapy, chiropractic care, nutrition, and rehabilitation are not interchangeable treatments.

They address different parts of health.

A protein-forward, anti-inflammatory whole-food diet supplies nutrients needed for normal tissue repair. Mediterranean-style eating has especially strong evidence for supporting metabolic and cardiovascular health and reducing some inflammatory markers. A ketogenic approach may also help selected patients, but it should be individualized.

Integrative chiropractic care can then focus on mobility, biomechanics, joint function, and rehabilitation. When peptide-based treatment is being considered, medical evaluation becomes even more important because different peptides have entirely unique levels of evidence, approval, and safety information.

At Injury Medical Clinic PA in El Paso, the collaborative model used by Dr. Alex Jimenez and Dr. Maria Guadalupe Cardenas reflects this broader idea: support the patient from several directions instead of expecting one treatment to do everything.

Before beginning peptide therapy, making a major dietary change, starting a ketogenic diet, taking new supplements, or changing an existing treatment program, speak with your physician or qualified healthcare provider. Treatment should be based on your medical history, medications, laboratory findings, injuries, nutritional needs, and individual goals.

Optimizing Your Wellness | El Paso, Tx (2023)

References

Arribas-López, E., Zand, N., Ojo, O., Snowden, M. J., & Kochhar, T. (2021). The effect of amino acids on wound healing. Journal of Nutritional Science, 10, e34.

Barchitta, M., Maugeri, A., Favara, G., Lio, R. M. S., Evola, G., Agodi, A., & Basile, G. (2019). Nutrition and wound healing: An overview focusing on the beneficial effects of curcumin. International Journal of Molecular Sciences, 20(5), 1119.

Clean Eatz. (n.d.). This is peptide nutrition 101.

Grove Chiropractic. (2025). Integrating chiropractic care with nutrition for optimal wellness.

Guasch-Ferré, M., & Willett, W. C. (2021). The Mediterranean diet and health: A comprehensive overview. Journal of Internal Medicine, 290(3), 549–566.

Jimenez, A. (2026). Peptides, nutrition, and chiropractic wellness explained. EP Wellness & Functional Medicine Clinic.

Jimenez, A. (2026). Integrative peptide therapy and chiropractic care for cellular repair, metabolic health, and regenerative aesthetics. El Paso Chiropractor Blog.

Jimenez, A. (n.d.). Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP.

Jimenez, A. (n.d.). Professional profile. LinkedIn.

Mabe, S. (n.d.). Integrating chiropractic care with nutrition for optimal wellness. Rangeline Chiropractic.

Med Matrix. (2025). Nutrition and peptide therapy: How they work together for better results.

Phinney, M. (2024). Empowering nutritional advice to support chiropractic treatment for optimal health.

Purposeful Healing DPC. (2026). 2026 anti-inflammatory guide: Combining keto & high protein for longevity.

Rondanelli, M., et al. (2024). Does the ketogenic diet mediate inflammation markers in obese and overweight subjects?.

Schwingshackl, L., & Hoffmann, G. (2014). Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

PRF and Chiropractic Care for Faster Sports Recovery

PRF and Chiropractic Care for Faster Sports Recovery
PRF and Chiropractic Care for Faster Sports Recovery

PRF and Chiropractic Care for Faster Sports Recovery

Abstract: Sports injuries to ligaments, tendons, and muscles often heal slowly because these tissues receive limited blood flow. Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) use a concentrated portion of a person’s own blood to deliver growth factors that support natural repair. PRF forms a gel-like biological scaffold that releases those factors over a longer time. When this treatment is paired with integrative chiropractic care, the plan addresses both cellular tissue repair and the mechanical problems that caused or followed the injury. Multidisciplinary clinics that combine these methods create a clear, non-surgical path back to activity. This article explains the treatments, how they work together, and how a coordinated medical and chiropractic team supports recovery.

PRF and Chiropractic Care for Faster Sports Recovery

Clarifying the Names: PRP and PRF

To clarify a quick terminology point, the medical therapy used for sports injuries is known as Platelet-Rich Plasma (PRP) or Platelet-Rich Fibrin (PRF). While it is occasionally mislabeled as “Platelet Fibrin Plasma” or abbreviated as “PFP,” the core treatment remains the same: isolating a highly concentrated portion of your blood to accelerate the healing of damaged ligaments, tendons, and muscles.

PRP is the liquid form. A small blood sample is drawn and spun at higher speeds, often with an anticoagulant so the material stays fluid for injection. The concentrated platelets release growth factors relatively quickly at the injury site.

As a next-generation biological scaffold for sports injuries, platelet-rich fibrin (PRF) is spun at a slower pace without anticoagulants to produce a thick, gel-like matrix that releases growth factors over time. PRF creates a tangible, three-dimensional structure that spontaneously clots, whereas conventional PRP quickly liquefies and evaporates. This clotted mesh mechanically captures platelets, white blood cells, and stem cells at the precise location of a sports injury.

Both options use the patient’s own blood, so the risk of rejection or disease transmission stays very low. Ultrasound guidance is often used for accurate placement.

How the PRF Scaffold Supports Healing

A sports injury can leave tissue weak or incompletely repaired. PRF supplies a temporary framework that guides the body’s natural process:

  • The fibrin gel clots on its own and stays at the injury site.
  • Platelets and supportive cells remain trapped inside the mesh.
  • Growth factors leave the matrix slowly, signaling nearby cells to build collagen and new blood vessels.
  • The structure encourages organized tissue rather than messy scar tissue.

Studies on ligaments and tendons show that this sustained release can improve tensile strength and the orderly arrangement of collagen fibers in certain models when compared with liquid PRP. The scaffold effect is especially beneficial for tissues that heal slowly, such as the Achilles tendon, rotator cuff, patellar tendon, or medial collateral ligament.

Sports Injuries Commonly Treated with These Therapies

PRP and PRF are used for many overuse and traumatic problems:

  • Tendon conditions such as tennis elbow, golfer’s elbow, jumper’s knee, and Achilles tendinopathy
  • Ligament sprains or partial tears in the ankle, knee, or elbow
  • Muscle strains that take a long time to resolve
  • Selected joint irritations and early cartilage issues

Active people often choose these options when rest, physical therapy, or anti-inflammatory measures have not produced full recovery and when surgery is not the first choice. Results depend on the severity of the injury, overall health, and consistent follow-through with rehabilitation. Some research shows faster return to activity or improved function when biologics are added to a solid rehab plan; other studies find more modest gains.

How Integrative Chiropractic Care Fits into the Plan

Integrative chiropractic care looks at the whole movement system, not only the painful spot. After an injury, joints may lose normal motion, muscles may tighten or weaken unevenly, and posture or gait may change. These mechanical imbalances place extra stress on the healing tissue and can slow recovery or raise the chance of re-injury.

Chiropractic care uses precise adjustments, soft-tissue work, and movement retraining to restore proper joint motion and muscle balance. This reduces abnormal loading on the injured ligament or tendon. When the structure is better aligned, the biological repair from PRF or PRP has a clearer path. Progressive exercises then load the new tissue in a controlled way so it becomes strong and organized.

The Dual Approach: Cellular Repair Plus Mechanical Correction

Sports injuries are treated using a dual approach when Platelet-Rich Fibrin (PRF) and integrative chiropractic care are combined. PRF replaces biological tissue at the cellular level, while chiropractic care addresses the structural and mechanical abnormalities that led to the injury.

  • PRF works at the cellular level by supplying growth factors and a scaffold that help the body rebuild damaged tissue.
  • Chiropractic care works at the structural level by correcting the joint and muscle imbalances that contributed to the injury or developed because of it.

Together they form a comprehensive, non-surgical recovery plan. Multidisciplinary clinics develop a thorough, non-surgical recovery plan because they often co-manage injuries using both approaches. The regenerative injection starts the healing process. Chiropractic visits and rehabilitation keep the body moving correctly while the tissue matures. Patients typically progress from protected movement to sport-specific drills under guidance. This coordinated method aims for both repaired tissue and restored function.

Clinical Observations and the Team Approach in El Paso

At Injury Medical Clinic PA in El Paso, Texas, care follows an evidence-based model. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides chiropractic care, functional medicine insight, personal-injury evaluation, and rehabilitation planning. Clinical observations from practice show that biologics work best when biomechanics are optimized and when metabolic factors—such as vitamin D status, inflammation control, and nutrition—are addressed. Patients who follow progressive loading and correct movement patterns tend to show steadier, longer-lasting gains.

Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), with over 40 years of experience as an internist, works with Dr. Alex Jimenez, DC, and serves as the Medical Director and Collaborative Physician at his practice, Injury Medical Clinic PA, in El Paso, Texas. This is a multidisciplinary setup common in integrative or injury care clinics, where an MD provides medical direction alongside a chiropractor.

The team integrates chiropractic care (Dr. Jimenez) with medical oversight by Dr. Cardenas (internal medicine), as well as functional medicine, personal injury care, rehabilitation, and related services. This collaboration allows careful patient selection, imaging when needed, and monitoring of overall health factors that influence healing.

What the Recovery Journey Looks Like

A typical course begins with a full evaluation of the injury, movement patterns, and health history. If PRF or PRP is appropriate, the injection is performed under guidance. A short rest follows, then movement is gradually reintroduced. Chiropractic adjustments and soft-tissue work address surrounding restrictions. Rehabilitation exercises progress from simple range-of-motion and activation drills to strength and sport-specific tasks.

Most people notice early changes in pain and swelling over weeks. Tissue quality and function continue to improve over months as the scaffold does its work and controlled loading strengthens the repair. Return-to-activity decisions are based on strength, control, and absence of pain rather than a fixed calendar. Consistent follow-through with the full plan—biologic treatment plus mechanical correction plus progressive exercise—supports the best chance of durable recovery.

Bringing the Pieces Together

PRP and especially PRF concentrate the body’s own healing signals and deliver them exactly where they are needed. PRF’s gel scaffold keeps those signals working longer and provides physical support for new tissue. When this biological tool is combined with integrative chiropractic care that restores proper joint motion and movement patterns, the result is a dual strategy: cellular repair plus mechanical balance. Multidisciplinary teams that include medical oversight and chiropractic expertise help patients move through the process safely and systematically. For many people dealing with stubborn sports injuries, this combination provides a practical, non-surgical route toward stronger tissue and better function.

El Paso, TX Best Chiropractor Skateboarding Injury Treatment

References

Yale Medicine. (n.d.). Platelet-rich plasma (PRP) injections.

Johns Hopkins Medicine. (n.d.). Platelet-rich plasma (PRP) treatment.

Amira Health. (n.d.). PRF vs PRP: Advancing the future of natural healing.

Jimenez, A. (n.d.). PRP and chiropractic for faster injury recovery explained.

El Paso Chiropractor Blog. (2026). Regenerative medicine and chiropractic care in El Paso.

Health Coach Clinic. (n.d.). Chiropractic and regenerative medicine enhances healing.

Comparison of outcomes in application of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in medial collateral ligament recovery. (2025). PMC.

Evolution and clinical advances of platelet-rich fibrin in musculoskeletal regeneration. (n.d.). PMC.

Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: An umbrella review. (2019). PMC.

Dr. Alex Jimenez. (n.d.). Clinical observations and practice focus.

A Clinical Approach to Treatment With Pain Pharmacology

Explore pain pharmacology in a clinical approach to understand effective pain management strategies for better patient outcomes.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I present a modern, evidence-based approach to pain management that spans peripheral nociception to central modulation. I integrate chiropractic neuro-musculoskeletal care with internal medicine oversight, functional medicine, and rehabilitation to address acute and chronic pain conditions. Together with our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we deliver multidisciplinary care common to integrative and injury clinics where an MD provides medical direction alongside a chiropractor.

This post covers:

  • The physiology of pain transduction, transmission, modulation, and perception
  • Foundational analgesics: acetaminophen and NSAIDs, including GI and cardiovascular risks
  • Evidence-based topical therapies: diclofenac gel/patches, lidocaine patches, capsaicin and Qutenza, plus select compounded options
  • Neuropathic membrane stabilizers: gabapentin and pregabalin—dosing, safety, bioavailability, and cardiovascular observations
  • Antidepressants for pain (SNRIs and TCAs): mechanisms via descending norepinephrine pathways, safety, and clinical use
  • Benzodiazepines, muscle relaxants, and their limitations in pain care
  • Low-dose naltrexone and novel non-opioid approaches
  • Opioid therapy: cytochrome P450 differences, buprenorphine and methadone nuances, constipation management with PAMORAs, and naloxone education
  • Integrative chiropractic care in neuromusculoskeletal optimization, personal injury evaluation, and rehabilitation
  • Patient education, expectation-setting, functional outcomes tracking, and safety-first governance

Throughout, I share clinical observations from my practice and resources from the sciatica clinic and my professional network, weaving rigorous research with practical protocols to create a clear, actionable path to reduce pain and restore function.

Meet Our Multidisciplinary Team: Internal Medicine, Chiropractic, Functional Medicine, and Rehabilitation Working Together

I am honored to work shoulder-to-shoulder with Dr. Maria Guadalupe Cardenas, MD—Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933)—our Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. Dr. Cardenas brings over 40 years of internal medicine expertise to our clinic, ensuring medical safety, diagnostic rigor, and appropriate pharmacologic oversight for complex multisystem cases. I provide chiropractic neuro-musculoskeletal care, functional medicine evaluation, and advanced practice nursing capabilities to unify and coordinate patient-centered plans.

This multidisciplinary setup is common in integrative and injury care clinics. The MD provides medical direction and diagnostic governance; the chiropractor addresses biomechanical and neuromusculoskeletal drivers; functional medicine identifies systemic contributors; and rehabilitation builds durable functional change. Together, we align interventions across the pain pathway to produce safer, more effective, and sustainable outcomes.

Key services we integrate:

  • Chiropractic neuro-musculoskeletal adjustments, manual therapy, soft tissue mobilization, neurodynamics, and biomechanical optimization
  • Internal medicine oversight with diagnostics, pharmacology, comorbidity risk management, and prescriptive safety
  • Functional medicine for immune, metabolic, endocrine, and gut-brain axis contributors to systemic sensitization
  • Rehabilitation and movement retraining for graded exposure, motor control, stability, mobility, and proprioceptive conditioning
  • Personal injury evaluation with mechanism-of-injury documentation, impairment guidance, and coordinated care

Setting Expectations: Pain Relief Is a Process, Not a Pill

Why Expectations Matter

In pain care, expectations define success. Many patients—understandably—hope for 100% relief. Research and clinical practice show meaningful improvement often looks like a 30–60% reduction in pain (clinically significant change). If a single intervention yields 30% relief, and two or three combined yield more, we can layer benefits through a multimodal strategy. Integrative care excels by compounding modest improvements across complementary domains.

Functional Outcomes Over 0–10 Scores

A 0–10 pain number is required administratively but often misses the lived context. A”10″ while immobilized on a couch is different from a “10” after walking the mall with a grandchild. We track function, not just intensity.

Tools and practices we use:

  • The Brief Pain Inventory (BPI): Assesses interference with general activity, mood, walking, work, relations, sleep, and enjoyment; averaged for a holistic picture (Kolasinski et al., 2020).
  • Patient-identified functional goals: Sleep through the night; walk the dog 15 minutes; sit through a family dinner; lift safely; return to work tasks. We document and track these goals as the narrative of progress.

Pain Physiology: A Clear Map From Periphery to Brain

The Four Stages of Pain Pathway

  • Transduction: Tissue injury releases mediators (prostaglandins, bradykinin, histamine, serotonin, substance P, CGRP) that sensitize nociceptors (pain-sensing neurons).
  • Transmission: Signals travel from peripheral nerves through dorsal root ganglia into the dorsal horn and ascend to the brain.
  • Modulation: Spinal gating and descending inhibitory pathways adjust signal flow.
  • Perception: Brain networks integrate signals with attention, emotion, memory, and context to produce the experience of pain.

By understanding and targeting each stage, we can intervene locally with topical agents, segmentally with manual therapy and neurodynamics, centrally with membrane stabilizers and SNRIs/TCAs, and systemically through functional medicine and rehabilitation.

Foundational Pharmacology: Acetaminophen and NSAIDs

Acetaminophen: Simple and Powerful, With Clear Limits

Acetaminophen relieves pain and fever via central mechanisms that remain partially elucidated. The safety threshold is critical: doses beyond 4 g/day can cause serious hepatotoxicity. In the U.S., approximately 30,000 hospitalizations annually are attributed to acetaminophen-related liver toxicity, with ~50% unintentional due to hidden inclusion in many OTC products. Patient education on total daily intake—Know Your Dose—is essential.

Clinical pearls:

  • In low-risk patients, scheduled acetaminophen can be effective for musculoskeletal pain phenotypes, including some with severe imaging findings.
  • We balance risk awareness with efficacy: appropriate doses are safe; exceeding thresholds is not.

NSAIDs: Potent Relief, Significant GI and Cardiovascular Risks

Key insights:

  • No single NSAID is universally superior. A true therapeutic trial requires consistent dosing for at least four days; switching chemical classes can help.
  • Celecoxib is a selective COX-2 inhibitor; unlike traditional NSAIDs, it does not impair platelet aggregation—potentially safer with anticoagulants but still carries systemic risks.
  • GI damage is systemic, not just local. By reducing protective prostaglandins, NSAIDs strip the gastroprotective mucus layer throughout the GI tract. In healthy volunteers, high-dose ibuprofen produced GI bleeding in 3–5 days.
  • Low-dose aspirin plus traditional NSAID doubles major GI bleed risk. PPIs protect against stomach ulcer risk but do not protect the small intestine.
  • COX-2 selectivity spares COX-1 gut protection so that celecoxib can have lower GI risk than diclofenac or naproxen, even with PPI co-therapy.
  • Cardiovascular risk is a class effect: NSAIDs, including celecoxib, increase risk of MI and stroke; risks are heightened post-MI and can rise rapidly (within days). Acute respiratory infections plus NSAID use may transiently increase MI risk.

Clinical approach:

  • We individualize risk–benefit for each patient, favor topical NSAIDs for focal pain, and use internal medicine oversight for systemic NSAID decisions considering cardiac, renal, and GI comorbidities.

Why Topical Therapies Belong at the Front of Pain Management

Peripheral Modulation: Treat the Chemical Storm Where It Starts

Topical agents target the earliest steps in nociceptor sensitization:

  • Topical NSAIDs (diclofenac gel, patches): Inhibit COX enzymes to reduce prostaglandin-driven sensitization (Derry et al., 2016; Kolasinski et al., 2020).
  • Topical anesthetics (lidocaine patches): Block voltage-gated sodium channels to stabilize neuronal membranes and reduce peripheral excitability (Baron et al., 2009; Gammaitoni et al., 2002).
  • Capsaicin and high-concentration Qutenza: Strong TRPV1 activation leads to desensitization and substance P depletion, suppressing neuropeptide-driven amplification (Simpson et al., 2020).

Our mechanistic goal is simple: lower nociceptor sensitivity at the source, diminish ascending input, and reduce reliance on systemic medications.

Diclofenac: Evidence, Dosing, and Integration

Why we recommend topical diclofenac:

  • Comparable local efficacy to oral NSAIDs for localized musculoskeletal pain with markedly safer systemic profiles (Derry et al., 2016; Kolasinski et al., 2020).
  • Practical adherence tips: apply consistently for several days; absorption occurs within ~20 minutes; keep tubes where use is frequent (bathroom, sink); patches for focal acute strain.

Clinical pathways:

  • Acute low back strain:
  • Days 1–7: diclofenac patch at focal region; spine-safe mobility; gentle chiropractic adjustments; posture education.
  • Reassess and transition to gel as mobility improves.
  • Hand osteoarthritis:
  • Gel 2 g up to four times daily on symptomatic joints; thumb CMC splinting during flares; task modification; tendon glides; forearm soft tissue care.
  • Safety: older adults benefit most; limited systemic absorption reduces GI and CV risks, but vigilance persists with large surface applications or comorbidities.

Lidocaine Patches: Membrane Stabilization for Neuropathic and Focal Pain

Mechanism: sodium channel blockade stabilizes hyperexcitable peripheral nerves. Clinical studies show substantial relief in postherpetic neuralgia (PHN), often with 65% pain improvement and 77% quality-of-life improvement by week one (Baron et al., 2009; Gammaitoni et al., 2002). Typical use is 12 hours on, 12 hours off, with local skin reactions being the limiting factor rather than systemic toxicity.

Applications:

  • PHN and intercostal neuropathy: dermatomal patch placement; thoracic mobility; breathing retraining; soft tissue desensitization.
  • Post-surgical focal neuropathy: patch alignment along tender scar bands with graded tactile exposure.

Capsaicin and Qutenza: TRPV1 Desensitization and Substance P Modulation

High-concentration capsaicin (8% patch) activates TRPV1 aggressively, causing short-term burning followed by meaningful desensitization; substance P depletion reduces presynaptic amplification. Effective in diabetic neuropathy and PHN with applications every ~3 months; patients often require 2–3 sessions for sustained benefit (Simpson et al., 2020).

Clinical integration:

  • Diabetic peripheral neuropathy:
  • Qutenza for focal allodynia; foot and ankle mobilization; intrinsic foot strengthening; gait retraining.
  • PHN:
  • Qutenza with thoracic and rib mechanics correction reduces ongoing nociceptive inputs; cooling measures during application support tolerability.

Select Compounded Options: Clonidine Gel and Specialty Topicals

For refractory sympathetically driven phenotypes such as CRPS, compounded topical clonidine (alpha-2 agonist) can modulate norepinephrine signaling. Access is variable; we reserve it for cases with prominent adrenergic features after conventional options are exhausted.

“Magic mouthwash” formulations offer mucosal anesthesia and protection for oral pain syndromes (mucositis; select burning mouth presentations) while functional medicine evaluates nutrient deficiencies, candidiasis, xerostomia, and glycemic dysregulation.

Neuropathic Membrane Stabilizers: Gabapentin and Pregabalin

Gabapentin: Alpha-2-Delta Binding, Dosing, and Bioavailability

I teach gabapentin as a membrane stabilizer: by binding the alpha-2-delta subunit of voltage-gated calcium channels, it reduces presynaptic excitatory neurotransmitter release, calming hyperexcitable nerves. Emerging data suggest potential glial modulation, contributing to decreased neuroinflammation (Taylor et al., 1998; Luo et al., 2012).

Indications and dosing:

  • FDA indication: PHN; common off-label use: neuropathic/radicular pain phenotypes, fibromyalgia (variable evidence).
  • Start low, go slow: 100–300 mg at night; titrate every 3–7 days; renal dosing required.
  • Bioavailability declines at higher doses; ~60% at ~900 mg/day, dropping as dosing escalates—more drug is not always better (Sommers et al., 2019).
  • Extended-release options (Gralise, Horizant) favor shingles-related pain but are limited off-label.

Safety:

  • Central sleep apnea has been associated with medication-induced cases; we coordinate with sleep medicine in at-risk patients (Mador et al., 2017).
  • Rare DRESS syndrome requires immediate discontinuation when systemic reactions appear (Mori et al., 2017).
  • Sedation, dizziness, ataxia necessitate careful titration to preserve adherence and function.

Pregabalin: Similar Mechanism, Faster Steady State, and Cardiovascular Observations

Pregabalin shares alpha-2-delta binding, stabilizing membranes with steady state in 48–72 hours. Typical dosing starts at 25–50 mg BID, titrated every 48–72 hours. Many patients obtain meaningful relief at ≤450 mg/day; beyond that, side effects often outpace benefits (Crofford et al., 2005).

Cardiovascular observations:

  • Emerging evidence indicates a potential increased risk of long-term adverse cardiovascular outcomes among patients with diabetic neuropathy and fibromyalgia treated with pregabalin, with short-term signals within ~3 months of initiation (Zentner et al., 2023). We assess CV risk and coordinate with primary care or cardiology when prescribing in metabolic syndrome or cardiac disease.

Integration:

  • Diabetic neuropathy: pregabalin titration; foot mechanics optimization; glycemic control via functional medicine; capsaicin/Qutenza where available.
  • Fibromyalgia: cautious dosing; sleep optimization; graded aerobic conditioning; soft tissue care; autonomic regulation strategies.

Balancing Body and Metabolism- Video

Balancing Body and Metabolism | El Paso, Tx (2023)

Antidepressants for Pain: SNRIs and TCAs Modulate Descending Inhibition

The Descending Norepinephrine Pathway: Pain’s Volume Control

Pain signals ascend to the brain, but the brain sends descending modulatory signals back down to shape pain reception at the dorsal horn. Norepinephrine and serotonin drive much of this inhibition. In many chronic pain states, descending inhibitory function is depleted. SNRIs and TCAs increase NE and 5-HT levels by blocking reuptake, strengthening endogenous inhibition and reducing perceived pain, independently of mood effects.

Key points:

  • These are real pain medications with robust evidence; they are non-addictive and often once-daily, improving adherence.
  • Trials demonstrating duloxetine’s analgesia excluded depressed patients, proving a direct pain effect.

Black Box Warning: Contextualizing Risk

The FDA Black Box Warning (2004) on antidepressants centers on increased suicidality in children and adolescents treated for depression, likely due to motivation rising before mood improves. Adult data show no increased risk over age 24; in those 65+, a protective effect is observed. We explain the context clearly, calibrate risk by age and indication, and monitor appropriately.

Serotonin Syndrome: Recognize the Real Signals

True serotonin syndrome typically arises acutely after initiation or dose increase: about 30% occur within 1 hour, 60% within 6 hours. The diagnostic triad includes cognitive changes (agitation/confusion), autonomic hyperactivity (tachycardia, hypertension, hyperthermia, diaphoresis), and neuromuscular abnormalities (tremor, hyperreflexia, clonus). The Hunter Criteria emphasize clonus and hyperreflexia. Absence of these signs makes the syndrome unlikely.

Duloxetine: The SNRI Front-Runner for Chronic Musculoskeletal Pain

Duloxetine is FDA-approved for diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. Evidence shows clinical benefits in knee osteoarthritis and chronic low back pain through central sensitization modulation.

Dosing:

  • Start at 30 mg daily for one week to reduce nausea; target 60 mg daily. Short courses of ondansetron can help patients through initial titration to preserve a valuable tool.
  • We set expectations around partial relief: approximately 50% of patients achieve ~50% reduction—an impactful change for many.

Broader use:

  • Central sensitization mechanisms allow reasonable use in chronic OA of hip or shoulder, even beyond initial trial populations. Duloxetine pairs naturally with chiropractic, rehabilitation, and functional medicine strategies for multimodal gains.

Other SNRIs: Milnacipran and Venlafaxine

  • Milnacipran is approved for fibromyalgia only and has high NE affinity, potentially more potent for pain but with increased NE side effects; access may be limited by cost. Positive fibromyalgia outcomes (≥30% reduction) reflect the condition’s severity.
  • Venlafaxine’s pain data is less robust; NE potency emerges at higher doses (~≥150 mg). Duloxetine’s broader indications and stronger evidence make it preferred.

TCAs: Low Dose, High Utility for Neuropathic Pain

TCAs—amitriptyline, nortriptyline—are older agents with broad receptor activity (NE, 5-HT reuptake; muscarinic, histamine, alpha-1 blockade). At low doses (10–75 mg nightly), analgesic effects are achieved with fewer side effects. We titrate slowly over 6–8 weeks and monitor anticholinergic burdens. QT prolongation becomes a concern at higher doses (>100 mg), rarely needed for pain.

Clinical PSA: Burning Mouth Syndrome (BMS)

BMS presents as severe oral burning without visible mucosal changes, often in perimenopausal/postmenopausal women. It is a true neuropathic pain condition; TCAs—especially nortriptyline—can be remarkably effective. We start 10 mg nightly and titrate by 10 mg weekly to ~50 mg. Functionally, we also evaluate nutrition, oral microbiota, xerostomia, and glycemic control in parallel.

Not Pain Medicines: Benzodiazepines and The Limits of Muscle Relaxants

Benzodiazepines Are Not Analgesics

Benzodiazepines produce anxiolysis and sedation but can antagonize opioid analgesia, leading patients to escalate opioid doses dangerously. Co-prescribing benzodiazepines and opioids increases overdose risk dramatically; our policy is extreme caution. Anxiety deserves treatment—preferably with non-benzodiazepine options and psychotherapy—but benzodiazepines are inappropriate for routine chronic pain management.

Muscle Relaxants: Understand Mechanisms and Use Strategically

Evidence shows no meaningful benefit in sciatica; modest relief may occur in acute non-radicular low back pain during the first week through general CNS depressant effects.

Common agents:

  • Diazepam: benzodiazepine risk profile; not superior to other relaxants; avoid outside narrow indications (e.g., MRI tolerance for severe claustrophobia).
  • Cyclobenzaprine: structurally similar to TCAs; beware mood disorder destabilization and rapid steady-state CNS depression in TID dosing.
  • Tizanidine: central alpha-2 agonist; primary indication is spasticity; short duration allows strategic nighttime use without daytime impairment.
  • Carisoprodol (Soma): Schedule IV due to abuse potential; rarely initiated.
  • Baclofen: GABA-B receptor action in spinal cord; indicated for spasticity. Abrupt discontinuation can cause severe withdrawal with seizures—must taper and manage pump malfunctions urgently. Watch for hyperglycemia, psychiatric exacerbations, lowered seizure threshold.

Topical NSAIDs and local rehabilitative strategies often outperform muscle relaxants for focal musculoskeletal pain while avoiding sedation.

Innovative and Emerging Approaches: Low-Dose Naltrexone and New Non-Opioid Pathways

Low-Dose Naltrexone (LDN): Glial Modulation and Endogenous Opioid Support

At 1.5–4.5 mg compounded doses, naltrexone exhibits paradoxical analgesia via:

  • Glial cell modulation: dampening neuroinflammation by calming activated microglia/astrocytes
  • Endorphin/enkephalin rebound: transient receptor blockade upregulates endogenous opioids after the drug clears

Applications:

  • Fibromyalgia: addresses central sensitization and neuroinflammatory drivers
  • Long COVID: emerging data suggests benefits for chronic pain and fatigue
  • Autoimmune/inflammatory conditions: EDS, Crohn’s disease (including endoscopic mucosal improvements), multiple sclerosis

Dosing:

  • Start 1.5 mg nightly; increase by 1.5 mg every 1–2 weeks to 4.5 mg; side effects are usually mild (vivid dreams/insomnia). Emergency opioids can override receptor blockade with adequate dosing.

Novel Non-Opioid Sodium Channel Targets

Precision analgesics that selectively block sodium channels such as Nav1.8—predominantly expressed in peripheral nociceptors—can reduce acute pain without opioid risks. When available, we integrate these medications under internal medicine oversight, counsel on drug interactions (including hormonal contraceptive efficacy), and navigate insurance coverage to expand access.

Opioid Therapy: Precision Prescribing Through Mechanism and Metabolism

Mechanisms: Ascending and Descending Modulation, GI Effects, and System Impacts

Opioids primarily act at mu receptors to reduce ascending pain transmission and enhance descending inhibition. Mu receptors are abundant in the GI system, which explains the inevitability of opioid-induced constipation. Partial mu agonists (e.g., buprenorphine) cap respiratory depression risk via ceiling effects and kappa antagonism. Clinically, opioids can increase antidiuretic hormone and water retention, potentially blunting diuretic efficacy in heart failure.

PPrescriber’sChecklist: Safety and Governance

We follow structured protocols:

  • Comprehensive physical exam and diagnosis confirmation
  • Validated risk assessments (SOAP-R, COMM)
  • Rule out correctable causes (e.g., surgical OA knee)
  • Medication agreement (pain contract) for education and accountability
  • PDMP check before every prescription
  • Meticulous documentation of trials, failures, and contraindications to alternatives

Cytochrome P450: Why Equianalgesic Charts Can Mislead

CYP450 enzymes (e.g., CYP3A4, CYP2D6) metabolize many opioids. Genetic and drug–drug differences mean some patients are slow metabolizers who experience prolonged effects at standard doses; others are fast metabolizers who obtain little benefit. Morphine and hydromorphone avoid CYP450 and undergo glucuronidation, explaining why some patients respond better to these than oxycodone. We tailor opioid choices to metabolic realities, not just equianalgesic tables (Gudin, 2020).

Buprenorphine: Safer Chronic Pain Option

Buprenorphine (Butrans patch, Belbuca buccal films) offers analgesia with a ceiling on respiratory depression. We start low (e.g., Butrans 5 mcg/hour weekly) for consistent relief in older adults or adherence-challenged patients. Current guidance allows continuation through surgery; anesthesiology can manage perioperative analgesia without discontinuation and withdrawal.

Methadone: Dual Mechanism, Complex Pharmacokinetics

Methadone is potent and inexpensive, acting at mu receptors and as an NMDA antagonist. It has a long and variable half-life (8–59 hours) while analgesia lasts 4–8 hours, demanding extremely slow titration to avoid fatal accumulation. QT prolongation risk becomes significant at higher doses; we monitor EKGs where indicated. Equianalgesic conversion is non-linear: higher prior opioid doses convert to disproportionately low methadone doses. Methadone is appropriate for pain without OUD history, but only in experienced hands (Webster, 2017).

Opioid-Induced Constipation: PAMORAs Are the Targeted Solution

Constipation is inevitable with mu agonism in the GI tract; tolerance does not develop. Bulk-forming fibers can worsen obstruction. We ask direct questions and use KUB imaging if needed.

Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs) reverse GI mu receptor blockade without crossing the blood–brain barrier, preserving central analgesia:

  • Methylnaltrexone (Relistor): subcutaneous option excellent for patients unable to swallow
  • Naloxegol (Movantik) and Naldemedine (Symproic): oral options

Patients may still need conventional laxatives for non-opioid contributors to constipation (Shaib & Hyman, 2019).

Naloxone Saves Lives: Education Is Prevention

My mantra: “Naloxone is for a risky drug, not a risky patient.” Any patient on long-term opioids should have naloxone available. A written prescription itself is associated with reduced overdose rates, likely due to improved awareness and safer behaviors. Naloxone is widely available without prescription; caregivers should know to administer it immediately, call 911, and anticipate that overdose may recur as naloxone’s half-life is shorter than many opioids. Store naloxone in an easily accessible place, not the medicine cabinet (Prescribe to Prevent, n.d.).

Integrative Chiropractic Care: Mechanical Solutions for Biologic Pain

How Adjustments and Manual Therapy Fit the Pain Pathway

Chiropractic care reduces nociception at multiple levels:

  • Peripheral tissue unloading: Restoring joint mechanics reduces local inflammatory mediator release
  • Spinal cord gating: A-beta mechanoreceptor input competes with nociceptive signals at the dorsal horn, lowering pain
  • Descending modulation: Movement and fear-avoidance reduction activate endogenous opioid, monoamine, and endocannabinoid systems
  • Neural glide and neurodynamics: Improved nerve mobility reduces ectopic firing and supports axoplasmic flow

In my clinical observations at sciatica. clinic, precise adjustments, nerve-glide protocols, trunk stabilization, and topical agents produce predictable improvements in lumbar radiculopathy, often decreasing reliance on systemic drugs.

Case Integration: Sciatica and Radiculopathy

  • Decompress and align lumbar segments and sacroiliac mechanics
  • Teach lateral glides and neural mobilization early, respecting irritability
  • Use topical diclofenac for paraspinal and gluteal pain points; lidocaine patches for trigger areas
  • Reserve membrane stabilizers for persistent neuropathic features; simultaneously optimize sleep, metabolic factors, and stress

Neck and Shoulder Pain

  • Scapular mechanics reduce cuff overload and neural tension
  • Topical NSAIDs for focal synovitis; lidocaine patches for suprascapular notch tenderness
  • Pregabalin reserved for refractory neuropathic features with cardiovascular risk evaluation before use

Functional Medicine: Reduce Systemic Sensitizers

Systemic factors modulate nociceptor sensitivity and central processing. We evaluate:

  • Metabolic drivers: insulin resistance and hyperglycemia, advanced glycation end-products, mitochondrial inefficiency
  • Nutrient status: vitamin D, B12, iron/folate, magnesium, omega-3 levels
  • Gut–brain axis: dysbiosis, increased permeability, endotoxin burden prime glial activation
  • Sleep: poor sleep diminishes descending inhibition and increases pro-inflammatory cytokines
  • Stress/autonomic balance: chronic sympathetic activation worsens adrenergic pain phenotypes; breath training and HRV biofeedback help restore balance

We combine chiropractic adjustments, topical modulation, sleep hygiene, nutritional interventions, and graded loading to reduce recurrent nociception and build resilience.

Personal Injury Care: Mechanism, Documentation, and Rehabilitation

Mechanism-of-injury analysis directs targeted interventions:

  • Rear-end collision with whiplash:
  • Facet capsule strain, dorsal root ganglion irritation, central sensitization
  • Early gentle mobilization, isometric cervical stabilization, diclofenac gel for paraspinal tenderness, lidocaine patches for trigger areas; avoid prolonged immobilization
  • Slip-and-fall lumbar strain:
  • Microtrauma to annulus and paraspinals via abrupt flexion/rotation
  • Diclofenac patches acutely; segmental adjustments; hip hinge training and core activation

Documentation aligns clinical findings with functional impairments, supports therapeutic timelines, and preserves continuity of care.

Stepwise Strategy Across the Pain Pathway: A Four-Level Framework

  1. Peripheral modulation
  • Topical NSAIDs to reduce prostaglandins
  • Lidocaine patches to stabilize sodium channels
  • Capsaicin/Qutenza to desensitize TRPV1 and substance P
  • Chiropractic soft tissue and joint optimization to lower local nociceptive input
  • Spinal segmental gating
  • Chiropractic adjustments to boost non-nociceptive input and segmental inhibition
  • Neurodynamic techniques to improve nerve mobility
  • Central processing
  • Membrane stabilizers (gabapentin/pregabalin) in carefully selected cases
  • SNRIs/TCAs to strengthen descending NE/5-HT inhibition
  • Sleep optimization and stress modulation to enhance endogenous control
  • Systemic milieu
  • Functional medicine strategies to reduce inflammation, correct deficits, optimize mitochondrial function, and restore autonomic balance
  • Rehabilitation to remodel movement patterns, reduce recurrent nociception, and build durable capacity

Patient Education Scripts That Work

  • Diclofenac gel: “Your tissues release prostaglandins that make nerves more sensitive. This gel blocks that process right at the surface, which helps reduce the pain where it starts.”
  • Lidocaine patches: “These patches calm overactive pain nerves by blocking sodium channels, so the nerve can’t fire as easily.”
  • Capsaicin/Qutenza: “This turns on heat-sensitive channels strongly enough that they eventually calm down and stop sending as many pain signals.”
  • Gabapentin/pregabalin: “Your nerve is firing too easily. These medicines slow the handoff of signals between nerve cells so that the network can settle down.”
  • Duloxetine: “We’re boosting your body’s natural descending pain brakes, especially norepinephrine, to turn down pain signals centrally.”

Patients adhere better when they understand mechanisms and rationale.

Case Pathways and Decision Trees

Acute low back pain:

  • Days 1–3:
  • Diclofenac patch or gel; gentle chiropractic mobilization as tolerated; posture education
  • Days 4–10:
  • Progress adjustments; add neural mobilization for radicular features; consider lidocaine patch for focal trigger zones
  • Weeks 2–4:
  • Initiate graded strengthening; consider membrane stabilizers if persistent neuropathic signs

Postherpetic neuralgia (PHN):

  • Week 1:
  • Lidocaine patches; thoracic mobility; sleep hygiene
  • Weeks 2–4:
  • Consider low-dose gabapentin titration; monitor sleep effects
  • Months 2–3:
  • Qutenza application if indicated; plan 3-month follow-up

Diabetic neuropathy:

  • Baseline:
  • Functional medicine workup: glycemic control, micronutrients, foot care; capsaicin/Qutenza for focal allodynia
  • Pharmacologic:
  • Pregabalin titration with cardiovascular risk evaluation; consider gabapentin alternative
  • Mechanics:
  • Chiropractic foot/ankle mobilization, orthotics assessment, gait retraining

Safety, Dosing, and Adherence Nuances

  • Start low and go slow with gabapentin/pregabalin; preserve adherence by avoiding early side effects
  • Monitor for central sleep apnea and coordinate sleep testing when indicated
  • Adjust for renal function
  • Respect gabapentin’s declining bioavailability at higher doses
  • Educate clearly on lidocaine patch schedules (12 hours on/off) and Qutenza expectations (transient burning; delayed benefit)
  • Track functional goals meticulously to demonstrate real-world value beyond numeric scores

Clinical Observations and Patient Stories

Hand osteoarthritis:

  • Retiree with MCP joint pain
  • Plan: diclofenac gel twice daily; tendon glides; ergonomic modifications; periodic wrist/hand mobilization
  • Outcome: reduced pain within one week; maintained function without oral NSAIDs

Chest wall PHN:

  • Teacher unable to tolerate clothing or sleep well
  • Plan: lidocaine patches 12 hours on/off; thoracic mobility; gentle rib adjustments; sleep hygiene; optional low-dose gabapentin titration
  • Outcome: 60–70% pain reduction in week one; improved sleep; later taper of gabapentin

Lumbar radiculopathy:

  • Professional driver with sitting intolerance and lateral leg pain
  • Plan: lateral glide mobilizations; lumbar adjustments; diclofenac gel for paraspinal tenderness; nerve glides; work modifications
  • Outcome: improved sitting tolerance within 10 days; avoided systemic analgesics

Practical Tips for Clinicians and Patients

  • Keep topical agents accessible at home and work
  • Map dermatomal pain bands for strategic patch placement
  • Titrate membrane stabilizers cautiously and preserve adherence
  • Pair mechanical care with topical modulation for synergy
  • Monitor sleep and stress diligently
  • Reassess and taper pharmacologic agents as function restores

How We Coordinate Care: Internal Medicine Governance and Integrative Delivery

With Dr. Cardenas’ medical direction, we:

  • Vet pharmacologic choices against comorbidities (cardiac, renal, metabolic)
  • Align topical regimens and membrane stabilizers with best-practice dosing and monitoring
  • Ensure labs and diagnostics are timely (A1C for diabetic neuropathy; B12/iron/folate for oral neuropathic pain; EKGs for high-risk TCAs/methadone)
  • Escalate to specialty referrals when red flags emerge (progressive neurologic deficit, systemic signs)

Our governance model ensures safety-first care that remains agile and patient-centered.

The Integrative Advantage: Why Layered Care Outperforms Single-Modal Approaches

From the first patient interaction, our strategy is to:

  • Quiet the periphery with targeted topicals (diclofenac, lidocaine patches, capsaicin/Qutenza)
  • Optimize mechanics with precise chiropractic adjustments, neurodynamics, and soft tissue care
  • Stabilize nervous system signaling with membrane-targeted agents and descending inhibition enhancers (SNRIs/TCAs) when appropriate
  • Remove systemic obstacles via functional medicine
  • Build durable change through rehabilitation and patient education

This layered approach reduces reliance on high-dose systemic drugs, enhances safety, and meaningfully improves function.

Extended Guidance: Revisiting Therapies, Optimizing Dosing, and Personalizing Care

  • Bodies and contexts change; retrying previously ineffective therapies at different doses or combinations can help
  • Optimize dosing times to match pain patterns (e.g., shifting midday dose to cover late-afternoon flare)
  • Use multimodal strategies rather than escalating single-agent doses
  • Emphasize that medications are one tool in a broader toolbox that includes chiropractic, rehab, nutrition, stress management, and psychological support.

Clinical Governance and Documentation: Protecting Patients and Providers

  • Document functional goals and objective progress
  • Record trials, failures, contraindications, and risk assessments
  • Use PDMP, pain agreements, and validated tools consistently
  • Align care plans with clear mechanisms and patient education to improve adherence and safety

References

Clinical Observations and Professional Resources

Conclusion

Pain begins in the periphery, but relief arises when we address the entire pathway. By combining targeted topicals, precise chiropractic mechanics, carefully selected membrane stabilizers and SNRIs/TCAs, and systemic functional medicine, we produce safer, more effective, and durable outcomes. With Dr. Cardenas’s leadership, our multidisciplinary model ensures evidence-based, safety-first care for complex pain. With rehabilitation and patient education, we transform improvements into long-term function.

SEO tags: integrative pain management, chiropractic neuro-musculoskeletal care, internal medicine oversight, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, diclofenac gel, lidocaine patches, capsaicin Qutenza, TRPV1 desensitization, gabapentin membrane stabilizer, pregabalin dosing, duloxetine musculoskeletal pain, tricyclic antidepressants, burning mouth syndrome, benzodiazepine risks, muscle relaxants sciatica, low-dose naltrexone, opioid metabolism CYP450, buprenorphine chronic pain, methadone NMDA, opioid-induced constipation PAMORAs, naloxone education, sciatica clinic, El Paso Injury Medical Clinic, functional medicine pain, spinal segmental gating, descending inhibition norepinephrine, personal injury rehabilitation, dorsal root ganglion, nociceptor sensitization, prostaglandins, substance P, CGRP

MFAT After an Injury: Innovative Treatment Options

MFAT After an Injury: Innovative Treatment Options
MFAT After an Injury: Innovative Treatment Options

When Is MFAT Recommended After an Auto or Work Injury?

Abstract

Motor vehicle accidents and workplace injuries can damage joints, cartilage, tendons, ligaments, muscles, and other soft tissues. Many injuries improve with rest, chiropractic care, physical rehabilitation, activity changes, and basic injection treatments. However, some injuries are more complex or heal very slowly.

Microfragmented adipose tissue, or MFAT, may be considered for moderate or advanced joint damage, cartilage injury, a larger partial tendon or ligament tear, or symptoms that continue after conservative care. MFAT uses a small amount of the patient’s own fat tissue to create a supportive biological product that is placed into an injured area.

This article explains when MFAT may be recommended after an auto accident or work injury, how it differs from platelet-rich plasma, when it may not be appropriate, and how it can fit into a coordinated plan that includes integrative chiropractic care, rehabilitation, functional medicine, and medical oversight.

MFAT After an Injury: Innovative Treatment Options

What Is Microfragmented Adipose Tissue?

Microfragmented adipose tissue is made from a small amount of the patient’s own fat. The fat is often collected from the abdomen, side, or thigh through a small lipoaspiration procedure.

The tissue is then:

  • Washed in a sterile system
  • Broken into very small fragments
  • Cleared of unwanted fluid and debris
  • Prepared for injection
  • Placed into the injured joint or soft tissue

MFAT keeps parts of the fat’s natural structure, including its supporting matrix and biological signaling components. It differs from laboratory-grown stem cell treatment because the tissue is usually processed and used during the same visit, without cell expansion.

University of Iowa Health Care describes MFAT as a nonsurgical procedure that uses a patient’s own adipose tissue. The processed tissue may provide cushioning and biological support inside damaged joints or around certain tendon injuries (University of Iowa Health Care, n.d.).

MFAT should not be described as a guaranteed way to regrow cartilage, rebuild a torn ligament, or cure arthritis. Its main goal is to create a healthier environment around the injured tissue, reduce irritation, support function, and possibly help the body’s normal healing response.

When Is MFAT Recommended for Personal Injuries?

MFAT is usually not the first treatment recommended after a motor vehicle accident or workplace injury. Most people begin with less invasive care.

Early treatment may include:

  • Activity changes
  • Chiropractic care
  • Physical rehabilitation
  • Home exercises
  • Soft-tissue treatment
  • Bracing
  • Anti-inflammatory lifestyle support
  • Platelet-rich plasma when appropriate

MFAT may be discussed when an injury is more complex, involves a larger amount of tissue damage, or has not improved enough with simpler care.

Moderate to Severe Post-Traumatic Joint Degeneration

A hard impact can injure the cartilage and other structures inside a joint. For example, a knee may strike the dashboard during a collision, or a worker may twist a knee while carrying a heavy object.

The original injury can cause inflammation, joint instability, meniscus damage, and uneven pressure on the cartilage. Over time, these problems may lead to post-traumatic osteoarthritis.

MFAT may be considered when the patient has:

  • Moderate joint degeneration
  • Ongoing joint swelling or stiffness
  • Pain with walking, lifting, or climbing stairs
  • Cartilage wear seen on imaging
  • Loss of function despite rehabilitation
  • Limited improvement after PRP or other injections

Several clinical sources describe MFAT as a possible option for patients with persistent osteoarthritis symptoms or moderate joint damage, especially after standard treatments have not provided enough improvement (Close, 2026; Kanaan, 2026; Sellers, 2025).

Research has found that MFAT may improve pain and function in some patients with knee osteoarthritis. However, recent reviews also report that MFAT may not provide better results than PRP or bone marrow concentrate for every patient. This means treatment selection should be based on the individual injury rather than the idea that MFAT is always the strongest option (Hohmann et al., 2025a, 2025b; Ye et al., 2024).

Larger Partial Tendon Tears

Tendons connect muscles to bones. They can be damaged when the body is suddenly pulled, twisted, or forced beyond its normal range.

Accident-related examples include:

  • Partial rotator cuff tears
  • Partial Achilles tendon tears
  • Patellar tendon injuries
  • Hamstring tendon injuries
  • Gluteal tendon injuries
  • Chronic elbow tendon damage

Smaller tendon injuries may respond to rehabilitation, load management, or PRP. MFAT may be considered for a larger partial tear, chronic degeneration, or an injury that has not improved after an appropriate rehabilitation program.

Clinical sources describe partial rotator cuff tears, Achilles problems, chronic tendon degeneration, and significant tendon damage as possible MFAT applications. However, the clinical evidence for tendon injuries is less developed than the evidence for knee osteoarthritis (Palm Beach Regenerative Sport & Spine, n.d.; University of Iowa Health Care, n.d.).

A complete tendon rupture may still require a surgical consultation. MFAT should not delay surgery when the tendon is fully torn, the muscle has lost function, or the tissue has pulled far away from its normal attachment.

Larger Partial Ligament Injuries

Ligaments connect one bone to another and help stabilize joints. A crash, fall, or sudden workplace twist can stretch or partially tear a ligament.

MFAT may be considered when:

  • The ligament has a larger partial tear
  • The joint remains unstable
  • The injury is healing slowly
  • Rehabilitation has not restored function
  • PRP has produced limited improvement
  • Surgery is not immediately required

The treatment plan must also address the cause of continued stress on the ligament. An injection cannot correct poor balance, weak stabilizing muscles, restricted joint motion, or unsafe lifting mechanics by itself.

Cartilage Defects and Meniscus-Related Problems

Cartilage has a limited blood supply, which can make it difficult to heal. A traumatic cartilage defect may occur in the knee, hip, shoulder, ankle, or another joint.

MFAT may be discussed when imaging shows:

  • A focal cartilage defect
  • Degenerative meniscus changes
  • Post-traumatic cartilage wear
  • Joint surface damage
  • Continued pain during weight-bearing activities
  • Loss of function despite conservative treatment

The fat tissue may provide a supportive matrix and cushioning effect within the joint. However, it should not be presented as a proven replacement for missing cartilage. More research is needed to determine whether MFAT changes the long-term structure of damaged joints.

When Is PRP Usually Tried Before MFAT?

Platelet-rich plasma, or PRP, is made from the patient’s own blood. It contains concentrated platelets and growth factors that may support the healing response.

PRP may be considered first for:

  • Mild to moderate joint degeneration
  • Tendinitis
  • Tendon irritation
  • Smaller partial tears
  • Mild ligament injuries
  • Early cartilage wear
  • Injuries that have not yet received injection treatment

PRP requires a blood draw, while MFAT requires the removal of a small amount of fat. MFAT is therefore more involved and may cause temporary soreness or bruising at both the harvest site and injection site.

Some providers consider MFAT after PRP has failed to return enough function. Others may recommend MFAT earlier when imaging shows a more advanced injury. Recent comparisons suggest that MFAT and PRP may produce similar results for many patients with knee osteoarthritis, so the more invasive treatment is not automatically the better option (Hohmann et al., 2025b; Ye et al., 2024).

Who May Not Be a Good MFAT Candidate?

A full evaluation is needed before MFAT is recommended. The clinician should review the patient’s health history, medications, examination findings, imaging, goals, and previous treatment.

MFAT may not be appropriate when a patient has:

  • An active infection
  • An uncontrolled bleeding disorder
  • Serious uncontrolled medical conditions
  • A complete tendon or ligament rupture
  • Severe joint deformity
  • Major mechanical instability
  • A fracture that has not been treated
  • A condition requiring urgent surgery
  • Unrealistic expectations
  • Symptoms that do not match the imaging findings

Patients taking blood thinners or living with diabetes, immune disorders, cardiovascular disease, or poor wound healing may need added medical screening.

The U.S. Food and Drug Administration states that regenerative medicine therapies have not been approved as treatments for orthopedic conditions such as osteoarthritis, tendonitis, back pain, or knee pain. A device used to collect or process tissue may have FDA clearance, but that does not mean the resulting orthopedic treatment is FDA-approved. Patients should receive clear information about evidence, risks, alternatives, costs, and regulatory status before agreeing to treatment (U.S. Food and Drug Administration, 2021).

How Integrative Chiropractic Care Fits With MFAT

MFAT focuses on the biological environment of an injured tissue. Integrative chiropractic care focuses on movement, joint mechanics, muscle control, posture, and physical function.

These approaches do different jobs.

Chiropractic and rehabilitation care may help:

  • Improve comfortable joint motion
  • Reduce unnecessary mechanical stress
  • Address muscle guarding
  • Improve posture and movement patterns
  • Restore balance and coordination
  • Rebuild joint stability
  • Prepare the patient to return to work
  • Track functional progress

The care must be properly timed. Immediately after an MFAT procedure, the treated tissue may need protection and gentle movement. High-force treatment, heavy exercise, deep pressure over the injection site, and rapid return to demanding activity may not be appropriate.

As healing progresses, the plan may move through several stages:

  1. Protection: Control load and protect the treated area.
  2. Mobility: Begin gentle, approved range-of-motion exercises.
  3. Stability: Improve muscle control around the joint.
  4. Strength: Increase resistance without overloading the tissue.
  5. Function: Practice job duties, walking, lifting, or sports movements.
  6. Prevention: Correct movement problems that could cause reinjury.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, has observed in his clinical work that injection procedures should not stand alone. His approach connects imaging and examination findings with joint movement, nerve function, rehabilitation, nutrition, and measurable daily activities. The goal is to support biological recovery while correcting movement patterns that may continue to overload the injured area (Jimenez, n.d.; ChiroMed, 2026).

These observations represent a clinical approach and should not be confused with proof that chiropractic adjustments make MFAT more effective. The combined plan is designed to address different parts of the recovery process.

Medical Oversight at Injury Medical Clinic PA

At Injury Medical Clinic PA in El Paso, Texas, Dr. Jimenez works with Dr. Maria Guadalupe Cardenas, MD, who is identified by clinic materials as Board Certified in Internal Medicine, Medical Director, and Collaborative Physician.

Dr. Cardenas has been an internist for more than 40 years. Public provider records identify her Texas medical license as J2933 and her NPI as 1164426748. Some clinic pages display 1164426749, but public provider listings identify 1164426748 as the valid NPI.

This multidisciplinary arrangement allows the team to combine:

  • Medical evaluation and oversight
  • Integrative chiropractic care
  • Functional medicine
  • Personal injury care
  • Imaging and laboratory review
  • Physical rehabilitation
  • Return-to-work planning
  • Progress examinations
  • Referrals when surgery or specialty care is needed

Dr. Cardenas’s internal medicine background can help the team review medical conditions, medications, infection risks, bleeding risks, cardiovascular concerns, diabetes, and other factors that may affect healing. Dr. Jimenez focuses on musculoskeletal evaluation, chiropractic care, functional recovery, rehabilitation, and injury documentation.

This type of coordinated model can be useful because a personal injury often affects more than one tissue. A patient may have joint damage, muscle guarding, nerve symptoms, poor sleep, reduced activity, inflammation, and health conditions that slow recovery.

A Careful Decision Is More Important Than a Stronger Injection

MFAT may be recommended for selected patients with moderate or advanced joint injury, cartilage damage, larger partial tendon or ligament tears, or slow-to-heal conditions that have not improved enough with conservative care.

It is not automatically the next step after every accident. A proper recommendation depends on:

  • The exact diagnosis
  • Injury severity
  • Imaging results
  • Previous treatment
  • Joint stability
  • Overall health
  • Functional limitations
  • Patient goals
  • Available evidence
  • Whether surgery is more appropriate

For the right patient, MFAT may become one part of a broader recovery plan. Medical oversight helps screen for risk. Chiropractic care and rehabilitation address movement and strength. Functional medicine may address nutrition, sleep, inflammation, and other health factors.

The best goal is not simply to receive an advanced injection. The goal is to select the safest treatment, protect the healing tissue, restore function, and help the patient return to work and normal daily life.

El Paso, TX Chiropractic Alignment

References

ChiroMed. (2026). Regenerative therapy for auto accident injury recovery.

Close, M. (2026, February 26). Comparing PRP, BMAC, and MFAT: Choosing the right regenerative treatment. Sports Medicine of the Rockies.

Health Coach Clinic. (n.d.). Regenerative options for injury recovery explained.

Hohmann, E., Keough, N., Frank, R. M., & Rodeo, S. A. (2025a). Microfragmented adipose tissue has no advantage over platelet-rich plasma and bone marrow aspirate injections for symptomatic knee osteoarthritis: A systematic review and meta-analysis. The American Journal of Sports Medicine.

Hohmann, E., et al. (2025b). Micro-fragmented adipose tissue demonstrates comparable clinical efficacy to other orthobiologic injections in treating symptomatic knee osteoarthritis: A systematic review of Level I to IV clinical studies. Arthroscopy, 41(2), 418–441.e14.

Jimenez, A. (n.d.). Dr. Alex Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN.

Kanaan, M. (2026, March 9). PRP vs. MFAT cell therapy: Which regenerative treatment is right for you?. Carolina Nonsurgical Orthopedics.

Palm Beach Regenerative Sport & Spine. (n.d.). Microfragmented adipose tissue—MFAT.

Sellers, T. (2025, November 3). Micro-fragmented adipose tissue: A breakthrough treatment for knee arthritis. Sellers Sports Medicine and Family Practice.

University of Iowa Health Care. (n.d.). Microfragmented adipose tissue—MFAT.

U.S. Food and Drug Administration. (2021, June 3). Important patient and consumer information about regenerative medicine therapies.

Ye, X., Shen, Z., Li, X., Zhang, B., Shen, G., & Wu, L. (2024). Microfragmented adipose tissue versus platelet-rich plasma in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Acta Orthopaedica Belgica, 90(3).

Regenerative Care for Disc Herniation Treatment Options

Regenerative Care for Disc Herniation Treatment Options
Regenerative Care for Disc Herniation Treatment Options

Regenerative Care for Automobile and Work Accident Disc Herniations

Abstract

Motor vehicle accidents and work injuries can place sudden pressure, twisting, or force on the spine. These forces may damage the soft spinal discs that cushion the bones of the neck and lower back. Common injuries include annular tears, disc protrusions, disc extrusions, and, in severe cases, separated disc fragments.

Many disc injuries improve with nonsurgical care. Treatment may include activity changes, rehabilitation, integrative chiropractic care, and medical pain management. Regenerative treatments, such as platelet-rich plasma, platelet-fibrin products, and microfragmented adipose tissue, may also be considered for carefully selected patients. However, these procedures are still being studied, and they cannot guarantee that a badly damaged disc will return to its original condition.

This article explains the common disc injuries caused by car crashes and workplace accidents, how each treatment may help, and why medical oversight is important.

Regenerative Care for Disc Herniation Treatment Options

What Is a Spinal Disc?

Spinal discs are soft cushions located between the bones of the spine. Each disc has two main parts:

  • Annulus fibrosus: The strong outer ring of the disc
  • Nucleus pulposus: The softer, gel-like center

The discs absorb shock, support movement, and help prevent the spinal bones from rubbing against each other. When the outer ring becomes weak or damaged, the inner material may push outward. This is known as a disc herniation.

A herniated disc can cause pain in two main ways. It may press against a spinal nerve, or chemicals from the damaged disc may create inflammation around the nerve. Symptoms can include neck pain, lower back pain, numbness, tingling, muscle weakness, sciatica, or pain traveling into an arm or leg (Dydyk et al., 2023).

How Car and Work Accidents Can Damage Discs

During a motor vehicle accident, the body may be thrown forward, backward, or sideways within seconds. The spine may experience compression, bending, twisting, and rapid changes in direction.

Work accidents can create similar forces. Disc injuries may happen during:

  • Heavy lifting
  • Repetitive bending
  • Sudden twisting
  • Falls from ladders or platforms
  • Slips and falls
  • Pushing or pulling heavy objects
  • Moving patients or equipment
  • Long periods of vibration or driving

Research has linked years of lifting, carrying, and extreme trunk bending with a higher risk of lumbar disc disease in some workers. However, determining whether one event caused a disc herniation can be complicated because many adults already have some disc wear before an accident (Seidler et al., 2020).

A careful evaluation should compare the accident details, symptoms, physical examination, prior medical history, and imaging findings. An MRI finding alone does not always explain the person’s pain.

Common Types of Disc Injuries

Annular Tear or Annular Fissure

An annular fissure is a split within the disc’s outer ring. It may be caused by gradual wear, repeated strain, or sudden trauma.

Some annular fissures do not cause symptoms. Others may allow inflammatory chemicals from inside the disc to irritate nearby tissues and nerves. This may create deep back pain, muscle guarding, or pain that becomes worse with sitting, bending, lifting, coughing, or sneezing.

Medical imaging experts often prefer the term “annular fissure” instead of “annular tear.” The word “tear” may suggest that the finding was definitely caused by one traumatic event, while a fissure can also develop over time (Fardon et al., 2014).

Disc Protrusion

A disc protrusion is a focused herniation in which part of the disc pushes outward, but the base of the displaced material remains wider than the portion extending away from the disc.

A protrusion may look like a bump on an MRI. It may cause no symptoms, or it may narrow the spinal canal or the opening where a nerve exits.

The severity depends on:

  • The size and location of the protrusion
  • Whether a nerve is compressed
  • The amount of inflammation
  • The patient’s symptoms
  • The presence of weakness or loss of function

A smaller protrusion in the wrong location may cause more pain than a larger protrusion that does not contact a nerve.

Disc Extrusion

A disc extrusion occurs when the inner disc material pushes farther through an opening in the outer ring. The portion outside the disc may be wider than the opening connecting it to the remaining disc.

Extrusions may create stronger inflammation and more direct pressure on a spinal nerve. Symptoms may include sharp leg or arm pain, numbness, tingling, muscle weakness, or loss of reflexes.

An extrusion sounds serious, but it does not always require surgery. Some extruded disc material may decrease in size as the body gradually breaks it down. The decision to use conservative care, injections, or surgery depends more on the symptoms and neurological findings than on the MRI wording alone (Dydyk et al., 2023).

Disc Sequestration

A sequestration is a more advanced extrusion. A piece of disc material separates from the main disc and becomes a free fragment.

The fragment may move within the spinal canal and irritate a nerve. This injury requires close evaluation, especially when the patient has increasing weakness, major numbness, or bowel and bladder changes.

Bulging Disc

A bulging disc is not exactly the same as a focal herniation. A bulge usually involves a wider portion of the disc’s outer border. Disc bulges are often related to aging and loss of disc hydration, although trauma may make a previously silent bulge painful.

Disc protrusions and extrusions are focused herniations, while a bulge affects a broader area of the disc (Fardon et al., 2014; Van, n.d.).

Can Regenerative Therapy Repair a Herniated Disc?

Regenerative medicine attempts to support the body’s healing response. However, “regenerative” does not mean that every damaged disc can be completely rebuilt.

Treatment success may depend on:

  • The type of herniation
  • The size and location of the injury
  • The severity of the annular fissure
  • The length of time symptoms have been present
  • The patient’s age and general health
  • Smoking, diabetes, and other health risks
  • The amount of disc degeneration
  • The presence of nerve compression
  • Participation in rehabilitation

Regenerative treatment should not be promoted as a guaranteed cure. The goal may be to reduce pain, calm inflammation, improve function, or support healing around the injured area.

Platelet-Rich Plasma for Disc Pain

Platelet-rich plasma, or PRP, is made from a sample of the patient’s own blood. The blood is placed in a centrifuge to create a solution with a higher concentration of platelets.

Platelets contain growth factors and signaling proteins involved in normal tissue healing. Depending on the diagnosis, PRP may be placed into the disc, around irritated spinal nerves, or into damaged supporting ligaments and joints.

Studies of intradiscal PRP have reported improvements in pain and physical function in some patients with disc-related lower back pain. However, the studies use different PRP preparations, injection methods, and patient selection rules. Some studies have shown improvement, while others have found little difference compared with a control injection (Machado et al., 2023; Pan et al., 2026).

PRP may be more reasonable for a stable disc injury with ongoing disc-related pain than for a severe extrusion causing progressive nerve damage. It should be viewed as one part of a complete treatment plan rather than a replacement for proper diagnosis and rehabilitation.

Platelet-Fibrin Products

Platelet-fibrin products, sometimes called PFP or platelet-rich fibrin, are related to PRP. They contain platelets within a fibrin network.

Fibrin is part of the body’s normal clotting and healing system. It may act as a temporary framework that holds platelets and signaling proteins near an injured area for a longer period.

Platelet-fibrin preparations are being explored for tissue healing, nerve-related pain, and surgical recovery. However, there is much less clinical research on PFP for nonsurgical disc herniations than there is for PRP. Preparation methods also vary between clinics.

Patients should ask:

  • What product is being used?
  • Is it made from their blood?
  • Where will it be injected?
  • Is imaging guidance used?
  • What evidence supports the procedure?
  • What are the risks and alternatives?

Microfragmented Adipose Tissue

Microfragmented adipose tissue, or MFAT, uses a small amount of the patient’s own fat tissue. The tissue is collected, processed, and placed into a damaged area.

MFAT contains structural tissue, blood vessel-supporting cells, and signaling substances that may help control inflammation and support healing. Most strong clinical research has focused on joint conditions such as knee arthritis. Evidence for placing MFAT into or around spinal discs remains limited.

MFAT should not automatically be described as a proven stem cell cure. The U.S. Food and Drug Administration states that regenerative products marketed for orthopedic conditions, including disc disease and back pain, may require FDA review and may not be approved for those uses. Patients should receive a clear explanation of a product’s regulatory status before treatment (U.S. Food and Drug Administration, 2021).

Can IV Infusions Heal a Herniated Disc?

IV infusions do not push a herniated disc back into place or close a major annular tear.

A medically necessary IV infusion may help correct dehydration, replace a documented nutrient deficiency, or deliver medication for a specific condition. In those situations, IV therapy may support the patient’s overall health during recovery.

However, evidence does not show that general vitamin infusions directly repair disc tissue. Reviews have found limited proof that wellness IV vitamin treatments benefit people who already have normal nutrition and vitamin levels (Alangari et al., 2025).

IV therapy should therefore be considered supportive care when there is a clear medical reason—not a primary treatment for a protrusion, extrusion, or annular fissure.

How Integrative Chiropractic Care Fits Into Recovery

Integrative chiropractic care focuses on movement, mechanical stress, muscle balance, posture, and physical function. It does not “pop” a herniated disc back into place.

Depending on the examination, chiropractic treatment may include:

  • Gentle spinal mobilization
  • Carefully selected adjustments
  • Flexion-distraction or decompression methods
  • Soft-tissue therapy
  • Posture correction
  • Core stabilization
  • Nerve-mobility exercises
  • Strength and flexibility training
  • Work and lifting instruction
  • Gradual return-to-activity plans

These treatments may help improve joint motion, reduce muscle guarding, and restore movement patterns that became limited after an accident. Research suggests that spinal manipulation may help selected patients with lumbar radiculopathy, although treatment must be matched to the individual and the quality of evidence varies (Ghasabmahaleh et al., 2021; Trager et al., 2022).

Forceful manipulation may not be appropriate when a patient has an unstable fracture, severe osteoporosis, spinal cord compression, progressive weakness, cauda equina symptoms, or another surgical emergency. Imaging and medical referral may be needed before manual care begins.

An Integrated El Paso Treatment Team

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides chiropractic, functional medicine, personal injury, and rehabilitation services.

His published clinical observations emphasize that disc injuries should not be managed by focusing only on the MRI. The patient’s movement, neurological function, pain pattern, physical demands, nutrition, and recovery goals must also be considered. His approach combines conservative spine care with progressive rehabilitation and referrals when a condition falls outside the appropriate scope of treatment.

Dr. Jimenez works with Dr. Maria Guadalupe Cardenas, MD, a board-certified internal medicine physician with more than 40 years of experience. Practice materials identify Dr. Cardenas as Medical Director and Collaborative Physician, with NPI number 1164426749 and Texas medical license J2933.

In this multidisciplinary model:

  • Dr. Jimenez evaluates spinal movement, musculoskeletal injuries, rehabilitation needs, and functional health concerns.
  • Dr. Cardenas provides medical direction and internal medicine oversight.
  • The clinical team coordinates personal injury care, functional medicine, rehabilitation, diagnostic testing, and referrals.
  • Treatment decisions can be reviewed from both medical and mechanical points of view.

This coordinated approach can be valuable because a patient injured in a crash or workplace accident may have more than one problem. Disc damage may occur together with muscle strains, ligament injuries, joint restrictions, nerve irritation, headaches, sleep problems, inflammation, or existing health conditions.

When Is Surgery or Emergency Care Needed?

Most disc herniations do not require immediate surgery. Conservative treatment is often tried first when the patient is medically stable and neurological function is not getting worse.

Urgent evaluation is needed for:

  • New loss of bladder or bowel control
  • Numbness around the groin or inner thighs
  • Rapidly increasing arm or leg weakness
  • Difficulty walking that is becoming worse
  • Signs of spinal cord compression
  • Severe pain with fever or unexplained weight loss
  • Pain after major trauma with a possible fracture

These symptoms may indicate cauda equina syndrome, spinal cord injury, infection, fracture, or another serious condition. Regenerative injections or chiropractic treatment should not delay emergency evaluation (Dydyk et al., 2023).

The Bottom Line

Disc protrusions, extrusions, annular fissures, and separated disc fragments may occur after motor vehicle accidents and workplace injuries. The MRI diagnosis is important, but treatment decisions should also be based on pain, nerve function, physical limitations, and the patient’s overall health.

PRP may reduce pain and improve function in selected patients with disc-related pain, but research results remain mixed. Platelet-fibrin products and MFAT are emerging options with less disc-specific evidence. IV infusions may support a documented medical need but are not proven to repair a herniated disc.

Integrative chiropractic care and rehabilitation may help restore movement, decrease mechanical stress, and rebuild strength. The safest plan is often a coordinated program that combines conservative care, medical oversight, imaging, rehabilitation, and specialist referral when needed.

Herniated Disc Rehabilitation | El Paso, Tx

References

Alangari, A., et al. (2025). To IV or not to IV: The science behind intravenous vitamin therapy.

Dydyk, A. M., Ngnitewe Massa, R., & Mesfin, F. B. (2023). Disk herniation. StatPearls Publishing.

Fardon, D. F., et al. (2014). Lumbar disc nomenclature: Version 2.0. The Spine Journal, 14(11), 2525–2545.

Ghasabmahaleh, S. H., et al. (2021). Spinal manipulation for subacute and chronic lumbar radiculopathy. The American Journal of Medicine, 134(1), 135–141.

Machado, E. S., et al. (2023). Systematic review of platelet-rich plasma for low back pain. Biomedicines, 11(9), 2404.

Naples Regenerative Institute. (n.d.). Can regenerative medicine repair my herniated disc?

Open Wellness PDX. (n.d.). What is regenerative injection therapy? A complete guide to PRP, prolotherapy, and perineural injection

Orthobiologics Associates. (n.d.). PRP for herniated disc: Everything you need to know

Pan, X., et al. (2026). Intradiscal platelet-rich plasma for discogenic low back pain. Scientific Reports.

Trager, R. J., et al. (2022). Association between chiropractic spinal manipulation and lumbar discectomy in adults with lumbar disc herniation and radiculopathy.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

Van, L. (n.d.). Types of disc injuries. Absolute Injury and Pain Physicians.

Insomnia: What to Know About Integrative Chiropractic Care

Find effective strategies for integrative chiropractic care for insomnia to help you achieve better sleep and wellness.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this comprehensive educational post, I guide you through an easy-to-understand journey into the world of insomnia: why it happens, how it affects the brain and body, and what truly works to restore healthy sleep. Drawing on the latest findings from leading researchers and my clinical experience in integrative care, I explain the neurophysiology of sleep, including the roles of circadian rhythm, sleep-wake homeostasis, adenosine, melatonin, histamine, and orexin; the architecture of non-REM and REM sleep; the glymphatic system’s nighttime waste clearance; and sleep’s impact on neuroplasticity, cognition, mood, metabolism, and disease risk.

I present modern, evidence-based strategies such as Cognitive Behavioral Therapy for Insomnia (CBT-I), sleep hygiene, stimulus control, sleep restriction, and pharmacologic options (e.g., dual orexin receptor antagonists, low-dose doxepin, melatonin agonists), explaining why and when to use each. I also show how integrative chiropractic care fits into a multidisciplinary model that addresses pain, autonomic regulation, and functional imbalances contributing to insomnia.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I collaborate with our Medical Director, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who brings over 40 years of clinical experience to provide medical oversight and co-management. Together, we integrate chiropractic care, internal medicine, functional medicine, rehabilitation, and personal injury services—aligning research-driven methods with personalized treatment to help you reclaim restorative sleep and overall health.

Our Multidisciplinary, Integrative Care Model in El Paso, Texas

I practice at Injury Medical Clinic PA—also known as Mission Plaza Injury Medical Clinic—in El Paso, Texas. My credentials (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST) enable me to assess health structurally, neurologically, metabolically, and functionally. Our model is collaborative at its core.

  • Medical Director and Collaborative Physician: Dr. Maria Guadalupe Cardenas, MD
    • Board Certified in Internal Medicine
    • NPI #1164426749
    • Texas MD License #J2933
    • Over 40 years of experience as an internist
    • Provides medical oversight to ensure safety, diagnostic accuracy, and evidence-based treatment alignment
  • Integrated Services We Provide
    • Integrative chiropractic care (structural alignment, neuromuscular optimization, autonomic balance)
    • Internal medicine evaluation and management (medical conditions, medication oversight, specialty referrals)
    • Functional medicine (root-cause analysis: hormonal, nutritional, inflammatory, gut-related, and metabolic drivers)
    • Personal injury care (acute and post-acute strategies for pain and sleep restoration)
    • Physical rehabilitation (movement retraining, pain modulation, and sleep-supportive exercise planning)
    • Nutritional counseling (metabolic support, circadian-friendly nutrition timing)

This multidisciplinary setup—an MD providing medical direction alongside a chiropractor—reflects best-practice standards in integrative and injury care clinics. It allows us to co-manage complex conditions like chronic insomnia safely, comprehensively, and efficiently.

The Pervasive Challenge of Modern Insomnia

In primary care and integrative settings, insomnia is commonplace and often chronic. Research estimates that between 20% and 50% of patients in primary care environments struggle with persistent insomnia that undermines health, productivity, and well-being (Morin & Benca, 2012). Yet insomnia remains under-recognized and undertreated.

  • Under-reporting: Only 25–50% of patients with insomnia raise sleep issues during medical visits.
  • Under-assessment: Approximately 75% of patients report that sleep was not discussed at their most recent appointment.

This disconnect is especially alarming in a modern lifestyle loaded with late-night screen exposure and high stress, both of which disrupt circadian rhythms and suppress melatonin. As clinicians, we must treat sleep as a vital sign—routinely screened, measured, and supported (Grandner, 2020).

How Much Sleep We Need Across the Lifespan

Sleep needs are age-dependent and biologically grounded (Hirshkowitz et al., 2015).

  • School-Aged Children (6–13 years): 9–11 hours
  • Teenagers (14–17 years): 8–10 hours
  • Adults (18–64 years): 7–9 hours
  • Older adults (65+ years): 7–8 hours

Consistently sleeping below these ranges is associated with short-term impairment and long-term health risks, including cardiovascular disease, diabetes, depression, and neurodegeneration.

Who Is at Risk for Insomnia

Insomnia emerges from a unique blend of biological, psychological, social, and environmental factors. Recognizing risk factors helps prevent, assess, and tailor treatment.

  • Advancing age: Changes in sleep architecture and increased medical comorbidities
  • Female gender: Hormonal transitions (peri- and postmenopause) increase susceptibility
  • Military service: Irregular schedules, deployment stress, and PTSD risk
  • Lower socioeconomic status and homelessness: Chronic stress, food insecurity, unstable environments
  • Poor health and comorbidities: Chronic pain, cardiovascular, respiratory, and metabolic conditions
  • Mental illness: Anxiety, depression, ADHD, bipolar disorder—bidirectional relationships with sleep
  • Traumatic brain injury (TBI): Disruption of sleep-regulating neural networks
  • Alcohol use disorder: Initial sedation with long-term REM suppression, fragmentation, and neurotoxicity

In my practice, these patterns frequently present, and they respond best to integrated approaches that address both medical and functional contributors.

Sleep Physiology: The Brain’s Master Clock and Sleep-Wake Dynamics

Understanding sleep’s neurophysiology makes insomnia treatment rational and effective. Two core processes govern our sleep-wake cycle: circadian rhythm and sleep-wake homeostasis (Saper, Scammell, & Lu, 2005).

Circadian Rhythm: The Master Timekeeper

  • The suprachiasmatic nucleus (SCN) in the hypothalamus acts as the master clock, synchronizing bodily systems to the 24-hour light-dark cycle.
  • Light input through retinal pathways informs the SCN, influencing alertness systems by day and melatonin release at night.
  • Evening exposure to blue light (screens, LEDs) suppresses melatonin and delays sleep timing—one of the top modern saboteurs of healthy sleep.

Sleep-Wake Homeostasis: The Pressure to Sleep

  • The longer we are awake, the stronger the drive to sleep.
  • Adenosine accumulates in the brain during wakefulness, inhibiting arousal circuits and stimulating sleep-promoting neurons (VLPO).
  • Caffeine blocks adenosine receptors, preventing the sleepiness signal. Mis-timed caffeine can destabilize sleep-wake homeostasis for hours (Porkka-Heiskanen & Kalinchuk, 2011).

Melatonin: The “Hormone of Darkness”

  • Melatonin signals nighttime and reduces alertness, body temperature, and readiness for wakefulness.
  • Correctly timed melatonin can help align circadian rhythms, particularly for delayed sleep phase, shift work, and jet lag.

Brain Energy and Sleep: Glycogen, Glymphatic Clearance, and Neuroplasticity

Sleep is an active state that restores brain energy, clears metabolic waste, and supports learning and memory.

Glycogen Restoration

  • Astrocyte glycogen stores deplete during wakefulness and replenish during deep sleep.
  • Adequate slow-wave sleep ensures neurons have energy reserves for optimal function the next day.

The Glymphatic System: Nightly Brain Cleanup

  • During deep sleep, the brain’s glymphatic system flushes metabolic byproducts via CSF flowing through perivascular pathways (Xie et al., 2013).
  • Key proteins cleared include beta-amyloid (Alzheimer’s), tau (neurofibrillary tangles), and alpha-synuclein (Parkinson’s, Lewy body dementia).
  • Chronic insufficient deep sleep can lead to toxic protein accumulation over years—linking insomnia to neurodegeneration risk.

Neuroplasticity and Synaptogenesis

  • Sleep supports synaptic homeostasis: strengthening important connections formed during the day and pruning unnecessary ones.
  • REM and deep NREM stages facilitate memory consolidation, learning, and emotional processing—critical for cognitive resilience.

Sleep Architecture: The Four Stages and Why They Matter

Sleep cycles through non-REM (NREM) Stages 1–3 and REM multiple times nightly, typically every ~90 minutes. Each stage plays a distinct role.

  • NREM Stage 1 (1–10 minutes): Light, easily interrupted sleep; transition from wakefulness
  • NREM Stage 2 (30–60 minutes): Parasympathetic shift, core temperature drops, sleep spindles and K-complexes support stability and memory processes
  • NREM Stage 3 (20–40 minutes): Slow-wave sleep (delta activity), deep physical restoration, growth hormone release, immune activity, pain modulation
  • REM (10–60 minutes): Active brain with muscle atonia, dreaming, procedural and emotional memory consolidation

From an integrative chiropractic and functional perspective, Stage 3 is indispensable for tissue repair, inflammatory modulation, and pain recovery—essential in personal injury care and chronic musculoskeletal conditions.

The Brain’s Wakefulness Systems: Histamine and Orexin

Two neurotransmitter systems heavily influence arousal and sleep stability:

  • Histamine: Tuberomammillary nucleus neurons promote wakefulness. Older antihistamines that cross the blood-brain barrier (e.g., diphenhydramine) induce drowsiness by blocking histamine, but are not ideal long-term sleep solutions due to anticholinergic risks.
  • Orexin (Hypocretin): Lateral hypothalamic neurons stabilize wakefulness. Loss of orexin neurons causes narcolepsy. Modern DORAs (dual orexin receptor antagonists) gently reduce wake signaling to promote sleep without GABAergic sedation (Neubauer, 2022).

Blue Light: A Modern Circadian Disruptor

Evening exposure to blue wavelengths from phones, tablets, TVs, and LEDs confuses the SCN’s time signals:

  • Suppression of melatonin release
  • Activation of arousal circuits
  • Delayed sleep onset and fragmented sleep

A “digital sunset” 1–2 hours before bed is one of the most potent behavioral levers to recover healthy sleep timing.

Why Untreated Insomnia Is a Serious Health Condition

Insomnia is not simply “being tired.” It disrupts multiple systems:

  • Cognitive deficits: attention, memory, executive function, processing speed
  • Mood dysregulation: anxiety, depression, irritability; increased suicide risk (Riemann, Krone, Wulff, & Nissen, 2020)
  • Injury risk: impaired motor coordination, reaction time; increased work errors and motor vehicle accidents
  • Immune dysregulation: elevated inflammatory cytokines (IL-6, CRP), reduced NK cells, lower vaccine antibody titers (Besedovsky, Lange, & Born, 2012; Irwin, 2015)
  • Metabolic instability: insulin resistance, dyslipidemia, appetite hormone shifts (ghrelin up, leptin down), weight gain and diabetes risk
  • Cardiovascular and cerebrovascular strain: hypertension, atherosclerosis, stroke
  • Neurodegeneration risk: inadequate glymphatic clearance, increased Alzheimer’s disease risk and all-cause mortality in older adults

Given these risks, routine sleep assessment is an essential part of modern healthcare (Grandner, 2020).

Making Sleep a Vital Sign in Clinical Practice

I integrate sleep assessment into initial encounters using validated tools:

  • Insomnia Severity Index (ISI): Seven-item measure of onset/maintenance difficulties, early awakenings, distress, and impairment
  • SATED: Satisfaction, Alertness, Timing, Efficiency, Duration—simple screening domains

A positive screen calls for deeper evaluation using a structured approach and sleep diaries (preferred over consumer wearables, which often lack clinical accuracy and can increase anxiety).

Comprehensive Sleep Evaluation: A Narrative, Patient-Centered Approach

I use OLD CARTS (adapted for sleep) to structure the evaluation:

  • Onset: When did insomnia begin? Triggers (stress, meds, illness)?
  • Location: Sleep environment (noise, light, comfort)
  • Duration: Acute vs. chronic (>3 months)
  • Characteristics: Onset vs. maintenance vs. early awakenings
  • Aggravating/Alleviating factors: Blue light, caffeine, stress, alcohol; relaxation routines
  • Radiation: Impact on functioning (work, family, safety)
  • Timing: Nightly patterns, variability
  • Severity: Distress and impairment, quantified

I also review health conditions and medications that fragment sleep: pain syndromes, asthma/COPD, GERD, RLS, Parkinson’s, dementia, anxiety, depression, PTSD, thyroid disease, diabetes (nocturia/hypoglycemia), menopause (hot flashes), heart failure (orthopnea), antidepressants/stimulants/steroids/beta-blockers/decongestants.

Balancing Body and Metabolism | El Paso, Tx (2023)

When to Refer to Sleep Medicine

Two common scenarios benefit from specialist evaluation:

  • Suspected Sleep Apnea: Loud snoring, choking/gasping events, witnessed apneas, nonrefreshing sleep, morning headaches, dry mouth, nocturia, daytime sleepiness—especially in patients with obesity or large neck circumference. Polysomnography is indicated.
  • Treatment-Resistant Insomnia: Failure of multiple evidence-based therapies warrants advanced diagnostics and co-management.

Integrative Chiropractic Care in Insomnia Treatment

Chiropractic care fits into insomnia management through structural and neurological mechanisms:

  • Pain modulation: Chronic pain is a top disruptor of sleep. Targeted adjustments, soft tissue work, and rehabilitation reduce nociceptive input and allow deeper Stage 3 sleep.
  • Autonomic regulation: Spinal and rib mechanics influence respiratory patterns and vagal tone. Adjustments can help shift sympathetic “fight-or-flight” dominance toward parasympathetic “rest-and-digest,” supporting sleep onset and maintenance.
  • Movement optimization: Functional rehabilitation refines postural dynamics and breath mechanics, reducing nocturnal discomfort and arousals.

Clinical observations from my practice (as reflected across my publications and case experiences on Sciatica Clinic and LinkedIn) show that integrating chiropractic and functional medicine with CBT-I and medical oversight creates durable improvements in pain and sleep quality:

  • Improved sleep continuity after thoracic mobility and diaphragmatic breathing retraining
  • Reduced nocturnal arousals in patients with cervical and TMJ-related discomfort following specific adjustments and stabilization exercises
  • Enhanced tolerance for sleep restriction therapy when musculoskeletal pain is concurrently addressed

Reference clinical insights:

Behavioral Foundations: Relaxation, Stimulus Control, and Sleep Restriction

Behavioral therapies form the backbone of modern insomnia care. They not only reduce symptoms but also rewire sleep-related conditioning.

Relaxation Techniques: Calming Hyperarousal

Insomnia often involves an overactive sympathetic system. My go-to methods:

  • Mindfulness meditation: Observing thoughts without judgment reduces rumination and sleep anxiety.
  • Guided imagery: Creating a multisensory calming scene distracts from worry, lowering physiological arousal.
  • Progressive muscle relaxation (PMR): Tension-release cycles heighten awareness of relaxation, easing somatic hyperarousal.
  • Diaphragmatic breathing: Slow, low, nasal breathing activates the vagus nerve, stabilizing heart rate and reducing cortisol.

These practices dovetail with chiropractic strategies in autonomic regulation and with rehabilitation exercises that encourage breath and posture balance. Digital tools like CBTI Coach, Headspace, and Calm can help patients practice consistently.

Stimulus Control: Reconditioning the Bed-Sleep Association

Five rules to re-link the bed with sleep:

  1. Only go to bed when genuinely sleepy.
  2. Use the bed only for sleep and sex—no TV, phones, reading, or worrying.
  3. If not asleep within 15–20 minutes, get out of bed. Do something quiet in dim light until sleepy returns; repeat as needed.
  4. Maintain a consistent wake time every day.
  5. Avoid napping.

This method breaks the cycle of frustrated wakefulness and anxiety in bed.

Sleep Restriction: Consolidating Sleep

Sleep efficiency is the percentage of time in bed spent asleep. In insomnia, it is often low due to prolonged wakefulness in bed. Sleep restriction improves efficiency by limiting time in bed to approximate actual sleep time, then gradually expanding it:

  • Determine average sleep time from diaries (e.g., 6 hours).
  • Restrict time in bed to 6 hours with a fixed wake time.
  • As efficiency rises (>85–90%), increase time in bed by 15–20 minutes.
  • Repeat until rested without sacrificing efficiency.

Evidence shows sleep restriction is one of the most powerful methods in CBT-I, but it requires coaching and accountability (Edinger et al., 2021).

Sleep Hygiene: Everyday Rules That Matter

Sleep hygiene supports circadian alignment and reduces sleep pressure conflicts.

  • Bedroom environment: Cool, dark, quiet; blackout curtains, white noise, and comfortable bedding
  • Minimize napping: If necessary, keep under 30–60 minutes and not late-afternoon
  • Caffeine: Avoid after ~2 PM; individualize based on sensitivity
  • Alcohol: Avoid near bedtime; it fragments sleep and suppresses REM, causing unrefreshing nights
  • Nicotine: Stimulant; avoid near bedtime and overnight
  • Consistent schedule: Regular sleep and wake times, even on weekends
  • Exercise timing: Morning or afternoon for vigorous activity; gentle stretching/yoga in the evening
  • Wind-down ritual: Warm bath, physical book, journaling, prayer/meditation
  • Reduce screen time: Digital sunset 1–2 hours before bed
  • Clock control: Avoid clock-watching; cover or remove bedside clocks

These habits become particularly effective when combined with stimulus control and sleep restriction.

CBT-I: The Gold Standard of Insomnia Treatment

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line, evidence-based treatment that provides durable outcomes and minimal side effects (Edinger et al., 2021; Trauer, Qian, Doyle, Rajaratnam, & Cunnington, 2015).

  • Cognitive work: Identify and reframe distortions (catastrophizing, unrealistic expectations, misattribution). Shift from “forcing sleep” to “allowing sleep.”
  • Behavioral strategies: Sleep hygiene, relaxation, stimulus control, sleep restriction, and tailored homework reinforce new patterns.
  • Durability: Skills persist after therapy ends, reducing relapse risk.
  • Accessibility: Digital CBT-I can bridge gaps when access to credentialed therapists is limited.

In integrative practice, CBT-I blends seamlessly with chiropractic care (reducing pain), functional medicine (resolving inflammatory and hormonal drivers), and medical oversight (addressing comorbidities).

Pharmacologic Options: Modern, Mechanism-Driven Choices

Medications are adjuncts, not replacements, for behavioral care. When used, I emphasize the lowest effective dose and safety.

Key Counseling Points

  • Use the lowest effective dose as little as needed.
  • Risks: Falls, confusion, complex sleep behaviors (sleepwalking, sleep-driving, sleep-eating), tolerance and dependence (class-specific).
  • Avoid mixing with alcohol, cannabis, muscle relaxants, opioids.
  • Avoid chronic OTC antihistamines (diphenhydramine) due to anticholinergic risks and links to cognitive impairment.

Neurochemical Targets

  • GABA: Inhibitory; benzodiazepines and Z-drugs enhance GABA-A signaling (sedative hypnotics).
  • Histamine: Wakefulness; low-dose doxepin blocks H1 receptors, aiding sleep maintenance.
  • Orexin: Wakeful stabilizer; DORAs block orexin receptors to reduce arousal without GABAergic sedation.
  • Melatonin: Circadian signal; melatonin supplement and ramelteon (prescription melatonin receptor agonist) support sleep onset and circadian alignment.

Antidepressants Used for Sleep

  • Doxepin (Silenor), 3–6 mg: Potent antihistamine effect at low doses; best for sleep maintenance; low dependency risk; common side effect is next-morning drowsiness.
  • Off-label agents used in practice: Trazodone, mirtazapine, amitriptyline (evidence mixed; clinical judgment required).

Benzodiazepines

  • Examples: Temazepam, triazolam, lorazepam, estazolam, flurazepam
  • Pros: Effective, affordable generics
  • Cons: High risks—tolerance, dependence, respiratory depression, falls and confusion—use short-term only and avoid in older adults or cognitive impairment

Z-Drugs (Benzodiazepine Receptor Agonists)

  • Examples: Zolpidem (IR and CR), eszopiclone, zaleplon
  • Pros: Effective; varied onset/duration profiles; generic options
  • Cons: Highest risk of complex sleep behaviors; use with caution and clear counseling

Dual Orexin Receptor Antagonists (DORAs)

  • Examples: Suvorexant (Belsomra), lemborexant (Dayvigo), daridorexant (Quviviq)
  • Mechanism: Block orexin-1 and -2 receptors to gently reduce wakefulness signaling
  • Pros: Lower tolerance/dependence risk; effective for sleep maintenance; safe for longer-term use; promising in cognitive impairment populations
  • Cons: Cost and prior authorization; food delays absorption—avoid high-fat meals near dosing (Neubauer, 2022)

Melatonin and Melatonin Agonists

  • Melatonin supplement: 1–3 mg, 1–2 hours before bedtime; earlier for delayed sleep phase; choose high-quality, third-party-tested brands
  • Ramelteon (Rozerem): Selective MT1/MT2 agonist; no abuse potential; best for sleep onset and circadian issues
  • Pros: Excellent safety, suitable for minors and circadian misalignment
  • Cons: Supplements not FDA-regulated; variability in dosing and purity

Complementary Options

  • Magnesium, valerian, lavender: Evidence is limited and inconsistent; I approach with caution, prioritize proven therapies, and monitor closely if patients opt to trial these.

Case-Based Integrative Reasoning: Applying Evidence to Real Patients

Case 1: M.C.—Insomnia with a History of Addiction

  • Patient: 57-year-old man; depression, anxiety, hypertension, obesity; past alcohol use disorder (sober >15 years); difficulty with sleep onset and maintenance
  • Concerns: Avoids controlled substances; melatonin ineffective
  • Assessment priorities:
    • Sleep hygiene deep dive
    • Autonomic tone assessment and pain contributors
    • Obstructive sleep apnea risk—consider sleep study
    • Chiropractic evaluation of biomechanical factors affecting sleep (e.g., cervical, thoracic, rib mechanics; TMJ contribution)
  • Treatment plan:
    • Behavioral foundations: Stimulus control, sleep restriction, relaxation practices
    • Pharmacologic options aligned with safety:
      • Low-dose doxepin for maintenance
      • Ramelteon for sleep onset and circadian support
      • Educate about DORAs (low abuse potential compared to GABAergic agents) if needed
    • Integrative chiropractic care: Adjustments, soft tissue work, breathing retraining, rib mobility to improve autonomic balance and reduce pain
    • Functional medicine workup: Nutrients (magnesium, B vitamins), cortisol rhythm, glycemic control, gut health
    • Sleep study referral: Rule out sleep-disordered breathing

This plan honors his preferences, reduces risk, and treats root contributors—pain, autonomic dysregulation, metabolic stress—alongside evidence-based sleep therapies.

Case 2: C.P.—Insomnia in an Older Adult with Mild Cognitive Impairment

  • Patient: 70-year-old woman; chronic insomnia; mild cognitive impairment; recurrent depression; eczema; osteoporosis; using zolpidem 5 mg for ten weeks—tolerance and maintenance insomnia
  • Risks: Falls (osteoporosis), cognitive worsening, complex sleep behaviors
  • Assessment priorities:
    • Address day naps (2–3 hours)
    • Remove TV from bed, reinforce stimulus control
    • Manage eczema flares (dermatology collaboration; functional triggers)
    • Evaluate mood relapse
  • Treatment plan:
    • Reconsider medication:
      • Avoid increasing zolpidem dose—elevated risk
      • Consider zolpidem CR 6.25 mg cautiously or better: switch to DORA (e.g., lemborexant or daridorexant) with safer profile in older adults and cognitive impairment.
    • Behavioral strategies: Strict stimulus control, sleep restriction adapted for safety, minimize or eliminate naps
    • Integrative care: Chiropractic for pain reduction and autonomic regulation; functional medicine for inflammatory skin triggers; coordinated dermatology care
    • Depression management: Ensure mood support doesn’t conflict with sleep restoration strategies

This approach prioritizes safety, avoids exacerbation of cognitive and fall risks, and addresses behavioral and medical contributors to fragmented sleep.

Stepwise Treatment Strategy: Adjust, Switch Mechanisms, Collaborate

When initial plans don’t achieve sufficient improvement:

  • Optimize dose cautiously within safe limits
  • Switch mechanisms: From histamine-blocking to orexin antagonism or melatonin agonism, based on insomnia subtype (onset, maintenance, or mixed)
  • Collaborate and refer: Sleep medicine for primary sleep disorders; psychiatry for complex psychopharmacology; dermatology, endocrinology, or cardiology for comorbid triggers.

Polypharmacy is reserved for advanced, treatment-resistant cases and should combine different mechanisms (e.g., ramelteon for onset + low-dose doxepin for maintenance) under close supervision.

Long-Term Management and Safe Discontinuation

Insomnia care is a longitudinal process:

  • Monitor for tolerance, misuse, and side effects
  • Reinforce sleep hygiene at every visit; troubleshoot barriers
  • Prioritize CBT-I for enduring skills and relapse prevention
  • Taper hypnotics gradually to avoid rebound insomnia or withdrawal, unless severe adverse effects necessitate immediate discontinuation.

How Integrative Chiropractic Care Fits within Medical Oversight and Functional Medicine

At Injury Medical Clinic PA, I co-manage insomnia with Dr. Cardenas, ensuring medical conditions are properly diagnosed and treated while integrative strategies address the broader ecosystem of sleep health.

  • Chiropractic care:
    • Pain modulation and biomechanical correction to reduce nocturnal arousals
    • Autonomic balance via spinal and rib mechanics, diaphragmatic support, and vagal activation
    • Rehabilitation to improve posture, breathing, and movement patterns that support sleep comfort
  • Internal medicine oversight (Dr. Cardenas):
    • Screening and management of medical comorbidities (OSA, thyroid, diabetes, cardiovascular disease)
    • Pharmacologic safety and monitoring
    • Specialist referrals (sleep medicine, dermatology, psychiatry)
  • Functional medicine:
    • Identify root causes—hormonal imbalances, micronutrient deficiencies, inflammation, gut dysbiosis
    • Circadian-aligned nutrition and timing strategies
    • Personalized lifestyle plans with measurable outcomes

This synergy addresses insomnia from every angle—structural, neurological, metabolic, and behavioral—resulting in more consistent and durable recovery of restorative sleep.

Clinical Observations from Practice: What I See in Real-World Care

Across hundreds of cases in our clinic:

  • Patients with chronic musculoskeletal pain achieve deeper Stage 3 sleep after targeted adjustments, rib mobility work, and breath retraining—consistent with autonomic downregulation and pain relief mechanisms.
  • Sleep restriction adherence improves significantly when daytime pain is controlled; patients report fewer nighttime awakenings due to discomfort.
  • In delayed sleep phase patterns, precise melatonin timing combined with a digital sunset and morning light exposure produces meaningful circadian re-anchoring within 2–3 weeks.
  • DORAs provide reliable maintenance benefits and reduced next-day effects for older adults compared to Z-drugs, aligning with research on balance and cognition safety.
  • Addressing eczema and GERD flares reduces nocturnal pruritus and reflux-related arousals, allowing behavioral therapies to take hold.

For additional context and clinical commentary, see practice content and case insights:

Practical Sleep Playbook: Putting It All Together

  • Assess sleep as a vital sign using ISI/SATED and diaries
  • Identify subtype: onset, maintenance, early awakenings, mixed
  • Screen for apnea and medical contributors; refer as needed
  • Initiate CBT-I components: stimulus control, sleep restriction, relaxation
  • Enforce sleep hygiene and digital sunset; stabilize wake time
  • Integrate chiropractic care for pain and autonomic balance; add functional medicine analysis
  • Choose pharmacologic options matched to subtype and patient profile:
    • Sleep onset: Ramelteon, zaleplon, zolpidem IR (caution), melatonin timed properly
    • Sleep maintenance: Low-dose doxepin, DORA (e.g., daridorexant, lemborexant)
    • Mixed insomnia: DORA often preferred
  • Monitor safety and progress; adjust doses within limits; switch mechanisms if needed
  • Collaborate across disciplines; prioritize long-term CBT-I and taper medications

This roadmap reflects modern, evidence-based methods aligned with patient-centered care.

Conclusion: A Comprehensive, Integrative Path to Restorative Sleep

Insomnia affects the brain and body at every level—from synapses and hormones to cognition, mood, and metabolic health. Treating it effectively demands an integrative model that combines the best of behavioral science (CBT-I), neurophysiology-informed pharmacology, chiropractic care for pain and autonomic regulation, functional medicine to resolve root causes, and internal medicine oversight for safety and comorbidity management.

At Injury Medical Clinic PA in El Paso, Texas, I partner with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933; >40 years of experience) to deliver precisely this kind of care. Our multidisciplinary team aligns research-driven methods with real-world clinical experience—so patients not only sleep better, but also heal deeper, think clearer, and live healthier.

Restorative sleep is not a luxury. It is a biological necessity we can help you reclaim.

References

SEO Tags: insomnia, chronic insomnia, sleep deprivation, CBT-I, cognitive behavioral therapy for insomnia, sleep hygiene, stimulus control, sleep restriction, dual orexin receptor antagonists, DORA, doxepin, ramelteon, melatonin, glymphatic system, neuroplasticity, circadian rhythm, adenosine, orexin, histamine, REM sleep, deep sleep, sleep architecture, autonomic nervous system, chiropractic care for sleep, integrative chiropractic care, functional medicine for insomnia, personal injury and sleep, El Paso Texas, Dr. Alex Jimenez DC APRN FNP-BC CFMP IFMCP ATN CCST, Dr. Maria Guadalupe Cardenas MD NPI 1164426749 Texas J2933, internal medicine oversight, treatment-resistant insomnia, polypharmacy, sleep as a vital sign, medical director collaborative physician, Mission Plaza Injury Medical Clinic